assay_chembl_id,assay_description,canonical_smiles,document_journal,molecule_chembl_id,standard_value,IC50_uM,Activity
CHEMBL708902,Inhibition of LNCaP human prostate carcinoma cell proliferation,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,J Med Chem,CHEMBL428690,16,0.016,Yes
CHEMBL708033,Compound was evaluated for cytotoxicity against LNCaP prostate cancer cells,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCC#C[C@]3(O)CC[C@@]4(C)C5CCC6=CC(=O)CC[C@]6(C)[C@@]5(C)CC[C@@]43C)=C(C[C@H](C)C[C@H](OC)[C@@H](O)[C@H](C)/C=C(\C)C[C@@H]1OC(N)=O)C2=O,Bioorg Med Chem Lett,CHEMBL267716,200,0.2,Yes
CHEMBL708033,Compound was evaluated for cytotoxicity against LNCaP prostate cancer cells,COC1=C2C[C@H](C)C[C@H](OC)[C@@H](O)[C@H](C)/C=C(\C)C[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Bioorg Med Chem Lett,CHEMBL25891,40,0.04,Yes
CHEMBL710847,Compound was evaluated for cytotoxicity against LNCaP prostate cancer cells (AR dependent cells),COC1=C2C[C@H](C)C[C@H](OC)[C@@H](O)[C@H](C)/C=C(\C)C[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Bioorg Med Chem Lett,CHEMBL25891,40,0.04,Yes
CHEMBL708033,Compound was evaluated for cytotoxicity against LNCaP prostate cancer cells,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCC#C[C@]3(O)CC[C@@]4(C)C5CCC6=CC(=O)CC[C@]6(C)[C@@]5(C)CC[C@@]43C)=C(C[C@H](C)C[C@H](OC)[C@@H](O)[C@H](C)/C=C(\C)C[C@@H]1OC(N)=O)C2=O,Bioorg Med Chem Lett,CHEMBL263627,100,0.1,Yes
CHEMBL710847,Compound was evaluated for cytotoxicity against LNCaP prostate cancer cells (AR dependent cells),CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCC#C[C@]3(O)CC[C@@]4(C)C5CCC6=CC(=O)CC[C@]6(C)[C@@]5(C)CC[C@@]43C)=C(C[C@H](C)C[C@H](OC)[C@@H](O)[C@H](C)/C=C(\C)C[C@@H]1OC(N)=O)C2=O,Bioorg Med Chem Lett,CHEMBL263627,100,0.1,Yes
CHEMBL709608,Tested in vitro for anticancer activity against LNCaP cells,O=C1NC(O)C(F)=CN1[C@H]1C=C[C@@H](CO)O1,J Med Chem,CHEMBL355426,67800,67.8,No
CHEMBL709608,Tested in vitro for anticancer activity against LNCaP cells,O=c1[nH]c(=O)n([C@@H]2C=C[C@@H](CO)O2)cc1F,J Med Chem,CHEMBL2368322,85800,85.8,No
CHEMBL709608,Tested in vitro for anticancer activity against LNCaP cells,Nc1nc(=O)n([C@@H]2C=C[C@H](CO)O2)cc1F,J Med Chem,CHEMBL38700,55200,55.2,No
CHEMBL709608,Tested in vitro for anticancer activity against LNCaP cells,O=c1[nH]c(=O)n([C@@H]2C=C[C@H](CO)O2)cc1F,J Med Chem,CHEMBL169267,57200,57.2,No
CHEMBL708112,The compound was evaluated for cytotoxicity by assessing 3H thymidine uptake in LNCaP cell line,N[C@@H](Cc1ccc(O)cc1)C(=O)Nc1ccc(COC(=O)N(CCCl)CCCl)cc1,Bioorg Med Chem Lett,CHEMBL60067,33000,33,No
CHEMBL711002,The compound was evaluated for cytotoxicity by assessing 3H thymidine uptake in LNCaP cell line in presence of PSA (1 ug),N[C@@H](Cc1ccc(O)cc1)C(=O)Nc1ccc(COC(=O)N(CCCl)CCCl)cc1,Bioorg Med Chem Lett,CHEMBL60067,34000,34,No
CHEMBL708112,The compound was evaluated for cytotoxicity by assessing 3H thymidine uptake in LNCaP cell line,CN(CCCl)CCCl,Bioorg Med Chem Lett,CHEMBL427,64000,64,No
CHEMBL709607,Inhibition of cellular proliferation in LNCaP (prostate).,COc1ccc(CCN2CCC[C@H]2COCc2ccccc2)cc1,Bioorg Med Chem Lett,CHEMBL123879,33000,33,No
CHEMBL709605,Inhibition of calcium influx in LNCaP (prostate).,COc1ccc(CCN2CCC[C@H]2COCc2ccccc2)cc1,Bioorg Med Chem Lett,CHEMBL123879,100000,100,No
CHEMBL709605,Inhibition of calcium influx in LNCaP (prostate).,Clc1ccc(C(OC[C@@H]2CCCN2CCc2ccccc2)c2ccccc2)cc1,Bioorg Med Chem Lett,CHEMBL331233,30000,30,No
CHEMBL709605,Inhibition of calcium influx in LNCaP (prostate).,CN1CCC[C@H]1COC(c1ccccc1)c1ccc(Cl)cc1,Bioorg Med Chem Lett,CHEMBL122893,50000,50,No
CHEMBL709605,Inhibition of calcium influx in LNCaP (prostate).,COc1ccc(CCCN2CCC[C@H]2COC(c2ccccc2)c2ccc(Cl)cc2)cc1,Bioorg Med Chem Lett,CHEMBL123213,30000,30,No
CHEMBL709605,Inhibition of calcium influx in LNCaP (prostate).,COc1ccc(CCN2CCC[C@H]2COC(c2ccccc2)c2ccccc2)cc1,Bioorg Med Chem Lett,CHEMBL123718,30000,30,No
CHEMBL710893,Antiproliferative effect of compound on LNcaP cell line expressing wild-type p53,O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1,J Med Chem,CHEMBL1180,320,0.32,Yes
CHEMBL710893,Antiproliferative effect of compound on LNcaP cell line expressing wild-type p53,O=C(O)/C=C/c1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,J Med Chem,CHEMBL442016,120,0.12,Yes
CHEMBL698278,Cytotoxic concentration in prostate specific antigen (PSA) producing human LNCaP cells,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,Bioorg Med Chem Lett,CHEMBL917,69.2,0.0692,Yes
CHEMBL698278,Cytotoxic concentration in prostate specific antigen (PSA) producing human LNCaP cells,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)N1CCOCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N(C)C(C)C(=O)OCC1OC(n2cc(F)c(=O)[nH]c2=O)CC1O,Bioorg Med Chem Lett,CHEMBL409971,117,0.117,Yes
CHEMBL826439,Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 hr of incubation with compounds (1-100 uM),COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,J Med Chem,CHEMBL2,67460,67.46,No
CHEMBL827468,Antioxidant activity against formation of ROS was determined in t-BuOOH treated LNCaP cells after 24 hr of incubation with compounds (1-100 uM),COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC,J Med Chem,CHEMBL178923,83530,83.53,No
CHEMBL826439,Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 hr of incubation with compounds (1-100 uM),COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC,J Med Chem,CHEMBL178673,52620,52.62,No
CHEMBL826439,Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 hr of incubation with compounds (1-100 uM),COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC,J Med Chem,CHEMBL175934,49590,49.59,No
CHEMBL827468,Antioxidant activity against formation of ROS was determined in t-BuOOH treated LNCaP cells after 24 hr of incubation with compounds (1-100 uM),O=C(O)CCCC[C@@H]1CCSS1,J Med Chem,CHEMBL134342,54860,54.86,No
CHEMBL834395,Concentration required to inhibit proliferation of LNCaP prostate cancer cell lines,CCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O,Bioorg Med Chem Lett,CHEMBL184774,44700,44.7,No
CHEMBL834395,Concentration required to inhibit proliferation of LNCaP prostate cancer cell lines,CCCCCCCCCCNC(=O)[C@H](N)CO,Bioorg Med Chem Lett,CHEMBL1161669,31000,31,No
CHEMBL834395,Concentration required to inhibit proliferation of LNCaP prostate cancer cell lines,CCCCCCCCNC(=O)[C@H](COCc1ccccc1)NC(=O)CCCCCCC,Bioorg Med Chem Lett,CHEMBL186844,35000,35,No
CHEMBL827469,Antiproliferative activity was evaluated against human prostate LNCaP cancer cell lines using the sulforhodamine B (STB) assay,COc1ccc(NC(=O)CN2C(=O)CSC2c2ccccc2)c(OC)c1,Bioorg Med Chem Lett,CHEMBL364876,82500,82.5,No
CHEMBL827469,Antiproliferative activity was evaluated against human prostate LNCaP cancer cell lines using the sulforhodamine B (STB) assay,O=C(CN1C(=O)CSC1c1ccccc1)Nc1cccc2ccccc12,Bioorg Med Chem Lett,CHEMBL184760,31400,31.4,No
CHEMBL827469,Antiproliferative activity was evaluated against human prostate LNCaP cancer cell lines using the sulforhodamine B (STB) assay,O=C(CN1C(=O)CSC1c1ccccc1)Nc1cc(F)cc(F)c1,Bioorg Med Chem Lett,CHEMBL362116,24100,24.1,No
CHEMBL834114,Antiproliferative activity against human prostate cancer LNCaP cell line by sulforhodamine B assay,CCCCCCCCCCCCCCCCCCNC(=O)[C@@H]1CSC(c2cc(OC)c(OC)c(OC)c2)N1,Bioorg Med Chem Lett,CHEMBL188399,820,0.82,Yes
CHEMBL825132,Antiproliferative activity against prostate cancer LNCaP Cell line using sulforhodamine B(SRB) assay,CCCCCCCCCCCCCCCCCCNC(=O)[C@H]1CSC(c2ccc(OC)c(OC)c2)N1.Cl,J Med Chem,CHEMBL540876,850,0.85,Yes
CHEMBL825132,Antiproliferative activity against prostate cancer LNCaP Cell line using sulforhodamine B(SRB) assay,CCCCCCCCCCCCCCCCCCNC(=O)[C@H]1CSC(c2cc(OC)c(OC)c(OC)c2)N1.Cl,J Med Chem,CHEMBL556756,820,0.82,Yes
CHEMBL825132,Antiproliferative activity against prostate cancer LNCaP Cell line using sulforhodamine B(SRB) assay,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,J Med Chem,CHEMBL428647,2,0.002,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3)c1C2,J Med Chem,CHEMBL432219,600,0.6,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cccc(Nc2[nH]nc3c2Cc2cc(OC)c(OC)cc2-3)c1,J Med Chem,CHEMBL120634,5,0.005,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C)c3)c1C2,J Med Chem,CHEMBL331760,1,0.001,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Br)c3)c1C2,J Med Chem,CHEMBL120862,2,0.002,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,J Med Chem,CHEMBL120077,9,0.009,Yes
CHEMBL861469,Antiproliferative activity against human prostate tumor cell line LnCAP,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C(F)(F)F)c3)c1C2,J Med Chem,CHEMBL184948,255,0.255,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,CC(C)=CCC/C(C)=C/[C@H]1OC(=O)C[C@]12C[C@H](OC(=O)c1ccc(Br)cc1)C=CC2=O,J Med Chem,CHEMBL382137,940,0.94,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,CC(C)=CCC/C(C)=C/[C@H]1OC(=O)C[C@]12C[C@H](OC(=O)c1c(Cl)cccc1Cl)C=CC2=O,J Med Chem,CHEMBL201380,360,0.36,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,COc1cc(C(=O)O[C@@H]2C=CC(=O)[C@@]3(CC(=O)O[C@@H]3/C=C(\C)CCC=C(C)C)C2)cc(OC)c1OC,J Med Chem,CHEMBL380823,490,0.49,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,COc1cc(OC)cc(C(=O)O[C@@H]2C=CC(=O)[C@@]3(CC(=O)O[C@@H]3/C=C(\C)CCC=C(C)C)C2)c1,J Med Chem,CHEMBL199604,800,0.8,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,COc1ccc(C(=O)O[C@@H]2C=CC(=O)[C@@]3(CC(=O)O[C@@H]3/C=C(\C)CCC=C(C)C)C2)cc1OC,J Med Chem,CHEMBL199601,670,0.67,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,COc1cccc(OC)c1C(=O)O[C@@H]1C=CC(=O)[C@@]2(CC(=O)O[C@@H]2/C=C(\C)CCC=C(C)C)C1,J Med Chem,CHEMBL200132,450,0.45,Yes
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,CC(=O)O[C@@H]1C=CC(=O)[C@@]2(CC(=O)O[C@@H]2/C=C(\C)C/C=C/C(C)(C)O)C1,J Med Chem,CHEMBL201637,23950,23.95,No
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,C=C(C)C(O)CC/C(C)=C/[C@H]1OC(=O)C[C@]12C[C@H](OC(C)=O)C=CC2=O,J Med Chem,CHEMBL437511,27620,27.62,No
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,CC(=O)O[C@@H]1C=CC(=O)[C@@]2(CC(=O)O[C@@H]2/C=C(\C)CC[C@H]2OC2(C)C)C1,J Med Chem,CHEMBL197594,51820,51.82,No
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,C/C(=C\[C@H]1OC(=O)C[C@]12C[C@H](O)C=CC2=O)CC[C@H]1OC1(C)C,J Med Chem,CHEMBL383534,29560,29.56,No
CHEMBL859115,Cytotoxicity against human prostate carcinoma LNCaP cell line,CC(C)=CCC/C(C)=C/[C@H]1OC(=O)C[C@]12CC(=O)C=CC2=O,J Med Chem,CHEMBL201579,43380,43.38,No
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,Cc1cc(NC(=O)NC(=O)c2ccccc2N(C)C)ccc1Oc1ncc(Br)cn1,J Med Chem,CHEMBL306688,500,0.5,Yes
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,O=C(NC(=O)c1ccccc1[N+](=O)[O-])Nc1ccc(S(=O)(=O)c2ncc(Br)cn2)cc1,J Med Chem,CHEMBL377936,500,0.5,Yes
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,Nc1ccccc1C(=O)NC(=O)Nc1ccc(Sc2ncc(Br)cn2)cc1,J Med Chem,CHEMBL203996,500,0.5,Yes
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,Nc1ccccc1C(=O)NC(=O)Nc1ccc(Oc2ncc(Br)cn2)cc1,J Med Chem,CHEMBL208272,750,0.75,Yes
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,O=C(NC(=O)c1ccccc1[N+](=O)[O-])Nc1ccc(Sc2ncc(Br)cn2)cc1,J Med Chem,CHEMBL205487,50,0.05,Yes
CHEMBL861032,Cytotoxicity against human LnCaP cell line by MTT assay,O=C(NC(=O)c1ccccc1[N+](=O)[O-])Nc1ccc(Sc2ncccn2)cc1,J Med Chem,CHEMBL205622,500,0.5,Yes
CHEMBL860819,Antiproliferative activity against human LNCaP cells,Cc1ccc2c(c1C)CN(C(=O)N(C)C)C[C@@H]2c1cccc(O)c1,Bioorg Med Chem Lett,CHEMBL205786,807,0.807,Yes
CHEMBL866054,Antiproliferative activity against human LNCaP cell line,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CN)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL1627803,900,0.9,Yes
CHEMBL866054,Antiproliferative activity against human LNCaP cell line,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CNC(=O)CCCCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL1628023,600,0.6,Yes
CHEMBL866054,Antiproliferative activity against human LNCaP cell line,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CNC(=O)CCCCCNC(=O)OC(C)(C)C)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL1628016,600,0.6,Yes
CHEMBL866054,Antiproliferative activity against human LNCaP cell line,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CNC(=O)CCCCCN)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL1628060,600,0.6,Yes
CHEMBL866054,Antiproliferative activity against human LNCaP cell line,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL299613,500,0.5,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,COc1ccc(/C=C/C(=O)C(/C=C/CO)=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,J Med Chem,CHEMBL210241,200,0.2,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,COc1ccc(/C=C/C(=O)C(/C=C/C#N)=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,J Med Chem,CHEMBL210880,200,0.2,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,CCNC(=O)/C=C/C(C(=O)/C=C/c1ccc(OC)c(OC)c1)=C(O)\C=C\c1ccc(OC)c(OC)c1,J Med Chem,CHEMBL210608,600,0.6,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,CO/C(O)=C/C=C(C(=O)/C=C/c1ccc(OC)c(OC)c1)C(=O)/C=C/c1ccc(OC)c(OC)c1,J Med Chem,CHEMBL379614,400,0.4,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,CCO/C(O)=C/C=C(C(=O)/C=C/c1ccc(OC)c(OC)c1)C(=O)/C=C/c1ccc(OC)c(OC)c1,J Med Chem,CHEMBL212693,200,0.2,Yes
CHEMBL866631,Cytotoxicity against human LNCaP cell line,COc1ccc(/C=C/C(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1,J Med Chem,CHEMBL426862,21800,21.8,No
CHEMBL866631,Cytotoxicity against human LNCaP cell line,CCOC(=O)CC/C(C(C)=O)=C(O)\C=C\c1ccc(O)c(OC)c1,J Med Chem,CHEMBL211533,51500,51.5,No
CHEMBL853865,Cytotoxicity against human LnCaP cell line by MTT assay after 72 hrs,O=C(N/N=C/c1ccc2ccccc2n1)c1ccccc1,J Med Chem,CHEMBL385902,20000,20,No
CHEMBL853865,Cytotoxicity against human LnCaP cell line by MTT assay after 72 hrs,O=C(N/N=C/c1ccc2ccccc2n1)c1ccccc1O,J Med Chem,CHEMBL1162934,31000,31,No
CHEMBL911385,Cytotoxicity against androgen sensitive human LNCaP cells,COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1O,J Nat Prod,CHEMBL89905,150,0.15,Yes
CHEMBL911385,Cytotoxicity against androgen sensitive human LNCaP cells,COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC,J Nat Prod,CHEMBL63970,30,0.03,Yes
CHEMBL911385,Cytotoxicity against androgen sensitive human LNCaP cells,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,J Nat Prod,CHEMBL28941,56,0.056,Yes
CHEMBL911385,Cytotoxicity against androgen sensitive human LNCaP cells,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,J Nat Prod,CHEMBL61,31,0.031,Yes
CHEMBL919563,Antiproliferative activity against androgen-sensitive human LNCaP cells after 72 hrs by MTT test,COC1(c2cc(F)cc(OCc3cc(-c4ccccc4)n(-c4ccc(S(C)(=O)=O)cc4)n3)c2)CCOCC1,J Med Chem,CHEMBL423638,83400,83.4,No
CHEMBL919563,Antiproliferative activity against androgen-sensitive human LNCaP cells after 72 hrs by MTT test,COC1(c2cc(F)cc(OCc3cc(-c4ccccc4)n(-c4ccc(S(N)(=O)=O)cc4)n3)c2)CCOCC1,J Med Chem,CHEMBL374427,49700,49.7,No
CHEMBL919563,Antiproliferative activity against androgen-sensitive human LNCaP cells after 72 hrs by MTT test,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,J Med Chem,CHEMBL118,50400,50.4,No
CHEMBL917367,Cytotoxicity against human LNCap cells after 72 hrs by MTT assay,O=C(NNc1nc2cc(F)ccc2n2cccc12)c1cnccn1,Bioorg Med Chem,CHEMBL225542,400,0.4,Yes
CHEMBL917367,Cytotoxicity against human LNCap cells after 72 hrs by MTT assay,O=C(NNc1nc2cccc(F)c2n2cccc12)c1cnccn1,Bioorg Med Chem,CHEMBL223329,400,0.4,Yes
CHEMBL893658,Growth inhibition of human LNCaP cells after 3 days by MTT colorimetric assay,O=c1cc(CO)oc(C(Nc2ccccc2)c2ccccc2)c1O,Bioorg Med Chem,CHEMBL242708,20900,20.9,No
CHEMBL893658,Growth inhibition of human LNCaP cells after 3 days by MTT colorimetric assay,Cc1ccc(S(=O)(=O)Nc2ccc(C)cc2[N+](=O)[O-])cc1,Bioorg Med Chem,CHEMBL242923,39800,39.8,No
CHEMBL893658,Growth inhibition of human LNCaP cells after 3 days by MTT colorimetric assay,O=C(CNCCCc1ccccc1)c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL415256,26900,26.9,No
CHEMBL897060,Cytotoxicity against human LnCap cells after 4 days by MTT assay,O=c1c2ccccc2oc2cc(OCC3CO3)cc(O)c12,Bioorg Med Chem Lett,CHEMBL231904,93100,93.1,No
CHEMBL897060,Cytotoxicity against human LnCap cells after 4 days by MTT assay,O=c1c2ccccc2oc2cc(OCC(O)CBr)cc(O)c12,Bioorg Med Chem Lett,CHEMBL233367,64400,64.4,No
CHEMBL902979,Antiproliferative activity against human LnCAP cells after 72 hrs,N=C(N)NCc1ccccc1,J Med Chem,CHEMBL288640,43700,43.7,No
CHEMBL902979,Antiproliferative activity against human LnCAP cells after 72 hrs,N=C(N)NCCCCNCc1c2ccccc2cc2ccccc12,J Med Chem,CHEMBL238151,28200,28.2,No
CHEMBL902979,Antiproliferative activity against human LnCAP cells after 72 hrs,N=C(N)NCc1ccc2ccc3cccc4ccc1c2c34,J Med Chem,CHEMBL391612,93300,93.3,No
CHEMBL902979,Antiproliferative activity against human LnCAP cells after 72 hrs,N=C(N)NCc1ccc2c(c1)Cc1ccccc1-2,J Med Chem,CHEMBL236012,27500,27.5,No
CHEMBL902979,Antiproliferative activity against human LnCAP cells after 72 hrs,N=C(N)NCc1cccs1,J Med Chem,CHEMBL93064,64600,64.6,No
CHEMBL944011,Antiproliferation activity against human LnCap cells,Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl,J Med Chem,CHEMBL404630,170,0.17,Yes
CHEMBL944015,Androgen receptor degradation in human LnCAP cells,Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl,J Med Chem,CHEMBL404630,330,0.33,Yes
CHEMBL929984,Antiproliferative activity against human LNCaP cells after 72 hrs by MTS assay,CC(=O)c1cccc2c1C(=O)c1cccc(O)c1C2=O,Bioorg Med Chem Lett,CHEMBL256439,34100,34.1,No
CHEMBL929984,Antiproliferative activity against human LNCaP cells after 72 hrs by MTS assay,CC(=O)c1cccc2c1C(=O)c1c(O)cccc1C2=O,Bioorg Med Chem Lett,CHEMBL403374,31500,31.5,No
CHEMBL945773,Cytotoxicity against human LNCap cells after 24 hrs by SRB assay,C=CC[S+]([O-])SC,Bioorg Med Chem Lett,CHEMBL255815,29700,29.7,No
CHEMBL950966,Growth inhibition of human LNCap cells,CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12)CC,J Med Chem,CHEMBL272197,160,0.16,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCC(=O)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL260313,699,0.699,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCOCC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL411950,966,0.966,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCC(C(=O)O)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL410071,500,0.5,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCC(C(=O)OC)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL273038,506,0.506,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCN(CCCN3CCOCC3)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL408074,637,0.637,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCN(CCN3CCOCC3)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL271982,794,0.794,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCN(CCCN(C)C)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL271780,831,0.831,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCN(c3ccccc3)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL271184,953,0.953,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCN(C3CCN(C)CC3)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL271430,782,0.782,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(CCC#N)Cc2ccccc2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL405157,144,0.144,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CC(O)CO)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL409620,168,0.168,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(CCO)CCO)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL412076,131,0.131,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCCC(=O)O)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL272593,365,0.365,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CC(=O)OC(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL272281,174,0.174,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCCN2CCN(c3ccc(OC)cc3)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL405258,620,0.62,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCCN2CCOCC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL407215,595,0.595,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCCN2CCN(C)CC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL407214,465,0.465,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(CCCN(C)C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL272595,259,0.259,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12)CCCN(C)C,J Med Chem,CHEMBL272897,535,0.535,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL409427,751,0.751,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(CCCN(C)C)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL272816,919,0.919,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL410643,389,0.389,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C,J Med Chem,CHEMBL411907,573,0.573,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N2CCCC2)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL428873,257,0.257,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,CCCCN(C)/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12,J Med Chem,CHEMBL409251,203,0.203,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/NC(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL272190,40700,40.7,No
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(C)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL270746,189,0.189,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,COC[C@H]1OC(=O)/C(=C/N(CCO)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,J Med Chem,CHEMBL271190,128,0.128,Yes
CHEMBL950966,Growth inhibition of human LNCap cells,CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](O)C[C@]2(C)[C@@H](O)CC[C@@H]12)CC,J Med Chem,CHEMBL406655,710,0.71,Yes
CHEMBL936595,Antiproliferative activity against human LNCap by MTT assay,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,Bioorg Med Chem,CHEMBL27759,360,0.36,Yes
CHEMBL923783,Inhibition of cell proliferation in human LNCAP cells,NC(=O)c1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)cc1NC1CCOCC1,Bioorg Med Chem Lett,CHEMBL257334,700,0.7,Yes
CHEMBL953528,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(OC)c(/C=C/C(=O)/C=C/c2c(OC)cc(OC)cc2OC)c(OC)c1,Bioorg Med Chem Lett,CHEMBL492966,500,0.5,Yes
CHEMBL953528,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OS(N)(=O)=O)c(OC)c2)ccc1O,Bioorg Med Chem Lett,CHEMBL493990,20000,20,No
CHEMBL953528,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)Oc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O,Bioorg Med Chem Lett,CHEMBL494409,20200,20.2,No
CHEMBL953528,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2cc(OC)c(O)c(OC)c2)cc(OC)c1O,Bioorg Med Chem Lett,CHEMBL209219,21100,21.1,No
CHEMBL953528,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1cccc(/C=C/C(=O)/C=C(O)/C=C/c2cccc(OC)c2)c1,Bioorg Med Chem Lett,CHEMBL492977,34700,34.7,No
CHEMBL960913,Cytotoxicity against human LNCAP cells after 72 hrs by sulforhodamine B assay,COc1cc(OC)c2[nH]c(=O)cc(C)c2c1OC,J Med Chem,CHEMBL493181,45760,45.76,No
CHEMBL960913,Cytotoxicity against human LNCAP cells after 72 hrs by sulforhodamine B assay,Cc1cc(=O)n(C)c2c1C(=O)C=CC2=O,J Med Chem,CHEMBL450666,58070,58.07,No
CHEMBL1036066,Cytotoxicity against human LNCAP cells,C=CC(/C=C\c1ccc(O)cc1)c1ccc(O)c(OC)c1,J Nat Prod,CHEMBL509757,23400,23.4,No
CHEMBL1036066,Cytotoxicity against human LNCAP cells,C=CC(/C=C\c1ccc(O)cc1)c1ccc(OC)c(O)c1,J Nat Prod,CHEMBL471603,41100,41.1,No
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCCN)c21,J Med Chem,CHEMBL493269,990,0.99,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNCCc3ccc(OC)cc3)c21,J Med Chem,CHEMBL494060,50,0.05,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21,J Med Chem,CHEMBL521642,190,0.19,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,J Med Chem,CHEMBL494089,20,0.02,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,J Med Chem,CHEMBL1794066,180,0.18,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNC3)c21,J Med Chem,CHEMBL494088,460,0.46,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC[C@@H](N)Cc3ccccc3)c21,J Med Chem,CHEMBL523859,30,0.03,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCN)c21,J Med Chem,CHEMBL453510,300,0.3,Yes
CHEMBL1028100,Antiproliferative activity against human LNCaP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,J Med Chem,CHEMBL1794065,220,0.22,Yes
CHEMBL948462,Cytotoxicity against human LNCAP cells by MTT assay,C=C[C@@H]1C=C(C)[C@H]2[C@@H]3[C@H](Oc4ccc(cc4)C[C@@]4(O)C=C(C(=O)N4)C(=O)[C@@H]13)[C@@H]1[C@@H](C)C[C@@H](C)C[C@]12C,Bioorg Med Chem Lett,CHEMBL520703,480,0.48,Yes
CHEMBL948462,Cytotoxicity against human LNCAP cells by MTT assay,CC1=C[C@H]2[C@@H]3C(=O)[C@]4(C[C@@H]2O)C[C@](O)(Cc2ccc(cc2)O[C@H]2[C@H]3[C@@H]1[C@]1(C)C[C@H](C)C[C@H](C)[C@@H]21)NC4=O,Bioorg Med Chem Lett,CHEMBL502235,20240,20.24,No
CHEMBL959248,Cytotoxicity against human LNCAP cells,NCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,Bioorg Med Chem Lett,CHEMBL512135,750,0.75,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL469590,45,0.045,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL470597,21,0.021,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](CC1CCCCC1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL470598,440,0.44,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccncc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL498051,750,0.75,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(-c3ccnc4[nH]ccc34)s2)cc1,Bioorg Med Chem Lett,CHEMBL524998,720,0.72,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccccc1F)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL498052,39,0.039,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL523586,18,0.018,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL496690,66,0.066,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccccc1C(F)(F)F)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL520788,24,0.024,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1cccc(C(F)(F)F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL482536,78,0.078,Yes
CHEMBL959248,Cytotoxicity against human LNCAP cells,NC[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,Bioorg Med Chem Lett,CHEMBL482537,440,0.44,Yes
CHEMBL1020868,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2Oc3c(OC)cc(/C=C/C(=O)NCCc4ccc(O)cc4)cc3[C@H]2C(=O)NCCc2ccc(O)cc2)ccc1O,J Nat Prod,CHEMBL500729,33000,33,No
CHEMBL1020868,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc(O)c(OC)cc3C=C(C(=O)NCCc3ccc(O)cc3)[C@H]2C(=O)NCCc2ccc(O)cc2)ccc1O,J Nat Prod,CHEMBL445592,81000,81,No
CHEMBL1020868,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(/C=C(C(=O)NCCc2ccc(O)cc2)\C(=C/c2ccc(O)c(OC)c2)C(=O)NCCc2ccc(O)cc2)ccc1O,J Nat Prod,CHEMBL445810,76000,76,No
CHEMBL1020873,Cytotoxicity against human LNCAP cells by MTT assay,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,J Nat Prod,CHEMBL65,86.1,0.0861,Yes
CHEMBL958778,Antiproliferative activity against human LNCaP 1740 cells assessed as cell growth after 4 days by sulforhodamine B assay,CCCCC[C@H]1OC(=O)c2ccc(OC)cc2[C@H]1OC(C)=O,J Nat Prod,CHEMBL529220,57500,57.5,No
CHEMBL981843,Antitumor activity against human LNCAP cells after 3 days by MTT assay,CC(C)[C@H]1NC(=O)C[C@@H]2NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CSSCCNC2=O)NC1=O,J Med Chem,CHEMBL502353,270,0.27,Yes
CHEMBL1006915,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,J Nat Prod,CHEMBL428647,20,0.02,Yes
CHEMBL1006915,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,CC1(C)CCC2=C(O1)C(=O)c1ccccc1C2=O,J Nat Prod,CHEMBL441441,29300,29.3,No
CHEMBL1026520,Cytotoxicity against androgen-dependent human LNCAP cells with T877A AR mutant after 72 hrs by MTT assay,CC1=C(/C=C/C(=O)/C=C/c2ccc(O)c([N+](=O)[O-])c2)C(C)(C)CCC1,Bioorg Med Chem Lett,CHEMBL514661,26800,26.8,No
CHEMBL1026520,Cytotoxicity against androgen-dependent human LNCAP cells with T877A AR mutant after 72 hrs by MTT assay,CC1=CCCC(C)(C)C1/C=C/C(=O)/C=C/c1ccccc1C(F)(F)F,Bioorg Med Chem Lett,CHEMBL474504,22600,22.6,No
CHEMBL1026520,Cytotoxicity against androgen-dependent human LNCAP cells with T877A AR mutant after 72 hrs by MTT assay,CC1=C(/C=C/C(=O)/C=C/c2cccc(C(F)(F)F)c2)C(C)(C)CCC1O,Bioorg Med Chem Lett,CHEMBL506089,740,0.74,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(N)cc3)n2)cc(OC)c1OC.Cl,J Med Chem,CHEMBL511796,13,0.013,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3cccs3)n2)cc(OC)c1OC,J Med Chem,CHEMBL510476,9,0.009,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,CCc1ccc(-c2nc(C(=O)c3cc(OC)c(OC)c(OC)c3)cs2)cc1,J Med Chem,CHEMBL459993,60,0.06,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(Br)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459992,44,0.044,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(C(F)(F)F)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459775,94,0.094,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(C#N)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL517098,15,0.015,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc([N+](=O)[O-])cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459774,39,0.039,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1ccc(-c2nc(C(=O)c3cc(OC)c(OC)c(OC)c3)cs2)cc1OC,J Med Chem,CHEMBL471410,38,0.038,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(F)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL513054,6,0.006,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3cccc(F)c3)n2)cc(OC)c1OC,J Med Chem,CHEMBL471208,11,0.011,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3F)n2)cc(OC)c1OC,J Med Chem,CHEMBL472454,53,0.053,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL499424,6,0.006,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(OC)cc(C(=O)c2csc(-c3ccccc3)n2)c1,J Med Chem,CHEMBL472248,323,0.323,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459773,28,0.028,Yes
CHEMBL1010706,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,J Med Chem,CHEMBL107,16,0.016,Yes
CHEMBL1025152,Antitumor activity against human LNCAP cells,CCNCCCCNCCCCNCCCCNCCCCNCC,J Med Chem,CHEMBL551489,100,0.1,Yes
CHEMBL1025152,Antitumor activity against human LNCAP cells,CCNC/C=C\CNCCCCNCCCCNCCCCNCC.Cl.Cl.Cl.Cl.Cl,J Med Chem,CHEMBL1237414,80,0.08,Yes
CHEMBL1025152,Antitumor activity against human LNCAP cells,CCNCCCCNCCCCNCCCCNC/C=C/CNCCCCNCCCCNCCCCNCC,J Med Chem,CHEMBL264287,130,0.13,Yes
CHEMBL1025152,Antitumor activity against human LNCAP cells,CCNCCCCNCCCCNCCCCNCCCCNC/C=C/CNCCCCNCCCCNCCCCNCCCCNCC,J Med Chem,CHEMBL226102,90,0.09,Yes
CHEMBL1025152,Antitumor activity against human LNCAP cells,CCNC/C=C\CNCCCCNCCCCNC/C=C\CNCC.Cl.Cl.Cl.Cl.Cl,J Med Chem,CHEMBL1237413,140,0.14,Yes
CHEMBL1026072,Antiproliferative activity against human LNCAP cells after 72 to 144 hrs by cyquant DNA dye method,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,J Med Chem,CHEMBL109480,82,0.082,Yes
CHEMBL1026072,Antiproliferative activity against human LNCAP cells after 72 to 144 hrs by cyquant DNA dye method,Cc1cn(-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)c2c1C(=O)CC(C)(C)C2,J Med Chem,CHEMBL563608,4,0.004,Yes
CHEMBL1026072,Antiproliferative activity against human LNCAP cells after 72 to 144 hrs by cyquant DNA dye method,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,J Med Chem,CHEMBL560895,3,0.003,Yes
CHEMBL1026072,Antiproliferative activity against human LNCAP cells after 72 to 144 hrs by cyquant DNA dye method,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1.CS(=O)(=O)O,J Med Chem,CHEMBL553939,31,0.031,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,Oc1cccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)c1,J Med Chem,CHEMBL550286,53,0.053,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL561844,66,0.066,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL561103,213,0.213,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1)OCCO,J Med Chem,CHEMBL552532,11,0.011,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL551440,3,0.003,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL550972,1.5,0.0015,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C)CC4)c3n2)cc1,J Med Chem,CHEMBL564099,733,0.733,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(C)=O)CC4)c3n2)cc1,J Med Chem,CHEMBL562365,817,0.817,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)N(C)C)CC4)c3n2)cc1,J Med Chem,CHEMBL562439,197,0.197,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL563985,31,0.031,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)c5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL540695,150,0.15,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL561708,355,0.355,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)OCCO)cc4)nc32)CC1,J Med Chem,CHEMBL564404,28,0.028,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,CCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL558486,55,0.055,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1,J Med Chem,CHEMBL561907,52,0.052,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1,J Med Chem,CHEMBL562999,42,0.042,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5cccnc5)cc4)nc32)CC1,J Med Chem,CHEMBL538378,31,0.031,Yes
CHEMBL1058641,Cytotoxicity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc32)CC1,J Med Chem,CHEMBL557963,60,0.06,Yes
CHEMBL1051537,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,C[C@H]1CC[C@H]2C(=CCCC2(C)C)[C@@]1(C)CCC(CCCC1=CC(=O)N(CCc2c[nH]cn2)C1=O)COS(=O)(=O)O,J Nat Prod,CHEMBL556261,21800,21.8,No
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,Fc1ccc(-c2nc(-c3ccccc3)no2)cc1,Bioorg Med Chem Lett,CHEMBL538388,23700,23.7,No
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(-c3ccc(F)cc3)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL551793,87930,87.93,No
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(-c3ccc(Cl)cc3)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL561248,20800,20.8,No
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(-c3ccc(O)cc3)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL564906,860,0.86,Yes
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(CC(C)=O)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL552745,28340,28.34,No
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(C3CCCN3)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL550754,43,0.043,Yes
CHEMBL1023641,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(-c2noc(C3CCNCC3)n2)cc1OC1CCCC1,Bioorg Med Chem Lett,CHEMBL558299,10,0.01,Yes
CHEMBL1060377,Cytotoxicity against human LNCAP cells after 72 hrs by CellTitter-Glo luminescent cell viability assay,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,J Med Chem,CHEMBL564481,570,0.57,Yes
CHEMBL1060377,Cytotoxicity against human LNCAP cells after 72 hrs by CellTitter-Glo luminescent cell viability assay,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,J Med Chem,CHEMBL707,28110,28.11,No
CHEMBL1051560,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2CC(=O)[C@H](Cc2ccccc2)NC1=O,J Nat Prod,CHEMBL553205,800,0.8,Yes
CHEMBL1060482,Cytotoxicity against human LNCAP cells after 4 days by MTT assay,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,Bioorg Med Chem,CHEMBL1358,18,0.018,Yes
CHEMBL1060498,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O,Bioorg Med Chem,CHEMBL378544,29300,29.3,No
CHEMBL1052598,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(/C=C/C(O)=C/C(=O)/C=C/C2=C(C)CCCC2(C)C)ccc1O,J Med Chem,CHEMBL560878,20600,20.6,No
CHEMBL1052598,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COc1ccc(/C=C/C(O)=C/C(=O)/C=C/C2=C(C)CCCC2(C)C)cc1O,J Med Chem,CHEMBL551878,25900,25.9,No
CHEMBL1052598,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(/C=C/C(O)=C/C(=O)/C=C/C2=C(C)CCCC2(C)C)cc(OC)c1OC,J Med Chem,CHEMBL551880,21400,21.4,No
CHEMBL1052598,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COc1ccc(/C=C/C(O)=C/C(=O)/C=C/C2=C(C)CCCC2(C)C)cn1,J Med Chem,CHEMBL558066,25100,25.1,No
CHEMBL1057254,Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)(C)CCC1,Eur J Med Chem,CHEMBL560471,270,0.27,Yes
CHEMBL1057254,Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)NCCC(=O)O)C(C)(C)CCC1,Eur J Med Chem,CHEMBL541957,270,0.27,Yes
CHEMBL1057254,Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,Eur J Med Chem,CHEMBL38,500,0.5,Yes
CHEMBL1056719,Cytotoxicity against human LNCAP cells by MTT assay,c1cncc(-c2nnc(-c3c[nH]c4ccccc34)o2)c1,Bioorg Med Chem Lett,CHEMBL559257,69400,69.4,No
CHEMBL1047616,Growth inhibition of human LNCAP cells after 3 days by MTS method,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL577137,9,0.009,Yes
CHEMBL1047616,Growth inhibition of human LNCAP cells after 3 days by MTS method,CCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL558486,55,0.055,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(CC)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL584734,16,0.016,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(CCN(C)C)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL585126,280,0.28,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)NCCN(C)C)cc3)nc21,Bioorg Med Chem Lett,CHEMBL565389,350,0.35,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CN(C)CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL565808,50,0.05,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(NC)nc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL567694,17,0.017,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(N(C)C)nc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL565987,6,0.006,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(N5CCOCC5)nc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL576304,0.8,0.0008,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccccc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL565787,0.8,0.0008,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(N5CCCC5)cc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL585397,55,0.055,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(NCCN(C)C)cc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL576507,2.8,0.0028,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(N(C)CCN(C)C)cc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL570870,0.8,0.0008,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(CN(C)C)cc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL585206,7,0.007,Yes
CHEMBL1039194,Antiproliferative activity against PTEN deficient human LNCAP cells after 3 days by MTS assay,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)Nc4ccc(OCCN(C)C)cc4)cc3)nc21,Bioorg Med Chem Lett,CHEMBL570635,0.7,0.0007,Yes
CHEMBL1046399,Inhibition of dihydrotestosterone-induced prostate specific antigen expression in human LNCAP cells by quantitative RT-PCR analysis,Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)[C@H](N)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)c7cc(NC(=O)c8nccn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cc1C(=O)NCCCO/N=C\c1cccc(C(=O)O)c1,J Med Chem,CHEMBL583533,300,0.3,Yes
CHEMBL1046399,Inhibition of dihydrotestosterone-induced prostate specific antigen expression in human LNCAP cells by quantitative RT-PCR analysis,Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)[C@H](N)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)c7cc(NC(=O)c8nccn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cc1C(=O)NCCCO/N=C\c1ccc(F)cc1,J Med Chem,CHEMBL576889,600,0.6,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)[C@H](N)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)c7cc(NC(=O)c8nccn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cc1C(=O)NCCCO/N=C\c1cccc(F)c1,J Med Chem,CHEMBL576888,600,0.6,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)[C@H](N)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)c7cc(NC(=O)c8nccn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cc1C(=O)NCCCO/N=C\c1ccc(F)cc1,J Med Chem,CHEMBL576889,400,0.4,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,NCCCO/N=C\c1cccc(C(=O)O)c1,J Med Chem,CHEMBL570373,20,0.02,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,CC(=O)NCCCO/N=C\c1ccc(F)cc1,J Med Chem,CHEMBL567483,20,0.02,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,NCCCO/N=C\c1ccc(F)cc1,J Med Chem,CHEMBL570372,20,0.02,Yes
CHEMBL1047212,Cytotoxicity against human LNCAP cells after 48 hrs by WST1 assay,CC(=O)NCCCO/N=C\c1cccc(C(=O)O)c1,J Med Chem,CHEMBL576642,20,0.02,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,Nc1ncc(-c2nc(N3CCOCC3)c3sccc3n2)cn1,Bioorg Med Chem Lett,CHEMBL594844,680,0.68,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL606131,85,0.085,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL595053,12,0.012,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(NCCF)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL595287,87,0.087,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(NCCO)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL593157,180,0.18,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1)NC1CC1,Bioorg Med Chem Lett,CHEMBL594793,40,0.04,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(Nc1ccccc1)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL594571,140,0.14,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1)Nc1cccnc1,Bioorg Med Chem Lett,CHEMBL595256,27,0.027,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL592917,10,0.01,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sc(CN4CCN(C)CC4)cc3n2)cc1,Bioorg Med Chem Lett,CHEMBL605529,500,0.5,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3sc(CN4CCN(S(C)(=O)=O)CC4)cc3n2)cc1,Bioorg Med Chem Lett,CHEMBL604167,120,0.12,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CN1CCN(Cc2cc3nc(-c4ccc(NC(=O)NC5CC5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL596426,400,0.4,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(NC(=O)NC5CC5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL594244,32,0.032,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CN1CCN(Cc2cc3nc(-c4ccc(NC(=O)Nc5cccnc5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL594606,148,0.148,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(NC(=O)Nc5cccnc5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL594549,22,0.022,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CN1CCN(Cc2cc3nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL594173,200,0.2,Yes
CHEMBL1067296,Cytotoxicity against human LNCAP cells,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc(N4CC5CCC(C4)O5)c3s2)CC1,Bioorg Med Chem Lett,CHEMBL594431,120,0.12,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,CNC(=O)Nc1ccc(-c2nc(C3=CCOCC3)c3cnn(CC(F)(F)F)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL589858,260,0.26,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(CC(F)(F)F)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL572932,230,0.23,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(NCCF)Nc1ccc(-c2nc(C3=CCOCC3)c3cnn(CC(F)(F)F)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL590104,72,0.072,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(NCCF)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(CC(F)(F)F)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL574234,60,0.06,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(Nc1ccc(-c2nc(C3=CCOCC3)c3cnn(CC(F)(F)F)c3n2)cc1)Nc1cccnc1,Bioorg Med Chem Lett,CHEMBL590105,380,0.38,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,CCNC(=O)Nc1ccc(-c2nc(C3=CCOCC3)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL600447,470,0.47,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(Nc1ccccc1)Nc1ccc(-c2nc(C3=CCOCC3)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL589622,800,0.8,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(Nc1ccc(-c2nc(C3=CCOCC3)c3sccc3n2)cc1)Nc1cccnc1,Bioorg Med Chem Lett,CHEMBL601895,210,0.21,Yes
CHEMBL1074682,Cytotoxicity against human LNCAP cells after 1 to 2 hrs by MTS assay,O=C(Nc1ccncc1)Nc1ccc(-c2nc(C3=CCOCC3)c3sccc3n2)cc1,Bioorg Med Chem Lett,CHEMBL601689,200,0.2,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,Bioorg Med Chem Lett,CHEMBL593490,190,0.19,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,Bioorg Med Chem Lett,CHEMBL596072,85,0.085,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,Bioorg Med Chem Lett,CHEMBL596073,830,0.83,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,Bioorg Med Chem Lett,CHEMBL596290,96,0.096,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,Bioorg Med Chem Lett,CHEMBL603197,540,0.54,Yes
CHEMBL1071319,Cytotoxicity against human LNCAP cells,Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,Bioorg Med Chem Lett,CHEMBL594933,230,0.23,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL568259,26,0.026,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCN(C(=O)OC(C)C)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL606423,6,0.006,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL600084,27,0.027,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601864,170,0.17,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CCn1ncc2c(N3CC4CCC(C3)O4)nc(-c3ccc(NC(=O)NC)cc3)nc21,Bioorg Med Chem Lett,CHEMBL600811,70,0.07,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C(C)C)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL604123,5,0.005,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(CC(F)(F)F)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL572944,38,0.038,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(CCO)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL602682,650,0.65,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(CCN(C)C)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL602884,400,0.4,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC(=O)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL603498,32,0.032,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn([C@H]4CC[C@H](O)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL610630,20,0.02,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn([C@H]4CC[C@@H](O)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL606621,20,0.02,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn([C@H]4CC[C@H](OC)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL602276,2,0.002,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn([C@H]4CC[C@@H](OC)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601445,1,0.001,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC(OC)(OC)CC4)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601660,2,0.002,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601661,2,0.002,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601876,8,0.008,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL600825,1,0.001,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,O=C(NCCF)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL601023,1,0.001,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,O=C(Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1)NC1CC1,Bioorg Med Chem Lett,CHEMBL600213,2,0.002,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,O=C(Nc1ccccc1)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL600366,4,0.004,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,Bioorg Med Chem Lett,CHEMBL600367,1,0.001,Yes
CHEMBL1068275,Cytotoxicity against human LNCAP cells,O=C(Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1)Nc1cccnc1,Bioorg Med Chem Lett,CHEMBL600368,1,0.001,Yes
CHEMBL1066494,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CCCCCCCCC/C=C\CCCCCCCNC(=O)[C@@H]1CSC(c2cc(OC)c(OC)c(OC)c2)N1,Bioorg Med Chem,CHEMBL603889,700,0.7,Yes
CHEMBL1066494,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CCCCCCCCC/C=C/CCCCCCCNC(=O)[C@@H]1CSC(c2cc(OC)c(OC)c(OC)c2)N1,Bioorg Med Chem,CHEMBL598664,600,0.6,Yes
CHEMBL1066494,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CCCCCCCCC/C=C/CCCCCCCNC(=O)[C@@H]1CSC(c2ccc(OC)c(OC)c2)N1,Bioorg Med Chem,CHEMBL598304,800,0.8,Yes
CHEMBL1066494,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CCCCCCCCCCCCCCCCNC(=O)[C@@H]1CSC(c2cccc(OC)c2)N1,Bioorg Med Chem,CHEMBL599749,500,0.5,Yes
CHEMBL1065576,Antiproliferative activity against human LNCAP cells,O=C(CCCCCCC(=O)Nc1ccccc1)NO,J Med Chem,CHEMBL98,580,0.58,Yes
CHEMBL1070379,Antiproliferative activity against human LNCAP cells after 48 hrs by ATPlite assay,O=[N+]([O-])c1ccc(/C=C/c2ccc3cccc(O)c3n2)o1,Bioorg Med Chem,CHEMBL589783,350,0.35,Yes
CHEMBL1070379,Antiproliferative activity against human LNCAP cells after 48 hrs by ATPlite assay,C/C(=N\O)c1ccc(Nc2cc(/C=C/c3ccc([N+](=O)[O-])o3)nc3ccccc23)cc1,Bioorg Med Chem,CHEMBL590052,950,0.95,Yes
CHEMBL1107813,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,Fc1ccc(-c2nc(-c3c[nH]c4ccccc34)co2)cc1,Eur J Med Chem,CHEMBL1088168,59800,59.8,No
CHEMBL1110245,Cytotoxicity against human LNCAP cells after 4 days by propidium iodide assay,CNC1=CC(=O)c2c(cnc(C)c2C)C1=O,J Nat Prod,CHEMBL1079851,21670,21.67,No
CHEMBL1102406,Cytotoxicity against human LNCAP cells after 72 hrs by XTT assay,C=C1OC(=O)/C(=C/CCCCCCCCCCCCCCCCCCCCCCCCCC)[C@@H]1O,J Nat Prod,CHEMBL1077858,42700,42.7,No
CHEMBL1102406,Cytotoxicity against human LNCAP cells after 72 hrs by XTT assay,C=C1C=C(C(CCCCCCCCCCCCCCCCCCC)OC)C(=O)O1,J Nat Prod,CHEMBL1078157,22200,22.2,No
CHEMBL1102406,Cytotoxicity against human LNCAP cells after 72 hrs by XTT assay,C=C1OC(=O)/C(=C\CCCCCCCCCCCCC)[C@@H]1O,J Nat Prod,CHEMBL490165,36400,36.4,No
CHEMBL1102406,Cytotoxicity against human LNCAP cells after 72 hrs by XTT assay,CC(C)C1=CC(=O)[C@]2(C)O[C@@]1(O)[C@@H]1[C@H](C)CC[C@@H]12,J Nat Prod,CHEMBL1077895,67100,67.1,No
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1088973,1.3,0.0013,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1092392,4,0.004,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN(C)Cc1ccc(NC(=O)Nc2ccc(-c3nc(N4C5CCC4COC5)nc(N4C5CCC4COC5)n3)cc2)cc1,Bioorg Med Chem Lett,CHEMBL1092393,5,0.005,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CNCc1ccc(NC(=O)Nc2ccc(-c3nc(N4C5CCC4COC5)nc(N4C5CCC4COC5)n3)cc2)cc1,Bioorg Med Chem Lett,CHEMBL1092394,3,0.003,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN(C)CCOc1ccc(NC(=O)Nc2ccc(-c3nc(N4C5CCC4COC5)nc(N4C5CCC4COC5)n3)cc2)cc1,Bioorg Med Chem Lett,CHEMBL1092395,3,0.003,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(CCOc2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1092396,0.8,0.0008,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,O=C(Nc1ccc(OCCN2CCCC2)cc1)Nc1ccc(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cc1,Bioorg Med Chem Lett,CHEMBL1092397,0.8,0.0008,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,O=C(Nc1ccc(OCCO)cc1)Nc1ccc(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cc1,Bioorg Med Chem Lett,CHEMBL1092398,0.8,0.0008,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CC(C)Nc1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nc(N2C3CCC2COC3)n1,Bioorg Med Chem Lett,CHEMBL1091345,50,0.05,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CC(C)N(C)c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nc(N2C3CCC2COC3)n1,Bioorg Med Chem Lett,CHEMBL1091346,240,0.24,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCSCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091347,800,0.8,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nc(N2C3CCC2COC3)n1,Bioorg Med Chem Lett,CHEMBL1091348,6,0.006,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(C5=CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091349,25,0.025,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091350,0.8,0.0008,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,O=C(Nc1ccc(-c2nc(C3CCOCC3)nc(N3C4CCC3COC4)n2)cc1)Nc1ccc(N2CCNCC2)cc1,Bioorg Med Chem Lett,CHEMBL1091351,20,0.02,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CC(C)N1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091353,18,0.018,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN(C)C1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091354,1,0.001,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091356,0.9,0.0009,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CN(C)CCOc1ccc(NC(=O)Nc2ccc(-c3nc(C4CCOCC4)nc(N4C5CCC4COC5)n3)cc2)cc1,Bioorg Med Chem Lett,CHEMBL1091359,9,0.009,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CCN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5CCOC[C@H]5C)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1076864,1,0.001,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,CC(C)N1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5CCOC[C@H]5C)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1091711,6,0.006,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCC(N(C)C)CC4)cc3)cc2)nc(N2C3CCC2COC3)n1,Bioorg Med Chem Lett,CHEMBL1091712,8,0.008,Yes
CHEMBL1108790,Antiproliferative activity against human LNCAP cells,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(OCCN(C)C)cc3)cc2)nc(N2C3CCC2COC3)n1,Bioorg Med Chem Lett,CHEMBL1091715,12,0.012,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3cccnc3)cc2)nc(N2C[C@@H]3C[C@H]2CO3)n1,Bioorg Med Chem Lett,CHEMBL1091665,250,0.25,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3cccnc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1091666,12,0.012,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3cccnc3)cc2)nc(C2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL1092914,2,0.002,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccncc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1093181,7,0.007,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)nc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1092034,12,0.012,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1092035,3,0.003,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCC(N(C)C)CC4)cc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1092036,40,0.04,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(CN(C)C)cc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1093182,21,0.021,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(OCCN(C)C)cc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1092037,8,0.008,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(C(=O)N4CCC(N(C)C)CC4)cc3)cc2)nc(N2CCOC[C@H]2C)n1,Bioorg Med Chem Lett,CHEMBL1092039,1,0.001,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)nc3)cc2)nc(C2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL1092041,40,0.04,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nc(C2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL1092042,1,0.001,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCNCC4)cc3)cc2)nc(C2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL1092043,2,0.002,Yes
CHEMBL1112504,Growth inhibition of human LNCAP cells after 3 days by MTS assay,C[C@@H]1COCCN1c1nc(-c2ccc(NC(=O)Nc3ccc(N4CCC(N(C)C)CC4)cc3)cc2)nc(C2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL1092044,16,0.016,Yes
CHEMBL1113409,Cytotoxicity against human androgen receptor positive LNCAP cells after 72 hrs by MTT assay,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,Bioorg Med Chem Lett,CHEMBL139835,43000,43,No
CHEMBL1113409,Cytotoxicity against human androgen receptor positive LNCAP cells after 72 hrs by MTT assay,C[C@]12CC[C@H]3[C@@H]([C@@H](C/C=C\C[C@H]4CC5=CC(=O)CC[C@]5(C)[C@H]5CC[C@]6(C)[C@@H](O)CC[C@H]6[C@H]45)CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,Bioorg Med Chem Lett,CHEMBL1090319,30300,30.3,No
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,Bioorg Med Chem Lett,CHEMBL586702,210,0.21,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,FC(F)c1nc2ccccc2n1-c1nc(N2CC3CCC(C2)O3)nc(N2CC3CCC(C2)O3)n1,Bioorg Med Chem Lett,CHEMBL1088919,680,0.68,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CC3CCC(C2)O3)n1,Bioorg Med Chem Lett,CHEMBL1089219,180,0.18,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)nc(N3CC4CCC(C3)O4)n2)cc1,Bioorg Med Chem Lett,CHEMBL1092642,190,0.19,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CCNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)nc(N3CC4CCC(C3)O4)n2)cc1,Bioorg Med Chem Lett,CHEMBL1092908,180,0.18,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccc(-c2nc(N3CC4CCC(C3)O4)nc(N3CC4CCC(C3)O4)n2)cc1)NC1CC1,Bioorg Med Chem Lett,CHEMBL1092909,90,0.09,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)nc(N3CC4CCC(C3)O4)n2)cc1,Bioorg Med Chem Lett,CHEMBL1092653,45,0.045,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5CC6CCC(C5)O6)nc(N5CC6CCC(C5)O6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1088970,2.3,0.0023,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C[C@H]6C[C@@H]5CO6)nc(N5C[C@H]6C[C@@H]5CO6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1088971,550,0.55,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C[C@@H]6C[C@H]5CO6)nc(N5C[C@@H]6C[C@H]5CO6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1088972,80,0.08,Yes
CHEMBL1117045,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5C6CCC5COC6)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1088973,1.3,0.0013,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1)c1cccnc1,Bioorg Med Chem Lett,CHEMBL1091708,300,0.3,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(Cc1ccccc1)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091707,20,0.02,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(Cc1ccccn1)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091706,40,0.04,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(Cc1ccncc1)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091705,23,0.023,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCC(C(=O)NCc4cccnc4)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091703,60000,60,No
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,COC1CCN(C(=O)C2CCN(c3ccnc4c3c(/C=C3\Oc5ccc(NC(=O)Nc6cccnc6)cc5C3=O)cn4C)CC2)C1,Bioorg Med Chem Lett,CHEMBL1091702,190,0.19,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCC(C(=O)N4CCCCC4)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091700,18,0.018,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCC(C(=O)N4CCCC4)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091699,12,0.012,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN1CCN(C(=O)C2CCN(c3ccnc4c3c(/C=C3\Oc5ccc(NC(=O)Nc6cccnc6)cc5C3=O)cn4C)CC2)CC1,Bioorg Med Chem Lett,CHEMBL1091698,330,0.33,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCC(C(=O)N4C5CCC4COC5)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091697,200,0.2,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCC(C(=O)N4CC5CCC(C4)O5)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091696,90,0.09,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CCN(CC)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091694,50,0.05,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(C)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4ccc(NC(=O)Nc5cccnc5)cc4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091693,80,0.08,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3C4CCC3COC4)ccnc21,Bioorg Med Chem Lett,CHEMBL1090710,6,0.006,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CC4CCC3CO4)ccnc21,Bioorg Med Chem Lett,CHEMBL1090709,1.8,0.0018,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CCOCC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1090387,50,0.05,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4cccnc4)cc3C2=O)c2c(N3CC4CCC(C3)O4)ccnc21,Bioorg Med Chem Lett,CHEMBL1093685,15,0.015,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3ccc(NC(=O)Nc4ccccc4)cc3C2=O)c2c(N3CC4CCC(C3)O4)ccnc21,Bioorg Med Chem Lett,CHEMBL1093334,280,0.28,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CN(C)CCNC(=O)Nc1ccc2c(c1)C(=O)/C(=C/c1cn(C)c3nccc(N4CC5CCC(C4)O5)c13)O2,Bioorg Med Chem Lett,CHEMBL1092110,60,0.06,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CNC(=O)Nc1ccc2c(c1)C(=O)/C(=C/c1cn(C)c3nccc(N4CC5CCC(C4)O5)c13)O2,Bioorg Med Chem Lett,CHEMBL1093069,140,0.14,Yes
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,CNC(=O)Nc1ccc2c(c1)C(=O)/C(=C/c1cn(C)c3nccc(-c4ccccc4)c13)O2,Bioorg Med Chem Lett,CHEMBL1090434,60000,60,No
CHEMBL1107896,Antiproliferative activity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccccc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1090043,200,0.2,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cc(O)cc(O)c3C2=O)c2c(-c3ccccc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091456,77,0.077,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccccc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1090043,200,0.2,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN(C)C(=O)c1ccc(-c2ccnc3c2c(/C=C2\Oc4cccc(O)c4C2=O)cn3C)cc1,Bioorg Med Chem Lett,CHEMBL1092815,4,0.004,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN(C)C(=O)C1CCN(c2ccnc3c2c(/C=C2\Oc4cccc(O)c4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1091491,1,0.001,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)N4CCOCC4)cc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1091492,1,0.001,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)N4CC5CCC(C4)O5)cc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1092120,8,0.008,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCC(C(=O)N4CC5CCC(C4)O5)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1090388,1,0.001,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN1CCN(C(=O)c2ccc(-c3ccnc4c3c(/C=C3\Oc5cccc(O)c5C3=O)cn4C)cc2)CC1,Bioorg Med Chem Lett,CHEMBL1092485,9,0.009,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)N4CCN(CCO)CC4)cc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1092781,1,0.001,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCC(C(=O)N4CCN(CCO)CC4)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1093754,1,0.001,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CCn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)N4CCN(CCO)CC4)cc3)ccnc21,Bioorg Med Chem Lett,CHEMBL1088745,4,0.004,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN(C)C(=O)c1cccc(-c2ccnc3c2c(/C=C2\Oc4cccc(O)c4C2=O)cn3C)c1,Bioorg Med Chem Lett,CHEMBL1088746,600,0.6,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCC(C(N)=O)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1094015,10,0.01,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCC(CN)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1094016,75,0.075,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCC(N)CC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1092474,240,0.24,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CCOCC3)ccnc21,Bioorg Med Chem Lett,CHEMBL1092768,5,0.005,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3CC4CCC(C3)O4)ccnc21,Bioorg Med Chem Lett,CHEMBL1090381,2,0.002,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(N3C4CCC3COC4)ccnc21,Bioorg Med Chem Lett,CHEMBL1090382,2,0.002,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN1CCN(c2ccnc3c2c(/C=C2\Oc4cccc(O)c4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1090383,3,0.003,Yes
CHEMBL1107901,Cytotoxicity against human LNCAP cells,CN1CCN(c2ccnc3c2c(/C=C2\Oc4cc(O)cc(O)c4C2=O)cn3C)CC1,Bioorg Med Chem Lett,CHEMBL1094017,110,0.11,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,Bioorg Med Chem Lett,CHEMBL494089,21,0.021,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN)cc21,Bioorg Med Chem Lett,CHEMBL1098241,296,0.296,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CNC)cc21,Bioorg Med Chem Lett,CHEMBL1098316,201,0.201,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN(C)C)cc21,Bioorg Med Chem Lett,CHEMBL1099290,114,0.114,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,Bioorg Med Chem Lett,CHEMBL1096290,313,0.313,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCN)cc21,Bioorg Med Chem Lett,CHEMBL1096291,497,0.497,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21,Bioorg Med Chem Lett,CHEMBL1098943,896,0.896,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](C)N)cc21,Bioorg Med Chem Lett,CHEMBL1098944,220,0.22,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](C)N)cc21,Bioorg Med Chem Lett,CHEMBL1099281,560,0.56,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1096634,124,0.124,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1096626,176,0.176,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)Cc3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1098938,20,0.02,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)Cc3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1098939,101,0.101,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1099276,27,0.027,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CN)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1099296,68,0.068,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CCN)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1099297,5,0.005,Yes
CHEMBL1109957,Antiproliferative activity against human LNCAP cells,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CCN)c3ccccc3)cc21,Bioorg Med Chem Lett,CHEMBL1099298,85,0.085,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccc(CCN6CCN(C)CC6)cc5)cc4)nc32)CC1,J Med Chem,CHEMBL1098247,1.4,0.0014,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL550972,1.5,0.0015,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL551440,3.4,0.0034,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccc(CCN6CCOCC6)cc5)cc4)nc32)CC1,J Med Chem,CHEMBL1098248,5,0.005,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1)OCCO,J Med Chem,CHEMBL552532,11,0.011,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(NCCO)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097896,26,0.026,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1,J Med Chem,CHEMBL1095933,27,0.027,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccccc5)cc4)nc32)CC1,J Med Chem,CHEMBL1098244,27,0.027,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC(C)C)CC4)c3n2)cc1,J Med Chem,CHEMBL1095932,28,0.028,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1098306,30,0.03,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,J Med Chem,CHEMBL563985,31,0.031,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,NC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1098305,32,0.032,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1,J Med Chem,CHEMBL1094981,40,0.04,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1,J Med Chem,CHEMBL562999,42,0.042,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1)NC1CC1,J Med Chem,CHEMBL1097895,50,0.05,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1,J Med Chem,CHEMBL1097942,50,0.05,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1,J Med Chem,CHEMBL561907,53,0.053,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(NCCF)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097893,95,0.095,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CN(C)CCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097898,95,0.095,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1,J Med Chem,CHEMBL1098242,110,0.11,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1,J Med Chem,CHEMBL1098243,160,0.16,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1)Nc1cccnc1,J Med Chem,CHEMBL1097901,180,0.18,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,O=C(Nc1ccccc1)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097900,200,0.2,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL561103,213,0.213,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1098301,500,0.5,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CONC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1095945,500,0.5,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CONC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1095946,500,0.5,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)NC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097894,560,0.56,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COCCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5ccccc5)CC4)c3n2)cc1,J Med Chem,CHEMBL1097897,800,0.8,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,J Med Chem,CHEMBL1095627,3.4,0.0034,Yes
CHEMBL1104616,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,J Med Chem,CHEMBL1095626,213,0.213,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,Cc1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1,J Med Chem,CHEMBL1083376,124,0.124,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc(CO)cc3)C2=S)cc1C(F)(F)F,J Med Chem,CHEMBL1082431,200,0.2,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,CC(O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1,J Med Chem,CHEMBL1084539,200,0.2,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc(C=O)cc3)C2=S)cc1C(F)(F)F,J Med Chem,CHEMBL1082432,200,0.2,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc(/C=C/C(N)=O)cc3)C2=S)cc1C(F)(F)F,J Med Chem,CHEMBL1084782,100,0.1,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc(/C=C/CO)cc3)C2=S)cc1C(F)(F)F,J Med Chem,CHEMBL1084783,100,0.1,Yes
CHEMBL1118293,Inhibition of prostate specific antigen secretion in human LNCAP cells expressing androgen receptor in presence of charcoal stripped serum,CNC(=O)CCCc1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1,J Med Chem,CHEMBL1083391,92,0.092,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,J Med Chem,CHEMBL1082410,122,0.122,Yes
CHEMBL1118289,Inhibition of prostate specific antigen expression in human LNCAP cells in presence of fetal bovine serum,CNC(=O)CCCc1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1,J Med Chem,CHEMBL1083391,92,0.092,Yes
CHEMBL1176968,Growth inhibition of human LNCAP cells after 3 days,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,J Med Chem,CHEMBL63560,870,0.87,Yes
CHEMBL1175940,Cytotoxicity against human LNCAP cells after 2 days,CCOC(=O)/C=C/C(C(=O)/C=C/c1ccc(OC)c(OC)c1)=C(O)\C=C\c1ccc(OC)c(OC)c1,J Nat Prod,CHEMBL1172583,200,0.2,Yes
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,Clc1ccc(-c2nnc(-c3c[nH]c4ccccc34)s2)cc1,Eur J Med Chem,CHEMBL1253965,53100,53.1,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CN(C)c1ccc(-c2nnc(-c3c[nH]c4ccccc34)s2)cc1,Eur J Med Chem,CHEMBL1253966,23000,23,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(-c2nnc(-c3c[nH]c4ccccc34)s2)cc1OC,Eur J Med Chem,CHEMBL1253967,21000,21,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2nnc(-c3c[nH]c4ccccc34)s2)cc(OC)c1OC,Eur J Med Chem,CHEMBL1254058,40000,40,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,c1ccc2c(-c3nnc(-c4ccncc4)s3)c[nH]c2c1,Eur J Med Chem,CHEMBL1253686,95000,95,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CN(C)c1ccc(-c2nnc(-c3c[nH]c4ccc(Br)cc34)s2)cc1,Eur J Med Chem,CHEMBL1254152,31300,31.3,No
CHEMBL1250828,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2nnc(-c3c[nH]c4ccc(Br)cc34)s2)cc(OC)c1OC,Eur J Med Chem,CHEMBL1254245,66400,66.4,No
CHEMBL1259839,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,COc1cc2c(cc1O)C[C@@H]1NCCc3cc4c(c-2c31)OCO4.O=C(O)C(F)(F)F,Bioorg Med Chem Lett,CHEMBL1258056,27400,27.4,No
CHEMBL1259839,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O,Bioorg Med Chem Lett,CHEMBL501867,2.9,0.0029,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1271737,150,0.15,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1c[nH]c(-c2ccccc2)n1,J Med Chem,CHEMBL1269807,610,0.61,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(F)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1271912,98,0.098,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1ccc(-c2nc(C(=O)c3cc(OC)c(OC)c(OC)c3)c[nH]2)cc1,J Med Chem,CHEMBL1271967,31,0.031,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1ccc(-c2nc(C(=O)c3ccc(F)cc3)c[nH]2)cc1,J Med Chem,CHEMBL1271968,28,0.028,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1272023,12,0.012,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,Cc1ccc(-c2nc(C(=O)c3ccc(F)cc3)c[nH]2)cc1,J Med Chem,CHEMBL1272024,45,0.045,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(Cl)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1272129,24,0.024,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1c[nH]c(-c2ccc(Cl)cc2)n1,J Med Chem,CHEMBL1272130,49,0.049,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(N(C)C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1272183,58,0.058,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,CN(C)c1ccc(-c2nc(C(=O)c3ccc(F)cc3)c[nH]2)cc1,J Med Chem,CHEMBL1272184,57,0.057,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1ccc(-c2nc(C(=O)c3cc(OC)c(OC)c(OC)c3)c[nH]2)cc1OC,J Med Chem,CHEMBL1272239,121,0.121,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1c[nH]c(-c2ccc(OCc3ccccc3)cc2)n1,J Med Chem,CHEMBL1271525,44,0.044,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C(F)(F)F)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1271580,134,0.134,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,J Med Chem,CHEMBL107,16,0.016,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1cnc(-c2ccccc2)n1S(=O)(=O)c1ccccc1,J Med Chem,CHEMBL1271740,573,0.573,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1ccc(-c2ncc(C(=O)c3ccc(F)cc3)n2S(=O)(=O)c2ccccc2)cc1,J Med Chem,CHEMBL1271800,31,0.031,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,Cc1ccc(-c2ncc(C(=O)c3ccc(F)cc3)n2S(=O)(=O)c2ccccc2)cc1,J Med Chem,CHEMBL1271801,55,0.055,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1cnc(-c2ccc(Cl)cc2)n1S(=O)(=O)c1ccccc1,J Med Chem,CHEMBL1271913,48,0.048,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1cc(C(=O)c2cnc(-c3ccc(N(C)C)cc3)n2S(=O)(=O)c2ccccc2)cc(OC)c1OC,J Med Chem,CHEMBL1271914,62,0.062,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,CN(C)c1ccc(-c2ncc(C(=O)c3ccc(F)cc3)n2S(=O)(=O)c2ccccc2)cc1,J Med Chem,CHEMBL1271969,56,0.056,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,COc1ccc(-c2ncc(C(=O)c3cc(OC)c(OC)c(OC)c3)n2S(=O)(=O)c2ccccc2)cc1OC,J Med Chem,CHEMBL1271970,114,0.114,Yes
CHEMBL1272403,Cytotoxicity against human LNCAP cells after 48 hrs by sulforhodamine B assay,O=C(c1ccc(F)cc1)c1cnc(-c2ccc(OCc3ccccc3)cc2)n1S(=O)(=O)c1ccccc1,J Med Chem,CHEMBL1272082,35,0.035,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(COC(=O)CC(C)C)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(C)cc2)C[C@H](C)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCCCCNC(=O)CC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)cs1)C(C)C,J Med Chem,CHEMBL1288706,6,0.006,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@]1(O)CCN2CCc3c([nH]c4ccccc34)[C@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@](O)(C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CNC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc5ccccc5)NC(=O)CCCCCCNC(=O)CC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)[C@@H](O)[C@@]5(CC)C=CCN6CC[C@@]43[C@@H]65)CC1C2,J Med Chem,CHEMBL1288711,31,0.031,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@@]1(OC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCCCCNC(=O)CC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)Cc2cc3n(c(=O)c2OC1=O)Cc1cc2ccccc2nc1-3,J Med Chem,CHEMBL1288712,115,0.115,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2CC(C)OC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCCCCNC(=O)CC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)[C@H](C)OC(=O)[C@H](CC)N(C)C(=O)[C@@H]2CCCN2C[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,J Med Chem,CHEMBL1288713,107,0.107,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(COC(=O)CC(C)C)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(C)cc2)C[C@H](C)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCNC(=O)CC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)cs1)C(C)C,J Med Chem,CHEMBL1288703,24,0.024,Yes
CHEMBL1293013,Cytotoxicity against human LNCAP cells after 2 hrs by [3H]thymidine incorporation assay,CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(COC(=O)CC(C)C)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(C)cc2)C[C@H](C)C(=O)NNC(=O)OCCSSC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)cs1)C(C)C,J Med Chem,CHEMBL1288714,5,0.005,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)C(C)O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,J Med Chem,CHEMBL2304286,2.8,0.0028,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC1=C[C@H]2O[C@@H]3C[C@H]4OC(=O)/C=C\C=C\C(=O)OCC[C@@H](C)[C@H](O)C(=O)OC[C@@]2(CC1)[C@]4(C)[C@]31CO1,J Med Chem,CHEMBL136985,3.3,0.0033,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,J Med Chem,CHEMBL53463,77.6,0.0776,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(COC(=O)CC(C)C)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(C)cc2)C[C@H](C)C(=O)NNC(=O)OCCSSc2ccncc2)cs1)C(C)C,J Med Chem,CHEMBL1288704,3.7,0.0037,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(COC(=O)CC(C)C)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(C)cc2)C[C@H](C)C(=O)O)cs1)C(C)C,J Med Chem,CHEMBL1288708,2.5,0.0025,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)NN)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL1288707,12.2,0.0122,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL238071,9.5,0.0095,Yes
CHEMBL1293011,Cytotoxicity against human LNCAP cells,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,J Med Chem,CHEMBL428647,22.3,0.0223,Yes
CHEMBL1647064,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Bioorg Med Chem,CHEMBL44,30650,30.65,No
CHEMBL1687524,Induction of apoptosis in human androgen-dependent LNCAP cells assessed as nuclei DNA fragmentation after 24 hrs by MTT assay,C=CC1CC2(O)CC3(O)CCC=CC3C2(O)C1(O)CCC,Bioorg Med Chem Lett,CHEMBL475046,95000,95,No
CHEMBL1693143,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CCc1c2c(nc3ccccc13)-c1c(N)c3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,J Med Chem,CHEMBL1688857,120,0.12,Yes
CHEMBL1693143,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CC[C@@]1(O)C(=O)OCc2c1c(N)c1n(c2=O)Cc2cc3ccccc3nc2-1,J Med Chem,CHEMBL1688855,110,0.11,Yes
CHEMBL1693143,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,J Med Chem,CHEMBL84,9,0.009,Yes
CHEMBL1693143,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,J Med Chem,CHEMBL481,9,0.009,Yes
CHEMBL1764198,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2nnc(Nc3ccc([N+](=O)[O-])cc3)s2)ccc1O,Bioorg Med Chem Lett,CHEMBL1761337,62300,62.3,No
CHEMBL1764198,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2nnc(Nc3ccccc3)s2)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL1761340,92800,92.8,No
CHEMBL1764198,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2nnc(Nc3ccc([N+](=O)[O-])cc3)s2)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL1761341,66500,66.5,No
CHEMBL1764198,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(Nc2nnc(-c3cc(OC)c(OC)c(OC)c3)s2)cc1,Bioorg Med Chem Lett,CHEMBL1761343,29500,29.5,No
CHEMBL1767649,Growth inhibition of human LNCAP cells after 7 days by MTS assay,O=C(Nc1cccc2c(=O)[nH]ccc12)c1ccccc1,J Med Chem,CHEMBL1767054,98000,98,No
CHEMBL1767649,Growth inhibition of human LNCAP cells after 7 days by MTS assay,O=C(Nc1cccc2c(=O)[nH]ccc12)C12CC3CC(CC(C3)C1)C2,J Med Chem,CHEMBL1765110,42000,42,No
CHEMBL1777429,Antiproliferative activity against human LNCAP cells,Cc1cc(Cl)cc(OCCn2cc(F)cn2)c1-c1nc(N)nc2c1CN(C(=O)NCC(C)(F)F)C2,J Med Chem,CHEMBL1774933,30,0.03,Yes
CHEMBL1777506,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,J Nat Prod,CHEMBL1201182,0.5,0.0005,Yes
CHEMBL1777506,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC[C@@H]1/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC1=O,J Nat Prod,CHEMBL1774942,8,0.008,Yes
CHEMBL1777506,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC[C@@H]1/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C1,J Nat Prod,CHEMBL1774941,13,0.013,Yes
CHEMBL1777506,Antiproliferative activity against human LNCAP cells after 3 days by MTS assay,CC[C@@H]1CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C[C@@H]([C@H](C)C[C@@H]3CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C3)OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]1(O)O2,J Nat Prod,CHEMBL1774940,2.5,0.0025,Yes
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(-c2noc(C3CCCCC3)n2)cc1OC1CCCC1,Eur J Med Chem,CHEMBL1798009,92600,92.6,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(-c2noc(C3CCN(C(=O)OC(C)(C)C)CC3)n2)cc1OC,Eur J Med Chem,CHEMBL1798011,85600,85.6,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CCOc1cc(-c2noc(C3CCN(C(=O)OC(C)(C)C)CC3)n2)ccc1OC,Eur J Med Chem,CHEMBL1798012,96100,96.1,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CCCCOc1cc(-c2noc(C3CCN(C(=O)OC(C)(C)C)CC3)n2)ccc1OC,Eur J Med Chem,CHEMBL1798013,91000,91,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2noc(C3CCN(C(=O)OC(C)(C)C)CC3)n2)cc(OC)c1OC,Eur J Med Chem,CHEMBL1798015,48200,48.2,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(-c2noc(C3CCNCC3)n2)cc1OC,Eur J Med Chem,CHEMBL1795417,38800,38.8,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CCCCOc1cc(-c2noc(C3CCNCC3)n2)ccc1OC,Eur J Med Chem,CHEMBL1795419,32500,32.5,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(-c2noc(C3CCNCC3)n2)ccc1OC1CCCC1,Eur J Med Chem,CHEMBL1795420,42200,42.2,No
CHEMBL1799178,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CCOC(=O)N1CCC(c2nc(-c3ccc(OC)c(OC4CCCC4)c3)no2)CC1,Eur J Med Chem,CHEMBL1795422,58700,58.7,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL806,900,0.9,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(F)cc2)NC(=S)N(c2ccc(Cl)cc2)C1=O,Eur J Med Chem,CHEMBL1807095,860,0.86,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Cl)cc2)NC(=S)N(c2ccc(F)c(Cl)c2)C1=O,Eur J Med Chem,CHEMBL1807099,98200,98.2,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Br)cc2)NC(=S)N(c2ccc(F)c(Cl)c2)C1=O,Eur J Med Chem,CHEMBL1806845,100000,100,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(F)cc2)NC(=S)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806846,100000,100,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Cl)cc2)NC(=S)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806847,960,0.96,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Br)cc2)NC(=S)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806848,500,0.5,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(F)cc2)NC(=S)N(c2ccc(C#N)c(Cl)c2)C1=O,Eur J Med Chem,CHEMBL1806849,93200,93.2,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Br)cc2)NC(=S)N(c2ccc(C#N)c(Cl)c2)C1=O,Eur J Med Chem,CHEMBL1806851,100000,100,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(F)cc2)NC(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806852,100000,100,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Cl)cc2)NC(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806853,507,0.507,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Br)cc2)NC(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806854,880,0.88,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(F)cc2)NC(=S)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806855,33000,33,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Cl)cc2)NC(=S)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806856,939,0.939,Yes
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,C[C@]1([C@@H](O)c2ccc(Br)cc2)NC(=S)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1806857,73400,73.4,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,CC1(C(O)c2ccc(F)cc2)OC(=S)N(c2ccc(Cl)cc2)C1=O,Eur J Med Chem,CHEMBL1806858,100000,100,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,CC1(C(O)c2ccc(Br)cc2)OC(=S)N(c2ccc(F)cc2)C1=O,Eur J Med Chem,CHEMBL1807011,54000,54,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,CC1(C(O)c2ccc(Cl)cc2)OC(=S)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1807016,84000,84,No
CHEMBL1810449,Anticancer activity against human LNCAP cells after 24 hrs by MTT assay in presence of testosterone,CC1(C(O)c2ccc(Br)cc2)OC(=S)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,Eur J Med Chem,CHEMBL1807017,70000,70,No
CHEMBL1817281,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,Nc1ncnc2c1c(-c1cccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,CHEMBL1814768,18,0.018,Yes
CHEMBL1817281,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,Nc1ncnc2c1c(-c1ccoc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,CHEMBL1814769,112,0.112,Yes
CHEMBL1817281,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,Nc1ncnc2c1c(-c1ccsc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,CHEMBL1814770,68,0.068,Yes
CHEMBL1817281,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,Nc1ncnc2c1c(-c1cc[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,CHEMBL1814773,21,0.021,Yes
CHEMBL1817281,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,J Med Chem,CHEMBL888,512,0.512,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C)cc3)n2)cc(OC)c1O,Bioorg Med Chem,CHEMBL1813152,130,0.13,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(Cl)cc3)n2)cc(OC)c1O,Bioorg Med Chem,CHEMBL1813153,550,0.55,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc(C(=O)c2cn(Cc3ccccc3)c(-c3ccc(C)cc3)n2)cc(OC)c1OC,Bioorg Med Chem,CHEMBL1813154,680,0.68,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc(C(=O)c2cn(C)c(-c3ccc(C)cc3)n2)cc(OC)c1OC,Bioorg Med Chem,CHEMBL1813155,30,0.03,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1ccc(S(=O)(=O)n2cc(C(=O)c3ccc(F)cc3)nc2-c2ccc(N(C)C)cc2)cc1,Bioorg Med Chem,CHEMBL1813157,70,0.07,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(Br)cc3)n2)cc(OC)c1OC,Bioorg Med Chem,CHEMBL1813158,30,0.03,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1ccc2[nH]c(C(=O)c3cc(OC)c(OC)c(OC)c3)cc2c1,Bioorg Med Chem,CHEMBL140681,50,0.05,Yes
CHEMBL1816399,Antiproliferative activity against human LNCAP cells after 96 hrs by sulforhodamine B assay,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,Bioorg Med Chem,CHEMBL107,20,0.02,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)[C@@H]2CSC(c3ccc(O[Si](C)(C)C(C)(C)C)cc3)=N2)cc(OC)c1OC,J Med Chem,CHEMBL1830229,549,0.549,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(/C(=C/C#N)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830217,580,0.58,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1.Cl,J Med Chem,CHEMBL1830238,658,0.658,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(/C(=N/O)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830210,169,0.169,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2coc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830200,331,0.331,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2cc(-c3ccccc3)n[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL1830206,101,0.101,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2cccc(-c3ccccc3)c2)cc(OC)c1OC,J Med Chem,CHEMBL1830201,52,0.052,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(O)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830197,103,0.103,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459773,28,0.028,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3cc4ccccc4[nH]3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830230,28,0.028,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2cccc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830203,27,0.027,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(/C(=N\C#N)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830219,23,0.023,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3)c2)cc(OC)c1OC,J Med Chem,CHEMBL1830205,17,0.017,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2ccc(-c3ccccc3)o2)cc(OC)c1OC,J Med Chem,CHEMBL1830204,23,0.023,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(Nc3ccc(C)cc3)n2)cc(OC)c1OC.Cl,J Med Chem,CHEMBL1830236,35,0.035,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(Nc3ccc(F)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830237,41,0.041,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(Nc3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830198,51,0.051,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc(CN)cc3)n2)cc(OC)c1OC.Cl,J Med Chem,CHEMBL1830233,13,0.013,Yes
CHEMBL1832179,Anticancer activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccc4[nH]ccc4c3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830231,10,0.01,Yes
CHEMBL1839442,Cytotoxicity against androgen receptor-positive human LNCAP cells after 24 hrs by MTT assay,COc1cc2c(c3c1c(=O)c1cccnc1n3C)C[C@H]([C@@]1(C)CO1)O2,Bioorg Med Chem Lett,CHEMBL1836989,480,0.48,Yes
CHEMBL1839441,Cytotoxicity against androgen receptor-positive human LNCAP cells after 48 hrs by MTT assay,COc1cc2c(c3c1c(=O)c1cccnc1n3C)C[C@H]([C@@]1(C)CO1)O2,Bioorg Med Chem Lett,CHEMBL1836989,140,0.14,Yes
CHEMBL1839441,Cytotoxicity against androgen receptor-positive human LNCAP cells after 48 hrs by MTT assay,COc1cc2c(c3c1c(=O)c1cccnc1n3C)C[C@H]([C@]1(C)CO1)O2,Bioorg Med Chem Lett,CHEMBL1836990,860,0.86,Yes
CHEMBL1839678,Cytotoxicity against human LNCAP cells by propidium iodide staining,CCCCCCCCCCCC/C=C\N(NC(=O)COC)C(=O)CCCCCCCCC,Bioorg Med Chem Lett,CHEMBL1834207,957,0.957,Yes
CHEMBL1839589,Cytotoxicity against human LNCAP cells,COc1ccc2c(-c3nsc(-c4c[nH]c5cc(OC)ccc45)n3)c[nH]c2c1,Bioorg Med Chem Lett,CHEMBL1834035,35800,35.8,No
CHEMBL1839589,Cytotoxicity against human LNCAP cells,c1ccc2c(Cc3nsc(Cc4c[nH]c5ccccc45)n3)c[nH]c2c1,Bioorg Med Chem Lett,CHEMBL1834038,43300,43.3,No
CHEMBL1839589,Cytotoxicity against human LNCAP cells,Brc1ccc2c(-c3nsc(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1,Bioorg Med Chem Lett,CHEMBL1834034,80100,80.1,No
CHEMBL1925687,"Cytotoxicity against human LNCAP cells expressing AR, wild type p53, BimEL, BimL and BimS assessed as growth inhibition after 24 hrs by MTS assay",CCCCC/C=C\C/C=C\CCCCCCCC(=O)C[C@@H](O)COC(C)=O,Bioorg Med Chem,CHEMBL465370,22000,22,No
CHEMBL1932411,Cytotoxicity against human LNCAP cells after 4 days by propidium iodide staining-based fluorometric analysis,COc1ccc2[nH]c(C(=O)c3cc4c(Nc5ccc(F)c(Cl)c5)ncnc4s3)cc2c1,Bioorg Med Chem,CHEMBL1928312,32500,32.5,No
CHEMBL1936635,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1,Bioorg Med Chem Lett,CHEMBL1933582,26,0.026,Yes
CHEMBL1936635,Antiproliferative activity against human LNCAP cells,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1,Bioorg Med Chem Lett,CHEMBL1933576,280,0.28,Yes
CHEMBL1936655,Cytotoxicity against human LNCAP cells,O=C(N/N=C\c1cn(Cc2ccc(Cl)cc2)c2cc(F)ccc12)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,CHEMBL1933942,55200,55.2,No
CHEMBL1936655,Cytotoxicity against human LNCAP cells,O=C(N/N=C\c1cn(Cc2ccc(Cl)cc2)c2cc(F)ccc12)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,CHEMBL1933944,24800,24.8,No
CHEMBL1936655,Cytotoxicity against human LNCAP cells,COc1ccc(Cn2cc(/C=N\NC(=O)c3c[nH]c4ccccc34)c3ccccc32)cc1,Bioorg Med Chem Lett,CHEMBL1933945,31900,31.9,No
CHEMBL1953408,Cytotoxicity against human LNCAP cells after 24 hrs by WST-1 assay,CCCCCCCCCCCCC[C@H](O)C[C@H](O)[C@H](C)NC,ACS Med Chem Lett,CHEMBL1951765,25000,25,No
CHEMBL1953408,Cytotoxicity against human LNCAP cells after 24 hrs by WST-1 assay,CCCCCCCCCCCCC[C@@H](O)C[C@@H](O)[C@H](C)N,ACS Med Chem Lett,CHEMBL1951764,50000,50,No
CHEMBL1960761,Cytotoxicity against human androgen-dependent LNCAP cells by MTT assay,CC(O)(CSc1ccc(Cl)cc1)c1nc(-c2ccc(F)c(Cl)c2)no1,Bioorg Med Chem Lett,CHEMBL1955954,26400,26.4,No
CHEMBL1960761,Cytotoxicity against human androgen-dependent LNCAP cells by MTT assay,CC(O)(CSc1ccc(Br)cc1)c1nc(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)no1,Bioorg Med Chem Lett,CHEMBL1955941,40000,40,No
CHEMBL2016165,Antiproliferative activity against human LNCAP cells after 72 to 144 hrs,Cc1cn(-c2ccc3c(C)nc(N)nc3c2)c2c1C(=O)CC(C)(C)C2,Bioorg Med Chem Lett,CHEMBL2011854,15,0.015,Yes
CHEMBL2014052,Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay,COC1=C2c3c4c5c(c(O)cc(OC)c5c5c(OC)cc(O)c(c35)C1=O)C(=O)[C@@H](OC)[C@@]41C[C@H](C)O[C@]2(O)[C@]1(C)O,J Nat Prod,CHEMBL2011657,24920,24.92,No
CHEMBL2025147,Cytostatic activity against human LNCAP cells after 4 days by MTT assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Eur J Med Chem,CHEMBL178,100,0.1,Yes
CHEMBL2025147,Cytostatic activity against human LNCAP cells after 4 days by MTT assay,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,Eur J Med Chem,CHEMBL34259,300,0.3,Yes
CHEMBL2025147,Cytostatic activity against human LNCAP cells after 4 days by MTT assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/OCC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCNC(=O)[C@H](CCC(=O)O)NC(=O)c1ccc(N(C)Cc2cnc4nc(N)nc(N)c4n2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Eur J Med Chem,CHEMBL2022064,28800,28.8,No
CHEMBL2039131,Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,Bioorg Med Chem,CHEMBL408,22000,22,No
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc2c(F)cccc12,Bioorg Med Chem Lett,CHEMBL2042472,250,0.25,Yes
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc2c(Br)cccc12,Bioorg Med Chem Lett,CHEMBL2042473,280,0.28,Yes
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1ccc(C2C(C#N)=C(N)Oc3cc(N(C)C)ccc32)c2ccccc12,Bioorg Med Chem Lett,CHEMBL2042474,760,0.76,Yes
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(F)c2ccccc12,Bioorg Med Chem Lett,CHEMBL2042555,410,0.41,Yes
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(N(C)C)c2ccccc12,Bioorg Med Chem Lett,CHEMBL2042556,140,0.14,Yes
CHEMBL2043898,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,Bioorg Med Chem Lett,CHEMBL107,20,0.02,Yes
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,Bioorg Med Chem,CHEMBL116438,36400,36.4,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem,CHEMBL409,74000,74,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Bioorg Med Chem,CHEMBL806,81800,81.8,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OC)c(OC)c2)ccc1O,Bioorg Med Chem,CHEMBL494826,47000,47,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC(C)(C)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c(OC)c2)ccc1O,Bioorg Med Chem,CHEMBL2048691,55000,55,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC(C)(C)C(=O)Nc3ccc(F)c(C(F)(F)F)c3)c(OC)c2)ccc1O,Bioorg Med Chem,CHEMBL2048692,54800,54.8,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCC(C)(O)C(=O)Nc3ccc([N+](=O)[O-])c(C(F)(F)F)c3)c(OC)c2)cc1OC,Bioorg Med Chem,CHEMBL2048698,41800,41.8,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCC(C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c(OC)c2)cc1OC,Bioorg Med Chem,CHEMBL2048699,73000,73,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCCCC(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c(OC)c2)cc1OC,Bioorg Med Chem,CHEMBL2048700,96300,96.3,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1ccc(/C=C/C(=O)/C(F)=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,Bioorg Med Chem,CHEMBL2048800,27300,27.3,No
CHEMBL2051321,Cytotoxicity against androgen-dependent human LNCAP cells after 72 hrs by SRB assay,COc1ccc(/C=C/C(=O)C(F)(F)C(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,Bioorg Med Chem,CHEMBL2048801,53800,53.8,No
CHEMBL2049791,Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay,O=C(CCCO[N+](=O)[O-])Oc1ccccc1C(=O)Oc1ccc(-c2cc(=S)ss2)cc1,ACS Med Chem Lett,CHEMBL2047532,88,0.088,Yes
CHEMBL2049791,Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay,O=C(CCC(=O)Oc1ccccc1C(=O)Oc1ccc(-c2cc(=S)ss2)cc1)OCCCCO[N+](=O)[O-],ACS Med Chem Lett,CHEMBL2047533,100,0.1,Yes
CHEMBL2049791,Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay,O=C(CCCC[C@@H]1CCSS1)Oc1ccccc1C(=O)OCCCCO[N+](=O)[O-],ACS Med Chem Lett,CHEMBL2047535,500,0.5,Yes
CHEMBL2061378,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay in presence of 10% FBS,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,J Med Chem,CHEMBL7002,60000,60,No
CHEMBL2061378,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay in presence of 10% FBS,CC1(COc2ccc(/C=C3\SC(O)=NC3=O)cc2)CCCCC1,J Med Chem,CHEMBL260373,28000,28,No
CHEMBL2064892,Cytotoxicity against human LNCAP cells after 4 days by MTT assay,CC(C)=CCCC(C)C12C=CC(C)(CC1)OO2,Bioorg Med Chem,CHEMBL2064724,23400,23.4,No
CHEMBL2065396,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc(Nc2nnc(-c3c[nH]c4ccccc34)s2)cc(OC)c1OC,Eur J Med Chem,CHEMBL2064076,150,0.15,Yes
CHEMBL2090142,Antineoplastic activity against human LNCAP cells after 24 hrs by MTT assay,O=C1O/C(=C/Br)CCC1c1ccccc1,Bioorg Med Chem Lett,CHEMBL2088285,31000,31,No
CHEMBL2090142,Antineoplastic activity against human LNCAP cells after 24 hrs by MTT assay,C#CCN1C/C(=C\I)OC(=O)[C@@H]1c1ccccc1,Bioorg Med Chem Lett,CHEMBL2088288,26000,26,No
CHEMBL2090142,Antineoplastic activity against human LNCAP cells after 24 hrs by MTT assay,C#CCN1C/C(=C\Br)OC(=O)[C@@H]1Cc1ccccc1,Bioorg Med Chem Lett,CHEMBL2088289,41000,41,No
CHEMBL2090142,Antineoplastic activity against human LNCAP cells after 24 hrs by MTT assay,C#CCN1CC(=O)O/C(=C/Br)C1,Bioorg Med Chem Lett,CHEMBL2088290,25000,25,No
CHEMBL2090141,Antineoplastic activity against human LNCAP cells after 48 hrs by MTT assay,C#CCN1C/C(=C\I)OC(=O)[C@@H]1c1ccccc1,Bioorg Med Chem Lett,CHEMBL2088288,23000,23,No
CHEMBL2090141,Antineoplastic activity against human LNCAP cells after 48 hrs by MTT assay,C#CCN1C/C(=C\Br)OC(=O)[C@@H]1Cc1ccccc1,Bioorg Med Chem Lett,CHEMBL2088289,26000,26,No
CHEMBL2090141,Antineoplastic activity against human LNCAP cells after 48 hrs by MTT assay,C#CCN1CC(=O)O/C(=C/Br)C1,Bioorg Med Chem Lett,CHEMBL2088290,29000,29,No
CHEMBL2090140,Antineoplastic activity against human LNCAP cells after 72 hrs by MTT assay,C#CCN1C/C(=C\I)OC(=O)[C@@H]1c1ccccc1,Bioorg Med Chem Lett,CHEMBL2088288,20000,20,No
CHEMBL2090140,Antineoplastic activity against human LNCAP cells after 72 hrs by MTT assay,C#CCN1C/C(=C\Br)OC(=O)[C@@H]1Cc1ccccc1,Bioorg Med Chem Lett,CHEMBL2088289,32000,32,No
CHEMBL2090140,Antineoplastic activity against human LNCAP cells after 72 hrs by MTT assay,C#CCN1CC(=O)O/C(=C/Br)C1,Bioorg Med Chem Lett,CHEMBL2088290,28000,28,No
CHEMBL2169234,Cytotoxicity against human LNCAP cells incubated for 72 hrs by MTT assay,Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2,J Med Chem,CHEMBL2165454,600,0.6,Yes
CHEMBL2169234,Cytotoxicity against human LNCAP cells incubated for 72 hrs by MTT assay,Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCC(C)(C)C2,J Med Chem,CHEMBL2165461,700,0.7,Yes
CHEMBL2169234,Cytotoxicity against human LNCAP cells incubated for 72 hrs by MTT assay,Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C,J Med Chem,CHEMBL187266,500,0.5,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,J Med Chem,CHEMBL107,16.3,0.0163,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3csc4ccccc34)n2)cc(OC)c1OC,J Med Chem,CHEMBL2163635,29.1,0.0291,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3coc4ccccc34)n2)cc(OC)c1OC,J Med Chem,CHEMBL2163634,14.1,0.0141,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2cn(C)c(-c3cn(C)c4ccccc34)n2)cc(OC)c1OC,J Med Chem,CHEMBL2163633,35.9,0.0359,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3cn(S(=O)(=O)c4ccccc4)c4ccccc34)n2)cc(OC)c1OC,J Med Chem,CHEMBL2163632,107,0.107,Yes
CHEMBL2168102,Antiproliferative activity against human LNCAP cells after 48 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3c[nH]c4ccccc34)n2)cc(OC)c1OC,J Med Chem,CHEMBL2163631,2.8,0.0028,Yes
CHEMBL2168449,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CCN(CCO)CCCC#C[C@H]1CC[C@H](N(C)C(=O)Oc2ccc(Cl)cc2)CC1.Cl,J Med Chem,CHEMBL2164234,23600,23.6,No
CHEMBL2175072,Cytotoxicity against human LNCAP cells measured on day 7 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=O)/C=C(/C)C(=O)[O-].[Na+],J Med Chem,CHEMBL2171645,458,0.458,Yes
CHEMBL2175072,Cytotoxicity against human LNCAP cells measured on day 7 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=O)/C=C(/C)C(=O)O,J Med Chem,CHEMBL2171642,368,0.368,Yes
CHEMBL2175072,Cytotoxicity against human LNCAP cells measured on day 7 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=S)[S-].[Na+],J Med Chem,CHEMBL2171637,79,0.079,Yes
CHEMBL2175072,Cytotoxicity against human LNCAP cells measured on day 7 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21.Cl.Cl,J Med Chem,CHEMBL493439,31.58,0.03158,Yes
CHEMBL2175074,Cytotoxicity against human LNCAP cells measured on day 5 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21.Cl.Cl,J Med Chem,CHEMBL493439,27.82,0.02782,Yes
CHEMBL2175073,Cytotoxicity against human LNCAP cells measured on day 3 by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21.Cl.Cl,J Med Chem,CHEMBL493439,37.87,0.03787,Yes
CHEMBL2173572,Cytotoxicity against human LNCAP cells assessed as inhibition of tumor growth incubated for 72 hrs by luminometry,C[C@H](O)C(=O)N1CCC(CCn2c(Sc3cc4c(cc3Br)OCO4)nc3c(N)ncnc32)CC1,J Med Chem,CHEMBL2170470,510,0.51,Yes
CHEMBL2187639,Cytotoxicity against human LNCAP cells assessed as reduction of resazurin to resorufin after 72 hrs,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,J Med Chem,CHEMBL2177390,95,0.095,Yes
CHEMBL2216649,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O,J Nat Prod,CHEMBL501867,6.1,0.0061,Yes
CHEMBL2216649,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CCC(C)C[C@@H](C)[C@@H](O)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)[C@@H](O)[C@@H](O)C(=O)NC(C(=O)N[C@H]1C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@H]([C@H](OC)c2ccc(O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C)C(C)C(C)C(N)=O,J Nat Prod,CHEMBL2208227,110,0.11,Yes
CHEMBL2216649,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CO[C@H](c1ccc(O)cc1)[C@H]1NC(=O)[C@H](CCC(=O)O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](NC(=O)C(NC(=O)[C@H](O)[C@H](O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)[C@H](O)[C@H](C)CC(C)C)C(C)C(C)C(N)=O)[C@@H](C)OC(=O)[C@@H]2CCCCN2C1=O,J Nat Prod,CHEMBL2208228,190,0.19,Yes
CHEMBL2216649,Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay,CO[C@H](c1ccc(O)cc1)[C@H]1NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](NC(=O)C(NC(=O)[C@H](O)[C@H](O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)[C@H](O)[C@H](C)CC(C)C)C(C)C(C)C(N)=O)[C@@H](C)OC(=O)[C@@H]2CCCCN2C1=O,J Nat Prod,CHEMBL2208229,230,0.23,Yes
CHEMBL2320748,Antiproliferative activity against human LNCAP cells after 72 hrs after ATPlite kit assay,COC[C@@H]1Oc2ccc([C@H]3Oc4cc(OC)cc(OC)c4C(=O)[C@@H]3O)cc2O[C@H]1c1ccc(OC)c(OC)c1,Bioorg Med Chem,CHEMBL2313580,30100,30.1,No
CHEMBL2320748,Antiproliferative activity against human LNCAP cells after 72 hrs after ATPlite kit assay,COc1cc(O)c2c(c1)O[C@H](c1ccc3c(c1)O[C@@H](c1ccc(O)c(OC)c1)[C@H](CO)O3)[C@@H](O)C2=O,Bioorg Med Chem,CHEMBL2313578,20100,20.1,No
CHEMBL2320748,Antiproliferative activity against human LNCAP cells after 72 hrs after ATPlite kit assay,COc1cc(OC)c2c(c1)O[C@H](c1ccc3c(c1)O[C@@H](c1ccc(OC)c(OC)c1)[C@H](CO)O3)[C@@H](O)C2=O,Bioorg Med Chem,CHEMBL2313577,40700,40.7,No
CHEMBL2320748,Antiproliferative activity against human LNCAP cells after 72 hrs after ATPlite kit assay,COc1cc([C@@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@H]2CO)ccc1O,Bioorg Med Chem,CHEMBL592675,69600,69.6,No
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)c(C)[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2322319,938,0.938,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)cn2-c2ccccn2)cc(OC)c1OC,J Med Chem,CHEMBL2322317,20,0.02,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)cn2C2CCCC2)cc(OC)c1OC,J Med Chem,CHEMBL2322316,51,0.051,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)cn2C(C)C)cc(OC)c1OC,J Med Chem,CHEMBL2322315,62,0.062,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,CCCn1cc(-c2ccccc2)nc1C(=O)c1cc(OC)c(OC)c(OC)c1,J Med Chem,CHEMBL2322314,49,0.049,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)cn2Cc2ccccc2)cc(OC)c1OC,J Med Chem,CHEMBL2322313,66,0.066,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,CCn1cc(-c2ccccc2)nc1C(=O)c1cc(OC)c(OC)c(OC)c1,J Med Chem,CHEMBL2322312,29,0.029,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)cn2C)cc(OC)c1OC,J Med Chem,CHEMBL2322311,10,0.01,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1ccc(C(=O)c2nc(-c3cc(OC)c(OC)c(OC)c3)c[nH]2)cc1,J Med Chem,CHEMBL2324338,708,0.708,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(-c2c[nH]c(C(=O)c3ccc(Br)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL2324337,131,0.131,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(-c2c[nH]c(C(=O)c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL2324336,195,0.195,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(O)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2324335,219,0.219,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(N(C)C)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2324334,96,0.096,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1ccc(-c2c[nH]c(C(=O)c3cc(OC)c(OC)c(OC)c3)n2)cc1,J Med Chem,CHEMBL2324333,30,0.03,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(C)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2321902,13,0.013,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(C(F)(F)F)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2323924,47,0.047,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(Br)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2323923,15,0.015,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(Cl)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2323922,22,0.022,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccc(F)cc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2323921,114,0.114,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2nc(-c3ccccc3)c[nH]2)cc(OC)c1OC,J Med Chem,CHEMBL2323920,6,0.006,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C(C)(C)C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL2323906,423,0.423,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C(C)C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL2323905,171,0.171,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,CCc1ccc(-c2nc(C(=O)c3cc(OC)c(OC)c(OC)c3)c[nH]2)cc1,J Med Chem,CHEMBL2323904,9,0.009,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3ccc(C)cc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1272023,12,0.012,Yes
CHEMBL2330839,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 96 hrs by SRB assay,COc1cc(C(=O)c2c[nH]c(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1271737,152,0.152,Yes
CHEMBL2340541,Cytotoxicity against human androgen-dependent LNCAP cells after 6 days by MTS/PMS assay,COc1ccc2c(c1OC)CCN(c1ccc(C(=O)Nc3cccc(C)n3)cn1)C2,J Med Chem,CHEMBL2336980,680,0.68,Yes
CHEMBL2395504,Cytotoxicity against human LNCAP cells expressing androgen receptor after 72 hrs by MTT assay,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL139835,43000,43,No
CHEMBL2399206,Cytotoxicity against human LNCAP cells assessed as cell viability after 2 days by cell counting method,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL409,23790,23.79,No
CHEMBL2399206,Cytotoxicity against human LNCAP cells assessed as cell viability after 2 days by cell counting method,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(F)c(Cl)c3)nc2C)c1,Bioorg Med Chem Lett,CHEMBL2397336,26650,26.65,No
CHEMBL2399206,Cytotoxicity against human LNCAP cells assessed as cell viability after 2 days by cell counting method,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3cc(Cl)cc(Cl)c3)nc2C)c1,Bioorg Med Chem Lett,CHEMBL2397335,22930,22.93,No
CHEMBL2399206,Cytotoxicity against human LNCAP cells assessed as cell viability after 2 days by cell counting method,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(C#N)cc3)nc2C)c1,Bioorg Med Chem Lett,CHEMBL2397333,39020,39.02,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,CC(=O)n1cc(/C=C(/C(=O)O)c2ccc3c(c2)OCO3)c2cc(OCc3ccccc3)ccc21,Bioorg Med Chem,CHEMBL2417641,99100,99.1,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1ccc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)cc1,Bioorg Med Chem,CHEMBL2417658,85000,85,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,CC(=O)n1cc(/C=C(/C(=O)O)c2ccc(OCc3ccccc3)cc2)c2cc(OCc3ccccc3)ccc21,Bioorg Med Chem,CHEMBL2417646,77700,77.7,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1cccc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)c1,Bioorg Med Chem,CHEMBL2417639,65100,65.1,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1cc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)cc(OC)c1OC,Bioorg Med Chem,CHEMBL2417643,59600,59.6,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1ccccc1/C(=C\c1cn(C(C)=O)c2ccc(OCc3ccccc3)cc12)C(=O)O,Bioorg Med Chem,CHEMBL2417640,48500,48.5,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1ccc(OC)c(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)c1,Bioorg Med Chem,CHEMBL2417645,44100,44.1,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1ccc(Cn2cc(/C=C(/C(=O)O)c3ccccc3)c3cc(OCc4ccccc4)ccc32)cc1,Bioorg Med Chem,CHEMBL2417656,38200,38.2,No
CHEMBL2423522,Cytotoxicity against human LNCAP cells assessed as cell viability after 72 hrs by MTT assay,COc1cc(OC)cc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)c1,Bioorg Med Chem,CHEMBL2417644,26100,26.1,No
CHEMBL2445959,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Bioorg Med Chem Lett,CHEMBL53463,200,0.2,Yes
CHEMBL2445959,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,COc1ccc(CNc2ccc(OS(=O)(=O)c3ccc(C)cc3)c3c2C(=O)c2ccccc2C3=O)cc1,Bioorg Med Chem Lett,CHEMBL2442835,900,0.9,Yes
CHEMBL2445959,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,Cc1ccc(S(=O)(=O)Oc2ccc(NCc3ccc(N)cc3)c3c2C(=O)c2ccccc2C3=O)cc1,Bioorg Med Chem Lett,CHEMBL2442836,400,0.4,Yes
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCC(c1ccccc1)c1ccccc1,Bioorg Med Chem,CHEMBL2441917,20800,20.8,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccc([N+](=O)[O-])cc1,Bioorg Med Chem,CHEMBL2441916,33500,33.5,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,COc1ccc(CCOC(=O)/C=C/c2ccc(O)c(O)c2)cc1,Bioorg Med Chem,CHEMBL2441915,47300,47.3,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccc(F)cc1,Bioorg Med Chem,CHEMBL2441913,20800,20.8,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCCCc1ccccc1,Bioorg Med Chem,CHEMBL131982,26600,26.6,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCc1ccccc1,Bioorg Med Chem,CHEMBL133714,45600,45.6,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)Oc1ccccc1,Bioorg Med Chem,CHEMBL471973,65900,65.9,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,C=C(C)CCOC(=O)/C=C/c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL2441911,20600,20.6,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,CC(C)CCOC(=O)/C=C/c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL490372,45400,45.4,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,CCCCOC(=O)/C=C/c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL29489,45400,45.4,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,CC(C)OC(=O)/C=C/c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL481890,51900,51.9,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,CCCOC(=O)/C=C/c1ccc(O)c(O)c1,Bioorg Med Chem,CHEMBL17362,60700,60.7,No
CHEMBL2444378,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,Bioorg Med Chem,CHEMBL319244,33700,33.7,No
CHEMBL3117746,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CCCC[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C,J Med Chem,CHEMBL3115764,90000,90,No
CHEMBL3117746,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL3115771,40000,40,No
CHEMBL3117746,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC/C=C/CNC(=N)N)C(C)C,J Med Chem,CHEMBL3115770,70000,70,No
CHEMBL3117746,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CCCC[C@@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C,J Med Chem,CHEMBL3115769,90000,90,No
CHEMBL3227704,Inhibition of human LNCAP cell proliferation,COc1cccc(-c2cc(C(=O)Nc3cc4cc(OC)c(OC(C)=O)c(C)c4oc3=O)ccc2OC)c1,Medchemcomm,CHEMBL1652176,420,0.42,Yes
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cc(C(=O)/C=C/c2ccc[nH]2)cc(OC)c1OC,Medchemcomm,CHEMBL3219603,59900,59.9,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1ccc(C(=O)/C=C/c2cccn2C)cc1,Medchemcomm,CHEMBL3219604,75500,75.5,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1ccc(C(=O)/C=C/c2cccn2C)cc1OC,Medchemcomm,CHEMBL3219605,56300,56.3,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cc(C(=O)/C=C/c2cccn2C)cc(OC)c1OC,Medchemcomm,CHEMBL3219606,69500,69.5,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1ccc(C(=O)/C=C/c2cncn2C)cc1,Medchemcomm,CHEMBL3219607,33500,33.5,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1ccc(C(=O)/C=C/c2cnc[nH]2)cc1OC,Medchemcomm,CHEMBL3219608,46200,46.2,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cc(C(=O)/C=C/c2cnc[nH]2)cc(OC)c1OC,Medchemcomm,CHEMBL3217775,48100,48.1,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cc(C(=O)/C=C/c2cncn2C)cc(OC)c1OC,Medchemcomm,CHEMBL3219610,30600,30.6,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cc(C(=O)/C=C/c2cn(C)cn2)cc(OC)c1OC,Medchemcomm,CHEMBL3219611,48400,48.4,No
CHEMBL3225961,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by MTS assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Medchemcomm,CHEMBL53463,154,0.154,Yes
CHEMBL3295142,Cytotoxicity against human LNCAP cells assessed as cell viability after 24 hrs by MTT assay,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,J Med Chem,CHEMBL116438,36000,36,No
CHEMBL3295142,Cytotoxicity against human LNCAP cells assessed as cell viability after 24 hrs by MTT assay,COc1cc(/C=C/C(=O)/C=C/c2cc(F)c(O)c(OC)c2)cc(F)c1O,J Med Chem,CHEMBL3290186,25100,25.1,No
CHEMBL3295142,Cytotoxicity against human LNCAP cells assessed as cell viability after 24 hrs by MTT assay,COc1cc(/C=C/C(=O)/C=C/c2cc(CC=C(C)C)c(O)c(OC)c2)cc(CC=C(C)C)c1O,J Med Chem,CHEMBL2392188,43800,43.8,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccccn4)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354480,42270,42.27,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccccc4C)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3352838,35760,35.76,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccc(C)cc4)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354482,35210,35.21,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4cc(C)ccc4C)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354484,36120,36.12,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccccc4OC)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354485,26290,26.29,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4cccc(OC)c4)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354488,20040,20.04,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4cc(Cl)ccc4OC)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354489,39810,39.81,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccc(F)cc4)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354923,35040,35.04,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccccc4Cl)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354925,32470,32.47,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4cccc(Cl)c4)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354927,36570,36.57,No
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1cc(OC)cc(OCc2ccc(CCN3CCN(c4ccccc4S(C)(=O)=O)CC3)cc2)c1.Cl,Bioorg Med Chem Lett,CHEMBL3354934,970,0.97,Yes
CHEMBL3378460,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 24 hrs by CCK-8 assay,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1,Bioorg Med Chem Lett,CHEMBL142635,22360,22.36,No
CHEMBL3389719,Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay,Cc1cc(C#CC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)ccc1F,Bioorg Med Chem,CHEMBL3357746,38400,38.4,No
CHEMBL3389719,Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay,Cc1cc(C)c(C#CC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)cc1C,Bioorg Med Chem,CHEMBL3357747,46200,46.2,No
CHEMBL3387880,Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay,COc1ccc(C#CC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)c(C)c1,Bioorg Med Chem,CHEMBL3357748,41700,41.7,No
CHEMBL3389719,Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(C#CC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)c(C)c1,Bioorg Med Chem,CHEMBL3357748,30800,30.8,No
CHEMBL3387880,Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)C#Cc1cccc(C(F)(F)F)c1,Bioorg Med Chem,CHEMBL3357750,26200,26.2,No
CHEMBL3389719,Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(C#CC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)cc1,Bioorg Med Chem,CHEMBL3357752,47600,47.6,No
CHEMBL3361817,Cytotoxicity against human LNCAP cells after 72 hrs by Alamar Blue assay,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,Bioorg Med Chem Lett,CHEMBL602937,540,0.54,Yes
CHEMBL3361817,Cytotoxicity against human LNCAP cells after 72 hrs by Alamar Blue assay,O=C1c2ccccc2-n2c1c1[nH]c3ccccc3c1cc2=O,Bioorg Med Chem Lett,CHEMBL3309494,22900,22.9,No
CHEMBL3361817,Cytotoxicity against human LNCAP cells after 72 hrs by Alamar Blue assay,O=C(O)c1ccccc1-n1ccc2c([nH]c3ccccc32)c1=O,Bioorg Med Chem Lett,CHEMBL3309495,44900,44.9,No
CHEMBL3361817,Cytotoxicity against human LNCAP cells after 72 hrs by Alamar Blue assay,O=C(O)c1ccccc1-[n+]1ccc2c(c1)[nH]c1ccccc12.[Cl-],Bioorg Med Chem Lett,CHEMBL487608,25860,25.86,No
CHEMBL3361817,Cytotoxicity against human LNCAP cells after 72 hrs by Alamar Blue assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Bioorg Med Chem Lett,CHEMBL53463,13.52,0.01352,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(S(C)(=O)=O)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327121,850,0.85,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(C#N)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327120,480,0.48,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(N)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327118,50,0.05,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc(N)c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327117,180,0.18,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COc1cc(CNC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)ccc1O,Eur J Med Chem,CHEMBL3327112,140,0.14,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(Cl)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327100,770,0.77,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccccc3Cl)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327098,410,0.41,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(S(N)(=O)=O)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327122,960,0.96,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(OC(F)(F)F)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327125,570,0.57,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc([N+](=O)[O-])c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327126,340,0.34,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Eur J Med Chem,CHEMBL109480,160,0.16,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Eur J Med Chem,CHEMBL278315,430,0.43,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccsc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327127,680,0.68,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cncn3C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327128,440,0.44,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(Cl)nc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327129,510,0.51,Yes
CHEMBL3364915,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(C(F)(F)F)nc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,Eur J Med Chem,CHEMBL3327130,350,0.35,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(-c2cccc3[nH]c(-c4ccc5[nH]ccc5c4)nc23)cc(OC)c1OC,J Med Chem,CHEMBL3326468,28,0.028,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(-c2cccc3[nH]c(-c4c[nH]c5ccccc45)nc23)cc(OC)c1OC,J Med Chem,CHEMBL3326469,800,0.8,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(-c2nccc3[nH]c(-c4ccc5[nH]ccc5c4)nc23)cc(OC)c1OC,J Med Chem,CHEMBL3326471,5,0.005,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL459773,28,0.028,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COCOc1c(OC)cc(C(=O)c2csc(-c3ccccc3)n2)cc1OC,J Med Chem,CHEMBL3326070,31,0.031,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(-c3ccccc3)n2)cc(OC)c1OCCN,J Med Chem,CHEMBL3326072,117,0.117,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(Nc3ccc4[nH]ccc4c3)n2)cc(OC)c1OC,J Med Chem,CHEMBL3326074,13,0.013,Yes
CHEMBL3372006,Antiproliferative activity against human LNCAP cells after 96 hrs by SRB assay,COc1cc(C(=O)c2csc(Nc3ccccc3)n2)cc(OC)c1OC,J Med Chem,CHEMBL1830198,28,0.028,Yes
CHEMBL3368101,Growth inhibition of human LNCAP cells expressing androgen receptor after 144 hrs,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CCCCCCC(=O)NCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)O,J Med Chem,CHEMBL3341968,217,0.217,Yes
CHEMBL3369089,Antiproliferative activity against human LNCAP cells after 4 days by MTS assay,Cc1ccc(CN(C(=O)c2cc3ccc(F)cc3[nH]2)C(C)C)o1,J Med Chem,CHEMBL3318068,550,0.55,Yes
CHEMBL3382596,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth after 24 hrs by MTS assay,C[C@]12C[C@H](N3CCN(C(=O)[C@@H]4CCCN4C(=O)c4ccc5ccccc5n4)CC3)[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,Bioorg Med Chem,CHEMBL3344120,800,0.8,Yes
CHEMBL3382596,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth after 24 hrs by MTS assay,C[C@]12C[C@H](N3CCN(C(=O)[C@@H]4CCCN4C(=O)c4cccc5ccccc45)CC3)[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,Bioorg Med Chem,CHEMBL3344114,300,0.3,Yes
CHEMBL3382596,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth after 24 hrs by MTS assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,Bioorg Med Chem,CHEMBL53463,200,0.2,Yes
CHEMBL3382596,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth after 24 hrs by MTS assay,C[C@]12C[C@H](N3CCN(C(=O)[C@@H]4CCCN4C(=O)c4cc5ccccc5cn4)CC3)[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,Bioorg Med Chem,CHEMBL3344111,70,0.07,Yes
CHEMBL3382596,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth after 24 hrs by MTS assay,C[C@]12C[C@H](N3CCN(C(=O)[C@@H]4CCCN4C(=O)c4ccc5ccccc5n4)CC3)[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,Bioorg Med Chem,CHEMBL3344109,40,0.04,Yes
CHEMBL3375837,Growth inhibition of human LNCAP cells,CC(O)(CS(=O)(=O)c1ccc(F)cc1)c1cn(-c2ccc(C#N)c(C(F)(F)F)c2)nn1,Bioorg Med Chem Lett,CHEMBL3335797,45000,45,No
CHEMBL3375837,Growth inhibition of human LNCAP cells,CC(O)(CS(=O)(=O)c1ccc(F)cc1)c1cn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)nn1,Bioorg Med Chem Lett,CHEMBL3335798,36000,36,No
CHEMBL3375837,Growth inhibition of human LNCAP cells,CC(O)(CS(=O)(=O)c1ccccc1)c1cn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)nn1,Bioorg Med Chem Lett,CHEMBL3335802,34000,34,No
CHEMBL3375837,Growth inhibition of human LNCAP cells,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL409,30000,30,No
CHEMBL3384506,Cytotoxicity against human LNCAP cells after 48 hrs by WST-1 assay,C/C=C(/C)C(=O)O[C@@H]1C[C@H]2C(=C1C)[C@@H]1OC(=O)[C@@](C)(O)[C@@]1(O)[C@@H](OC(=O)[C@@H](C)CC)C[C@]2(C)OC(C)=O,J Med Chem,CHEMBL3343188,500,0.5,Yes
CHEMBL3384506,Cytotoxicity against human LNCAP cells after 48 hrs by WST-1 assay,C/C=C(/C)C(=O)O[C@@H]1C[C@H]2C(=C1C)[C@@H]1OC(=O)[C@@](C)(O)[C@@]1(O)[C@@H](OC(=O)CCOCCOCCOCCOCCn1cc(COc3ccc(C4=C5C=CC=[N+]5[B-](F)(F)n5cccc54)cc3)nn1)C[C@]2(C)OC(C)=O,J Med Chem,CHEMBL3343191,400,0.4,Yes
CHEMBL3384507,Cytotoxicity against human LNCAP cells after 72 hrs by WST-1 assay,C/C=C(/C)C(=O)O[C@@H]1C[C@H]2C(=C1C)[C@@H]1OC(=O)[C@@](C)(O)[C@@]1(O)[C@@H](OC(=O)[C@@H](C)CC)C[C@]2(C)OC(C)=O,J Med Chem,CHEMBL3343188,400,0.4,Yes
CHEMBL3384507,Cytotoxicity against human LNCAP cells after 72 hrs by WST-1 assay,C/C=C(/C)C(=O)O[C@@H]1C[C@H]2C(=C1C)[C@@H]1OC(=O)[C@@](C)(O)[C@@]1(O)[C@@H](OC(=O)CCOCCOCCOCCOCCn1cc(COc3ccc(C4=C5C=CC=[N+]5[B-](F)(F)n5cccc54)cc3)nn1)C[C@]2(C)OC(C)=O,J Med Chem,CHEMBL3343191,20500,20.5,No
CHEMBL3413429,Cytotoxicity against human LNCAP cells,CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,J Med Chem,CHEMBL2381408,100,0.1,Yes
CHEMBL3421405,Cytotoxicity against human LNCAP cells after 48 hrs by WST-8 assay,COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1,Eur J Med Chem,CHEMBL3415014,52310,52.31,No
CHEMBL3421405,Cytotoxicity against human LNCAP cells after 48 hrs by WST-8 assay,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1,Eur J Med Chem,CHEMBL3415017,26730,26.73,No
CHEMBL3421405,Cytotoxicity against human LNCAP cells after 48 hrs by WST-8 assay,COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,Eur J Med Chem,CHEMBL3415018,28440,28.44,No
CHEMBL3421405,Cytotoxicity against human LNCAP cells after 48 hrs by WST-8 assay,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1,Eur J Med Chem,CHEMBL3415020,25540,25.54,No
CHEMBL3421405,Cytotoxicity against human LNCAP cells after 48 hrs by WST-8 assay,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,Eur J Med Chem,CHEMBL707,27890,27.89,No
CHEMBL3420445,Cytotoxicity against human LNCAP cells incubated for 72 hrs by sulforhodamine B assay,Ic1ccc(OCCCCCn2ccnc2)cc1,Eur J Med Chem,CHEMBL3415244,27790,27.79,No
CHEMBL3420445,Cytotoxicity against human LNCAP cells incubated for 72 hrs by sulforhodamine B assay,c1ccc2sc(SCCCn3ccnc3)nc2c1,Eur J Med Chem,CHEMBL3415248,55030,55.03,No
CHEMBL3420445,Cytotoxicity against human LNCAP cells incubated for 72 hrs by sulforhodamine B assay,c1ccc2sc(SCCCCn3ccnc3)nc2c1,Eur J Med Chem,CHEMBL3415249,54730,54.73,No
CHEMBL3420445,Cytotoxicity against human LNCAP cells incubated for 72 hrs by sulforhodamine B assay,Brc1cccc(OCCCCn2ccnc2)c1,Eur J Med Chem,CHEMBL482686,27610,27.61,No
CHEMBL3419780,Antiproliferative activity against human LNCAP cells assessed as suppression of cell viability after 24 hrs by MTT assay,CC(C)CCCC1(C)CCc2cc(O)cc(O)c2O1,J Med Chem,CHEMBL3414678,27000,27,No
CHEMBL3419780,Antiproliferative activity against human LNCAP cells assessed as suppression of cell viability after 24 hrs by MTT assay,COc1cc(O)cc2c1OC(C)(CCCC(C)C)CC2,J Med Chem,CHEMBL3414679,26000,26,No
CHEMBL3419780,Antiproliferative activity against human LNCAP cells assessed as suppression of cell viability after 24 hrs by MTT assay,CC(C)CCCC1(C)CCc2ccc(O)c(O)c2O1,J Med Chem,CHEMBL3414683,23000,23,No
CHEMBL3419780,Antiproliferative activity against human LNCAP cells assessed as suppression of cell viability after 24 hrs by MTT assay,CC(C)CCCC1(C)CCc2cc(S(N)(=O)=O)cc(F)c2O1,J Med Chem,CHEMBL3414687,20000,20,No
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CC,J Med Chem,CHEMBL3576989,590,0.59,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CCC,J Med Chem,CHEMBL3576990,780,0.78,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CCCC,J Med Chem,CHEMBL3576991,490,0.49,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCCCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CCCCC,J Med Chem,CHEMBL3576992,590,0.59,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nccn1C(C)CCC,J Med Chem,CHEMBL3576995,240,0.24,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCC(CC)n1ccnc1/C=C/C(=O)/C=C/c1nccn1C(CC)CC,J Med Chem,CHEMBL3576872,580,0.58,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CC(C)CCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CCC(C)C,J Med Chem,CHEMBL3576996,570,0.57,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CC(C)=CCn1ccnc1/C=C/C(=O)/C=C/c1nccn1CC=C(C)C,J Med Chem,CHEMBL3576997,390,0.39,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,Cn1cc(Br)c(/C=C/C(=O)/C=C/c2nn(C)cc2Br)n1,J Med Chem,CHEMBL3577001,310,0.31,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,Cc1csc(/C=C/C(=O)/C=C/c2nc(C)cs2)n1,J Med Chem,CHEMBL3577004,460,0.46,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,Cc1nc(C(F)(F)F)c(/C=C/C(=O)/C=C/c2sc(C)nc2C(F)(F)F)s1,J Med Chem,CHEMBL3577006,600,0.6,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,Cc1cccc(/C=C/C(=O)/C=C/c2cccc(C)n2)n1,J Med Chem,CHEMBL3577008,230,0.23,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,O=C(/C=C/c1ccncc1F)/C=C/c1ccncc1F,J Med Chem,CHEMBL3577011,670,0.67,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,O=C(/C=C/c1ccnc2ccccc12)/C=C/c1ccnc2ccccc12,J Med Chem,CHEMBL3577013,410,0.41,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,Cn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C)nc2ccccc21,J Med Chem,CHEMBL3577017,270,0.27,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CC)nc2ccccc21,J Med Chem,CHEMBL3577018,380,0.38,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CCC)nc2ccccc21,J Med Chem,CHEMBL3577019,520,0.52,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCCn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CCCC)nc2ccccc21,J Med Chem,CHEMBL3577104,580,0.58,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCCCn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CCCCC)nc2ccccc21,J Med Chem,CHEMBL3577105,860,0.86,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CC(C)n1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C(C)C)nc2ccccc21,J Med Chem,CHEMBL3577108,450,0.45,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CC(C)Cn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CC(C)C)nc2ccccc21,J Med Chem,CHEMBL3577109,380,0.38,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCC(C)n1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C(C)CC)nc2ccccc21,J Med Chem,CHEMBL3577110,790,0.79,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCCC(C)n1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C(C)CCC)nc2ccccc21,J Med Chem,CHEMBL3577111,700,0.7,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CCC(CC)n1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C(CC)CC)nc2ccccc21,J Med Chem,CHEMBL3577112,540,0.54,Yes
CHEMBL3579909,Antiproliferative activity against human LNCAP cells assessed as inhibition of cell proliferation after 3 days by WST1 assay,CC(C)CCn1c(/C=C/C(=O)/C=C/c2nc3ccccc3n2CCC(C)C)nc2ccccc21,J Med Chem,CHEMBL3577113,920,0.92,Yes
CHEMBL3588708,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation by MTS assay,CN(C)CCOc1ccc2[nH]c(C(=O)N3CC(CCl)c4c3cc(N)c3ccccc43)cc2c1,Bioorg Med Chem,CHEMBL314487,18,0.018,Yes
CHEMBL3588708,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation by MTS assay,CN(C)CCOc1ccc2[nH]c(C(=O)N3CC(CCl)c4c3cc(NC(=O)OC(C)(C)C)c3ccccc43)cc2c1.Cl,Bioorg Med Chem,CHEMBL3586001,218,0.218,Yes
CHEMBL3590993,Cytotoxicity against human LNCAP cells assessed as reduction in cell number incubated for 72 hrs,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,J Med Chem,CHEMBL76,32870,32.87,No
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)CO)cc1F,Eur J Med Chem,CHEMBL3588965,212.2,0.2122,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@]2(C)COC)cc1F,Eur J Med Chem,CHEMBL3588961,184.8,0.1848,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)COC)cc1F,Eur J Med Chem,CHEMBL3588960,344,0.344,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]2C)cc1F,Eur J Med Chem,CHEMBL3588959,398.1,0.3981,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2C)cc1F,Eur J Med Chem,CHEMBL3589390,944.4,0.9444,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCOCC3)cc1F,Eur J Med Chem,CHEMBL3589387,539.8,0.5398,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,N#Cc1ccc(N2C(=O)[C@]3(CCOC3)N(c3ccc(C(N)=O)c(F)c3)C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL3589385,71.4,0.0714,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,COC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,Eur J Med Chem,CHEMBL3589383,59,0.059,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,Eur J Med Chem,CHEMBL3589381,79.2,0.0792,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCOC3)cc1F,Eur J Med Chem,CHEMBL3589380,195.6,0.1956,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,Eur J Med Chem,CHEMBL3183409,174,0.174,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL1082407,127.1,0.1271,Yes
CHEMBL3592211,Antiproliferative activity against human LNCAP cells after 3 days,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL409,732.7,0.7327,Yes
CHEMBL3602810,Cytotoxic activity against human LNCAP cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,O=C(OC[C@@]1(O)C(=O)C=C[C@@H](O)[C@@H]1O)c1ccccc1,Bioorg Med Chem Lett,CHEMBL3601258,45430,45.43,No
CHEMBL3602539,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,C=C(C)CCC[C@]1(C)OC(=O)[C@]23CC=C4[C@@H](CC[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](OS(=O)(=O)[O-])[C@H](O)[C@H]6O[C@@H]6O[C@H](C)[C@@H](O[C@@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]2(C)CC(=O)[C@@H]31.[Na+].[Na+],Bioorg Med Chem Lett,CHEMBL3601155,230,0.23,Yes
CHEMBL3602539,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,CO[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3[C@H](O)[C@@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H](O[C@H]4[C@H](O[C@H]5CC[C@]6(C)C7=CC[C@]89C(=O)O[C@@](C)(CCCC(C)C)[C@H]8C(=O)C[C@@]9(C)[C@@H]7CC[C@H]6C5(C)C)OC[C@@H](OS(=O)(=O)[O-])[C@@H]4O)O[C@@H]3C)O[C@H](COS(=O)(=O)[O-])[C@H]2O)O[C@H](CO)[C@H]1O.[Na+].[Na+],Bioorg Med Chem Lett,CHEMBL3601066,170,0.17,Yes
CHEMBL3607324,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,Bioorg Med Chem,CHEMBL50588,37,0.037,Yes
CHEMBL3607324,Cytotoxicity against human LNCAP cells after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=S)[S-].[Na+],Bioorg Med Chem,CHEMBL2171637,565,0.565,Yes
CHEMBL3607327,Cytotoxicity against human LNCAP cells after 5 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=S)[S-].[Na+],Bioorg Med Chem,CHEMBL2171637,88,0.088,Yes
CHEMBL3607327,Cytotoxicity against human LNCAP cells after 5 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,Bioorg Med Chem,CHEMBL50588,27,0.027,Yes
CHEMBL3607330,Cytotoxicity against human LNCAP cells after 7 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=S)[S-].[Na+],Bioorg Med Chem,CHEMBL2171637,79,0.079,Yes
CHEMBL3607330,Cytotoxicity against human LNCAP cells after 7 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,Bioorg Med Chem,CHEMBL50588,37,0.037,Yes
CHEMBL3607999,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation/survival after 72 hrs by resazurin dye reduction assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Med Chem,CHEMBL3605562,440,0.44,Yes
CHEMBL3607999,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation/survival after 72 hrs by resazurin dye reduction assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Med Chem,CHEMBL3605564,70,0.07,Yes
CHEMBL3607999,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation/survival after 72 hrs by resazurin dye reduction assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@H]4O[C@]45CC=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Med Chem,CHEMBL3605565,20,0.02,Yes
CHEMBL3607999,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation/survival after 72 hrs by resazurin dye reduction assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@@H]4O[C@@]45CC=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Med Chem,CHEMBL3605566,320,0.32,Yes
CHEMBL3607999,Cytotoxicity against human LNCAP cells assessed as inhibition of cell proliferation/survival after 72 hrs by resazurin dye reduction assay,CC1=C(CO)C(=O)O[C@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,J Med Chem,CHEMBL1221986,870,0.87,Yes
CHEMBL3619929,Antiproliferative activity against human LNCAP cells in lipid reduced medium,CC1(C)N=C(c2ccc(-c3ccc4cccnc4c3)cc2)N(C[C@@H]2CCN(C(=O)C3CC3)C2)C1=O,ACS Med Chem Lett,CHEMBL3617742,218.78,0.21878,Yes
CHEMBL3619929,Antiproliferative activity against human LNCAP cells in lipid reduced medium,Cn1ncc2cc(-c3ccc(C4=NC(C)(C)C(=O)N4C[C@@H]4CCN(C(=O)C5CC5)C4)c(F)c3)ccc21,ACS Med Chem Lett,CHEMBL3617744,724.44,0.72444,Yes
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=S)Nc3ccc([N+](=O)[O-])cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3617869,53150,53.15,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=S)Nc3c(C)cc(C)cc3C)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3617870,39760,39.76,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1ccc(NC(=S)N[C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)c([N+](=O)[O-])c1,Bioorg Med Chem Lett,CHEMBL3617871,25600,25.6,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=S)Nc3ccc(Cl)c(Cl)c3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3617874,20020,20.02,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=S)Nc3cccc(C(F)(F)F)c3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3617876,22230,22.23,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=S)Nc3ccc(C(C)C)cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3617883,84780,84.78,No
CHEMBL3620606,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,Bioorg Med Chem Lett,CHEMBL44657,50330,50.33,No
CHEMBL3620518,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in presence of 10% FBS,COc1ccc2[nH]cc(-c3nc(C(=O)Nc4cc(OC)c(OC)c(OC)c4)cs3)c2c1,Bioorg Med Chem Lett,CHEMBL3618273,84800,84.8,No
CHEMBL3620518,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in presence of 10% FBS,COc1ccc(NC(=O)c2csc(-c3c[nH]c4ccc(F)cc34)n2)cc1,Bioorg Med Chem Lett,CHEMBL3618276,75420,75.42,No
CHEMBL3620518,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in presence of 10% FBS,COc1cc(NC(=O)c2csc(-c3c[nH]c4ccc(F)cc34)n2)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3618277,88510,88.51,No
CHEMBL3620518,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in presence of 10% FBS,O=C(Nc1ccccc1)c1csc(-c2cn(Cc3ccc(Cl)cc3)c3ccccc23)n1,Bioorg Med Chem Lett,CHEMBL3618278,68940,68.94,No
CHEMBL3618652,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in absence of 10% FBS,COc1ccc(NC(=O)c2csc(-c3c[nH]c4ccc(F)cc34)n2)cc1,Bioorg Med Chem Lett,CHEMBL3618276,66410,66.41,No
CHEMBL3618652,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in absence of 10% FBS,O=C(Nc1ccccc1)c1csc(-c2cn(Cc3ccc(Cl)cc3)c3ccccc23)n1,Bioorg Med Chem Lett,CHEMBL3618278,64070,64.07,No
CHEMBL3618652,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay in absence of 10% FBS,COc1cc(NC(=O)c2csc(-c3cn(Cc4ccc(Cl)cc4)c4ccccc34)n2)cc(OC)c1OC,Bioorg Med Chem Lett,CHEMBL3618280,97700,97.7,No
CHEMBL3624806,Cytotoxicity against human LNCAP cells,CCS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,ACS Med Chem Lett,CHEMBL3623127,153,0.153,Yes
CHEMBL3625665,Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Bioorg Med Chem Lett,CHEMBL50,45500,45.5,No
CHEMBL3625665,Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Bioorg Med Chem Lett,CHEMBL44,37400,37.4,No
CHEMBL3627258,Growth inhibition of human LNCAP cells (androgen receptor positive),COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,J Med Chem,CHEMBL372231,100,0.1,Yes
CHEMBL3627258,Growth inhibition of human LNCAP cells (androgen receptor positive),CCc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,J Med Chem,CHEMBL190451,100,0.1,Yes
CHEMBL3632054,Antiproliferative activity against human LNCAP cells incubated for 48 hrs by MTT assay,CC(C)(C)OC(=O)N1[C@@H](/C=C\c2ccc([N+](=O)[O-])cc2)COC1(C)C,Medchemcomm,CHEMBL3627822,27000,27,No
CHEMBL3632054,Antiproliferative activity against human LNCAP cells incubated for 48 hrs by MTT assay,COC(=O)c1ccc(CC[C@H]2COC(C)(C)N2C(=O)OC(C)(C)C)cc1,Medchemcomm,CHEMBL3627825,37000,37,No
CHEMBL3635955,Cytotoxicity against human LNCAP cells after 48 hrs by MTS assay,COc1cc(-c2nccc3ccc(-c4ccc5[nH]ccc5c4)cc23)cc(OC)c1OC,ACS Med Chem Lett,CHEMBL3633350,81,0.081,Yes
CHEMBL3635955,Cytotoxicity against human LNCAP cells after 48 hrs by MTS assay,c1cc2ccc(-c3ccc4[nH]ccc4c3)cc2c(-c2ccc3[nH]ccc3c2)n1,ACS Med Chem Lett,CHEMBL3633353,98,0.098,Yes
CHEMBL3635955,Cytotoxicity against human LNCAP cells after 48 hrs by MTS assay,Fc1ccc(-c2nccc3ccc(-c4ccc5[nH]ccc5c4)cc23)cc1,ACS Med Chem Lett,CHEMBL3633354,38,0.038,Yes
CHEMBL3743261,Cytotoxicity against human LNCAP cells after 120 hrs by MTT assay,Nc1ccc2c(c1)CN1C(=O)c3ccccc3C1=N2,Eur J Med Chem,CHEMBL114283,90200,90.2,No
CHEMBL3750048,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 4 days by MTT assay in presence of DHT and E2,COc1cccc(NC(=O)c2cnc(N3CCc4ccccc4C3)nc2)c1,Bioorg Med Chem,CHEMBL3746283,580,0.58,Yes
CHEMBL3750048,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 4 days by MTT assay in presence of DHT and E2,COc1ccc2c(c1)CCN(c1cnc(C(=O)Nc3cccc(C)n3)cn1)C2,Bioorg Med Chem,CHEMBL3747061,490,0.49,Yes
CHEMBL3750048,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 4 days by MTT assay in presence of DHT and E2,Cc1cccc(NC(=O)c2ccc(N3CCc4cc(OCCCc5ccccc5)ccc4C3)nc2)n1,Bioorg Med Chem,CHEMBL3747674,350,0.35,Yes
CHEMBL3750048,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 4 days by MTT assay in presence of DHT and E2,CCCCOc1ccc2c(c1)CCN(c1ccc(C(=O)Nc3cccc(C)n3)cn1)C2,Bioorg Med Chem,CHEMBL3746643,410,0.41,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@]23C[C@H](OC(C)=O)[C@]4(O)[C@@]5(C)C[C@H](O)C[C@]46C([C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C/C)[C@@H](OC(=O)/C(C)=C/C)[C@H]36)N(C)C5.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3759949,3.1,0.0031,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@]23C[C@H](OC(C)=O)[C@]4(O)[C@@]5(C)C[C@H](O)C[C@]46C([C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C/C)[C@@H](OC(=O)/C(C)=C/CO)[C@H]36)N(C)C5.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3759235,10.9,0.0109,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@]23C[C@H](O)[C@]4(O)[C@@]5(C)C[C@H](O)C[C@]46C([C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C/C)[C@@H](OC(=O)/C(C)=C/CO)[C@H]36)N(C)C5.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3759076,378.8,0.3788,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@]23C[C@H](O)[C@]4(O)[C@@]5(C)C[C@H](O)C[C@]46C([C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C/C)[C@@H](OC(=O)c1ccccc1)[C@H]36)N(C)C5.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3758552,190.3,0.1903,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@]23C[C@H](O)[C@]4(O)[C@@]5(C)C[C@H](O)C[C@]46C([C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C/C)[C@@H](OC(=O)/C(C)=C/C)[C@H]36)N(C)C5.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3760006,27.2,0.0272,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@@]23[C@H]4[C@H](OC(=O)/C(C)=C/C)[C@H](OC(=O)/C(C)=C/C)[C@@H]1[C@@H]2C1N(C)C[C@]2(C)C[C@H](O)C[C@@]14[C@]2(O)[C@@H](O)[C@@H]3O.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3758751,50.8,0.0508,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@@]23[C@H]4[C@H](OC(=O)/C(C)=C/CO)[C@H](OC(=O)/C(C)=C/C)[C@@H]1[C@@H]2C1N(C)C[C@]2(C)C[C@H](O)C[C@@]14[C@]2(O)[C@@H](O)[C@@H]3O.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3759946,72.6,0.0726,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,C=C1C[C@@]23[C@H]4[C@H](OC(=O)c5ccccc5)[C@H](OC(=O)/C(C)=C/C)[C@@H]1[C@@H]2C1N(C)C[C@]2(C)C[C@H](O)C[C@@]14[C@]2(O)[C@@H](O)[C@@H]3O.O=C(O)C(F)(F)F,J Nat Prod,CHEMBL3758293,6.7,0.0067,Yes
CHEMBL3761145,Cytotoxicity against human LNCAP cells after 72 hrs by AlamarBlue end point assay,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Nat Prod,CHEMBL22969,3.2,0.0032,Yes
CHEMBL3768855,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 cell proliferation assay,CCOc1cc(O)c2c(c1)O[C@H](c1ccc3c(c1)OC(c1ccc(O)c(OC)c1)C(CO)O3)[C@@H](O)C2=O,Eur J Med Chem,CHEMBL3763893,350,0.35,Yes
CHEMBL3768855,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 cell proliferation assay,COc1cc(O)c2c(c1)O[C@H](c1ccc3c(c1)OC(c1ccc(O)c(OC)c1)C(CO)O3)[C@@H](O)C2=O,Eur J Med Chem,CHEMBL3764710,440,0.44,Yes
CHEMBL3768855,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 cell proliferation assay,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,Eur J Med Chem,CHEMBL9509,43030,43.03,No
CHEMBL3768855,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 cell proliferation assay,CCCCOc1cc(O)c2c(=O)c(OCCCC)c(-c3ccc4c(c3)OC(c3ccc(O)c(OC)c3)C(CO)O4)oc2c1,Eur J Med Chem,CHEMBL3764016,46570,46.57,No
CHEMBL3768855,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 cell proliferation assay,CCCCCOc1cc(O)c2c(=O)c(OCCCCC)c(-c3ccc4c(c3)OC(c3ccc(O)c(OC)c3)C(CO)O4)oc2c1,Eur J Med Chem,CHEMBL3764735,28740,28.74,No
CHEMBL3767797,Antiproliferative activity against human LNCAP cells after 96 hrs by MTT assay,FC(F)(F)Oc1cccc(Nc2nnnc3ccc(N4CCOCC4)nc23)c1,Bioorg Med Chem Lett,CHEMBL3765468,30990,30.99,No
CHEMBL3767797,Antiproliferative activity against human LNCAP cells after 96 hrs by MTT assay,CN1CCN(c2ccc3nnnc(Nc4cccc(OC(F)(F)F)c4)c3n2)CC1,Bioorg Med Chem Lett,CHEMBL3764036,20270,20.27,No
CHEMBL3767797,Antiproliferative activity against human LNCAP cells after 96 hrs by MTT assay,OCCNc1ccc2nnnc(Nc3cccc(OC(F)(F)F)c3)c2n1,Bioorg Med Chem Lett,CHEMBL3765460,42880,42.88,No
CHEMBL3772615,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay,C[C@]12CC[C@H](OC(=O)[C@H]3CCCN3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)c3nnsc3C[C@@H]12,Eur J Med Chem,CHEMBL3769913,31600,31.6,No
CHEMBL3772615,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay,C[C@]12CC[C@H](OC(=O)[C@@H]3CCCN3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)c3nnsc3C[C@@H]12,Eur J Med Chem,CHEMBL3771045,36200,36.2,No
CHEMBL3772615,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)c3nnsc3C[C@@H]12,Eur J Med Chem,CHEMBL3770683,48100,48.1,No
CHEMBL3804637,Antiproliferative activity against human LNCAP cells expressing prostate specific antigen after 72 hrs by MTT assay,C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)Nc1ccc(COP(N)(=O)N(CCCl)CCCl)cc1F)C1CCCCC1,Bioorg Med Chem,CHEMBL3797786,29000,29,No
CHEMBL3804637,Antiproliferative activity against human LNCAP cells expressing prostate specific antigen after 72 hrs by MTT assay,C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)Nc1cc(F)c(COP(N)(=O)N(CCCl)CCCl)c(F)c1)C1CCCCC1,Bioorg Med Chem,CHEMBL3800423,20000,20,No
CHEMBL3800867,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,O=C(Nc1nnc(-c2ccccc2)o1)c1ccc2ccccc2c1,Bioorg Med Chem Lett,CHEMBL3800452,32330,32.33,No
CHEMBL3800867,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,O=c1[nH]cc(F)c(=O)[nH]1,Bioorg Med Chem Lett,CHEMBL185,30,0.03,Yes
CHEMBL3813412,Cytotoxicity against human LNCAP cells assessed as decrease in cell viability after 48 hrs by MTT assay,O=c1[nH]cc(F)c(=O)[nH]1,Bioorg Med Chem Lett,CHEMBL185,47180,47.18,No
CHEMBL3815356,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 3 days by WST-1 assay,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,Bioorg Med Chem Lett,CHEMBL9509,43030,43.03,No
CHEMBL3829945,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by propidium iodide staining based fluorescence assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL409,45270,45.27,No
CHEMBL3829945,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by propidium iodide staining based fluorescence assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL63560,45200,45.2,No
CHEMBL3829945,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by propidium iodide staining based fluorescence assay,CC(O)(COc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL3828469,990,0.99,Yes
CHEMBL3829945,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by propidium iodide staining based fluorescence assay,CC(O)(COc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Bioorg Med Chem Lett,CHEMBL3828507,23980,23.98,No
CHEMBL3829945,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by propidium iodide staining based fluorescence assay,C[C@](O)(CSc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL3827995,790,0.79,Yes
CHEMBL4011400,Cytotoxicity against wild type p53 expressing human LNCAP cells assessed as cell growth inhibition by WST8 assay,O=C(NC12CCC(C(=O)O)(CC1)CC2)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,J Med Chem,CHEMBL4072857,36,0.036,Yes
CHEMBL4011400,Cytotoxicity against wild type p53 expressing human LNCAP cells assessed as cell growth inhibition by WST8 assay,CN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2,J Med Chem,CHEMBL4064867,30,0.03,Yes
CHEMBL4011400,Cytotoxicity against wild type p53 expressing human LNCAP cells assessed as cell growth inhibition by WST8 assay,CCN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2,J Med Chem,CHEMBL4091801,18,0.018,Yes
CHEMBL4019576,Antiproliferative activity against human LNCAP cells after 72 hrs by phosphatase assay,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL22969,5.1,0.0051,Yes
CHEMBL4019576,Antiproliferative activity against human LNCAP cells after 72 hrs by phosphatase assay,CC[C@]1(NC(=O)c2ccc(C)c(C)c2)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL4088308,3,0.003,Yes
CHEMBL4019576,Antiproliferative activity against human LNCAP cells after 72 hrs by phosphatase assay,CC[C@]1(NC(=O)c2ccc3c(c2)CCCC3)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL4091990,3.9,0.0039,Yes
CHEMBL4019576,Antiproliferative activity against human LNCAP cells after 72 hrs by phosphatase assay,CC[C@]1(NC(=O)c2ccc3c(c2)CCCO3)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,J Med Chem,CHEMBL4069142,0.8,0.0008,Yes
CHEMBL4019576,Antiproliferative activity against human LNCAP cells after 72 hrs by phosphatase assay,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,J Med Chem,CHEMBL428647,1.9,0.0019,Yes
CHEMBL4033844,Cytotoxicity against human LNCAP cells after 24 to 72 hrs by MTT assay,COc1ccc([C@H]2SS[C@@]34C[C@]5(O)[C@H](Cl)C=C[C@@H](O)[C@@H]5ON3C(=O)[C@@H]2N(C)C4=O)c(O)c1OC,J Nat Prod,CHEMBL4073822,510,0.51,Yes
CHEMBL4035862,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,CC(C)C[C@H](O)C[C@]1(C)OC(=O)[C@]23CC[C@H]4C(=CC[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]2(C)CC[C@@H]31,Bioorg Med Chem Lett,CHEMBL4092894,59310,59.31,No
CHEMBL4035862,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,C=C(C)CCC(O)[C@]1(C)OC(=O)[C@]23CC[C@H]4C(=CC[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](O)[C@H]6O)CC[C@]45C)[C@]2(C)CC[C@H]13.[Na+],Bioorg Med Chem Lett,CHEMBL4083089,51470,51.47,No
CHEMBL4035862,Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay,C=C(C)CCC(O)[C@]1(C)OC(=O)[C@]23CC[C@H]4C(=CC[C@H]5C(C)(C)[C@@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]45C)[C@]2(C)CC[C@H]13,Bioorg Med Chem Lett,CHEMBL4062943,51560,51.56,No
CHEMBL4042132,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@]12C=CCN3CC[C@]4(C(=C(C(=O)OC)C1)Nc1cc5c(cc14)[C@@H]1[C@H](O5)[C@@H](O)[C@@]4(CC)CC(C(=O)OC)=C5Nc6c(cc(O)c(OC)c6OC)[C@@]56CCN1[C@@H]46)[C@@H]32,J Nat Prod,CHEMBL220132,900,0.9,Yes
CHEMBL4042132,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@@]12CC(C(=O)OC)=C3Nc4c(cc(O)c(OC)c4OC)[C@@]34CCN([C@@H]3c5cc6c(cc5O[C@@H]3[C@H]1O)NC1=C(C(=O)OC)C[C@]35CCO[C@H]3CCN3CC[C@@]16[C@@H]35)[C@@H]24,J Nat Prod,CHEMBL4087281,300,0.3,Yes
CHEMBL4044375,Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,Bioorg Med Chem,CHEMBL56367,26690,26.69,No
CHEMBL4044745,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,Bioorg Med Chem,CHEMBL9509,43730,43.73,No
CHEMBL4044745,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCOc1ccc(C2Oc3cc(-c4oc5cc(O)cc(OCC)c5c(=O)c4O)ccc3OC2CO)cc1OC,Bioorg Med Chem,CHEMBL4091557,33630,33.63,No
CHEMBL4044852,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1cc(-c2oc3ccccc3c(=O)c2OC)cc(OC)c1OC,Bioorg Med Chem,CHEMBL2047489,24700,24.7,No
CHEMBL4044852,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCN(CC)CCCOc1c(-c2cc(OC)c(OC)c(OC)c2)oc2ccccc2c1=O,Bioorg Med Chem,CHEMBL4092738,37600,37.6,No
CHEMBL4044852,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Bioorg Med Chem,CHEMBL50,45460,45.46,No
CHEMBL4044852,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,Bioorg Med Chem,CHEMBL31574,34100,34.1,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4077533,50000,50,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4075606,28000,28,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4061737,26000,26,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C)C(C)C,J Med Chem,CHEMBL4075692,60000,60,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4067486,40000,40,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4070834,80000,80,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4085516,31000,31,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4065627,40000,40,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4072868,50000,50,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4102947,40000,40,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4095200,41000,41,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4094278,40000,40,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C)C(C)C,J Med Chem,CHEMBL4061196,70000,70,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4089351,39000,39,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C)[C@@H](C)CC,J Med Chem,CHEMBL4095698,30000,30,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C)[C@@H](C)CC,J Med Chem,CHEMBL4068349,60000,60,No
CHEMBL4050601,Antiproliferative activity against human LNCAP cells assessed as reduction in metabolic activity after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4103458,40000,40,No
CHEMBL4051860,Antiproliferative activity against PTEN deficient human LNCAP cells after 72 hrs by CCK-8 assay,O=C(O)c1cc2nc(N3CCOCC3)nc(N3CCOCC3)c2s1,J Med Chem,CHEMBL4066144,23550,23.55,No
CHEMBL4051860,Antiproliferative activity against PTEN deficient human LNCAP cells after 72 hrs by CCK-8 assay,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccn[nH]4)cc3n2)C[C@H](C)O1,J Med Chem,CHEMBL4071083,210,0.21,Yes
CHEMBL4051860,Antiproliferative activity against PTEN deficient human LNCAP cells after 72 hrs by CCK-8 assay,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,J Med Chem,CHEMBL521851,340,0.34,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCn1ccnc1/C=C/C=C/C(=O)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4076898,750,0.75,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCn1ccnc1/C=C/C=C/C(=O)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4066242,580,0.58,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4088318,730,0.73,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4094378,540,0.54,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCn1ccnc1/C=C/C(=O)/C=C/C=C/c1nccs1,Eur J Med Chem,CHEMBL4102117,420,0.42,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCn1ccnc1/C=C/C(=O)/C=C/C=C/c1nccs1,Eur J Med Chem,CHEMBL4077861,670,0.67,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CC(C)n1ccnc1/C=C/C(=O)/C=C/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4086636,660,0.66,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,Cc1nc(C(F)(F)F)c(/C=C/C=C/C(=O)/C=C/c2nccn2C(C)C)s1,Eur J Med Chem,CHEMBL4104530,410,0.41,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/C=C/c1nccs1,Eur J Med Chem,CHEMBL4104463,740,0.74,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCC(C)n1ccnc1/C=C/C(=O)/C=C/C=C/c1nccs1,Eur J Med Chem,CHEMBL4065086,690,0.69,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCC(C)n1ccnc1/C=C/C(=O)/C=C/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4076566,550,0.55,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCn1ccnc1/C=C/C=C/C(=O)/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4072615,370,0.37,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4074414,380,0.38,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4098154,280,0.28,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4065705,380,0.38,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,Cc1nc(C(F)(F)F)c(/C=C/C=C/C(=O)/C=C/c2nc3ccccc3n2C(C)C)s1,Eur J Med Chem,CHEMBL4090481,350,0.35,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CC(C)n1c(/C=C/C(=O)/C=C/C=C/c2nccs2)nc2ccccc21,Eur J Med Chem,CHEMBL4098134,270,0.27,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)C,Eur J Med Chem,CHEMBL4079389,600,0.6,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)CC,Eur J Med Chem,CHEMBL4086611,300,0.3,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCC(C)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)CCC,Eur J Med Chem,CHEMBL4075905,550,0.55,Yes
CHEMBL4053656,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCC(CC)n1ccnc1/C=C/C=C/C(=O)/C=C/c1nc2ccccc2n1C(CC)CC,Eur J Med Chem,CHEMBL4087606,720,0.72,Yes
CHEMBL4058431,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,C[C@]12CCC(=O)O[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)N(Cc3ccccc3)Cc3ccccc3)CC[C@@H]12,Bioorg Med Chem Lett,CHEMBL4076351,29780,29.78,No
CHEMBL4058431,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CCCCN(CCCC)C(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4OC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Bioorg Med Chem Lett,CHEMBL4083721,32410,32.41,No
CHEMBL4058431,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,Cc1ccc(NC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@H]5OC(=O)CC[C@]5(C)[C@H]4CC[C@]23C)cc1,Bioorg Med Chem Lett,CHEMBL4061869,26470,26.47,No
CHEMBL4058431,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL806,47550,47.55,No
CHEMBL4123803,Antiproliferative activity against docetaxel-sensitive human LNCAP cells after 3 days by WST-1 assay,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,Bioorg Med Chem,CHEMBL92,0.2,0.0002,Yes
CHEMBL4132069,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,COC(=O)[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)c(NC(=O)Cn4cc(-c5cccc(NC(=O)OC(C)(C)C)c5)nn4)c3CC[C@@H]12,Eur J Med Chem,CHEMBL4160194,600,0.6,Yes
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4ccccc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4159370,31100,31.1,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CC12Cc3ccccc3CN1C(=S)N(c1ccc(C#N)c(C(F)(F)F)c1)C2=O,Eur J Med Chem,CHEMBL4175560,65300,65.3,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4ccccc4CN3C2=S)cc1F,Eur J Med Chem,CHEMBL4167689,70300,70.3,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CNC(=O)c1cc2c(cc1F)CC1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4173847,28100,28.1,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4ccc(O)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4163553,50700,50.7,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4cc([N+](=O)[O-])ccc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4170819,56400,56.4,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4ccc([N+](=O)[O-])cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4160191,43000,43,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,N#Cc1ccc(N2C(=O)C3Cc4cc(N)ccc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4169593,73000,73,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CCOc1ccc2c(c1)CN1C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4176788,22600,22.6,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CC(=O)Nc1ccc2c(c1)CN1C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4175965,83800,83.8,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CC(C)(C)C(=O)Nc1ccc2c(c1)CN1C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4168764,21200,21.2,No
CHEMBL4141635,Antiproliferative activity against human LNCAP cells after 3 days by MTT assay,CS(=O)(=O)Nc1ccc2c(c1)CN1C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4177031,31100,31.1,No
CHEMBL4148685,Antiproliferative activity against human LNCAP cells after 72 hrs by Cell-Titer Glo assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL1082407,33840,33.84,No
CHEMBL4154868,Antiproliferative activity against human LNCAP cells,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,Eur J Med Chem,CHEMBL1957266,109.6,0.1096,Yes
CHEMBL4154868,Antiproliferative activity against human LNCAP cells,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,Eur J Med Chem,CHEMBL1232461,356.5,0.3565,Yes
CHEMBL4154868,Antiproliferative activity against human LNCAP cells,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2,Eur J Med Chem,CHEMBL3581647,111.4,0.1114,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL1082407,42370,42.37,No
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,Eur J Med Chem,CHEMBL1957266,160,0.16,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,CCCCC1Oc2cc(-c3c(C)noc3C)ccc2NC1=O,Eur J Med Chem,CHEMBL4176247,820,0.82,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,Cc1noc(C)c1-c1ccc2c(c1)OC(CC(C)C)C(=O)N2,Eur J Med Chem,CHEMBL4160349,570,0.57,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1F)C(=O)N2,Eur J Med Chem,CHEMBL4161994,640,0.64,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC(C)C)C(=O)N2,Eur J Med Chem,CHEMBL4167192,460,0.46,Yes
CHEMBL4154889,Antiproliferative activity against human LNCAP cells treated at 12 hrs post cell seeding measured at 72 to 144 hrs post cell seeding by Cell-Titer Glo assay,Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2,Eur J Med Chem,CHEMBL4175060,580,0.58,Yes
CHEMBL4186338,Antiproliferative activity against human LNCAP cells expressing PSA after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=O)OCc1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)NC(C)=O)cc1,Bioorg Med Chem,CHEMBL4205245,757,0.757,Yes
CHEMBL4186338,Antiproliferative activity against human LNCAP cells expressing PSA after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=O)OCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)NC(C)=O)cc1,Bioorg Med Chem,CHEMBL4215066,59.01,0.05901,Yes
CHEMBL4186338,Antiproliferative activity against human LNCAP cells expressing PSA after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@@H]1c2cc(OC)c(OC)cc2CCN1C(=O)OCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)cc1,Bioorg Med Chem,CHEMBL4218985,100,0.1,Yes
CHEMBL4186338,Antiproliferative activity against human LNCAP cells expressing PSA after 3 days by MTT assay,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,Bioorg Med Chem,CHEMBL50588,31.6,0.0316,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1conc1C,Eur J Med Chem,CHEMBL4207359,240,0.24,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1sc(C)nc1C(F)(F)F,Eur J Med Chem,CHEMBL4206838,220,0.22,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1cc(C)on1,Eur J Med Chem,CHEMBL4211719,240,0.24,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nn(C)cc1Br,Eur J Med Chem,CHEMBL4211442,310,0.31,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4206557,170,0.17,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1cc(OC)c(OC)c(OC)c1,Eur J Med Chem,CHEMBL4202475,660,0.66,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1ccc(OC)c(OC)c1,Eur J Med Chem,CHEMBL4203962,910,0.91,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1cccc(C)n1,Eur J Med Chem,CHEMBL4215642,260,0.26,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1ccccn1)/C=C/c1nccs1,Eur J Med Chem,CHEMBL4218527,450,0.45,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1ccccn1,Eur J Med Chem,CHEMBL4211207,240,0.24,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cn1cc(Br)c(/C=C/C(=O)/C=C/c2ccccn2)n1,Eur J Med Chem,CHEMBL4210793,220,0.22,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cc1cc(/C=C/C(=O)/C=C/c2ccccn2)no1,Eur J Med Chem,CHEMBL4205915,310,0.31,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cc1nc(-c2ccncc2)sc1/C=C/C(=O)/C=C/c1nccn1C(C)C,Eur J Med Chem,CHEMBL4205315,540,0.54,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CC(C)n1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)C,Eur J Med Chem,CHEMBL4212601,260,0.26,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)CC,Eur J Med Chem,CHEMBL4217554,330,0.33,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CC(C)Cn1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1CC(C)C,Eur J Med Chem,CHEMBL4208223,560,0.56,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CC(C)CCn1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1CCC(C)C,Eur J Med Chem,CHEMBL4213143,930,0.93,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)CCC,Eur J Med Chem,CHEMBL4205744,370,0.37,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCCn1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1CCC,Eur J Med Chem,CHEMBL4210606,220,0.22,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCCCn1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1CCCC,Eur J Med Chem,CHEMBL4209044,400,0.4,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cc1nc(C(F)(F)F)c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C)s1,Eur J Med Chem,CHEMBL4204169,340,0.34,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCn1c(/C=C/C(=O)/C=C/c2sc(C)nc2C(F)(F)F)nc2ccccc21,Eur J Med Chem,CHEMBL4213439,250,0.25,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCCn1c(/C=C/C(=O)/C=C/c2sc(C)nc2C(F)(F)F)nc2ccccc21,Eur J Med Chem,CHEMBL4208508,460,0.46,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cc1nc(C(F)(F)F)c(/C=C/C(=O)/C=C/c2nc3ccccc3n2C(C)C)s1,Eur J Med Chem,CHEMBL4216894,300,0.3,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,COc1cc(/C=C/C(=O)/C=C/c2ccccn2)cc(OC)c1OC,Eur J Med Chem,CHEMBL4211918,400,0.4,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cc1cccc(/C=C/C(=O)/C=C/c2ccccn2)n1,Eur J Med Chem,CHEMBL4204699,300,0.3,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,Cn1c(/C=C/C(=O)/C=C/c2ccccn2)nc2ccccc21,Eur J Med Chem,CHEMBL4209980,180,0.18,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCn1c(/C=C/C(=O)/C=C/c2ccccn2)nc2ccccc21,Eur J Med Chem,CHEMBL4205097,120,0.12,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CCCn1c(/C=C/C(=O)/C=C/c2ccccn2)nc2ccccc21,Eur J Med Chem,CHEMBL4204189,170,0.17,Yes
CHEMBL4191525,Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,CC(C)n1c(/C=C/C(=O)/C=C/c2ccccn2)nc2ccccc21,Eur J Med Chem,CHEMBL4209057,30,0.03,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4[C@@H](O)C=C5CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL4216841,330,0.33,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4[C@@H](O)C=C5C=CCC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL4211870,940,0.94,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,C[C@H]1C[C@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56CC=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)OC(=O)[C@@H]1C,J Nat Prod,CHEMBL4203685,290,0.29,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL502563,160,0.16,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56CC=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL1097107,60,0.06,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CO[C@H]1C=CC(=O)[C@]2(C)[C@H]3CC[C@]4(C)[C@](O)([C@@](C)(O)[C@H]5CC(C)=C(C)C(=O)O5)CC[C@@]4(O)[C@@H]3C[C@H]3O[C@]132,J Nat Prod,CHEMBL4203165,330,0.33,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4[C@@H](O)[C@H]5O[C@]56CC=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL4213383,330,0.33,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4CC=C5[C@@H](O)C=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL4208456,110,0.11,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(CO)C[C@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4CC=C5CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)OC1=O,J Nat Prod,CHEMBL4218593,240,0.24,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4CC=C5CC=CC(=O)[C@]5(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL488913,130,0.13,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@H]4O[C@]45CC=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL3605565,20,0.02,Yes
CHEMBL4191628,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,J Nat Prod,CHEMBL53463,20,0.02,Yes
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,Clc1cccc2cc3c(nc12)-c1nc2ccccc2n1C3,Eur J Med Chem,CHEMBL4204704,24000,24,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,Cc1cccc2cc3c(nc12)-c1nc2ccccc2n1C3,Eur J Med Chem,CHEMBL4212193,23800,23.8,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,Cc1ccc2cc3c(nc2c1)-c1nc2ccccc2n1C3,Eur J Med Chem,CHEMBL4209046,39000,39,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,Cc1ccc2nc3c(cc2c1)Cn1c-3nc2ccccc21,Eur J Med Chem,CHEMBL4213969,62500,62.5,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,COc1cccc2cc3c(nc12)-c1nc2ccccc2n1C3,Eur J Med Chem,CHEMBL4215395,20000,20,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,COc1ccc2cc3c(nc2c1)-c1nc2ccccc2n1C3,Eur J Med Chem,CHEMBL4210447,25000,25,No
CHEMBL4193086,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay,COc1ccc2nc3c(cc2c1)Cn1c-3nc2ccccc21,Eur J Med Chem,CHEMBL4203205,24700,24.7,No
CHEMBL4220998,Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Bioorg Med Chem,CHEMBL44,24000,24,No
CHEMBL4221000,Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Bioorg Med Chem,CHEMBL44,31700,31.7,No
CHEMBL4223197,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by CCK8 assay,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1,Bioorg Med Chem Lett,CHEMBL142635,22360,22.36,No
CHEMBL4223197,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by CCK8 assay,Cl.Cl.Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1,Bioorg Med Chem Lett,CHEMBL4225239,48180,48.18,No
CHEMBL4223197,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by CCK8 assay,COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1.Cl.Cl,Bioorg Med Chem Lett,CHEMBL4224794,46160,46.16,No
CHEMBL4223197,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by CCK8 assay,CCOc1ccccc1N1CCN(CCc2ccc(COc3ccc4c(c3)CCCC4)cc2)CC1.Cl.Cl,Bioorg Med Chem Lett,CHEMBL4224922,27980,27.98,No
CHEMBL4223197,Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by CCK8 assay,Cc1ccccc1N1CCN(CCc2ccc(COc3ccc4c(c3)CCCC4)cc2)CC1.Cl.Cl,Bioorg Med Chem Lett,CHEMBL4225686,32850,32.85,No
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1ncc[nH]1)/C=C/c1ncc[nH]1,Bioorg Med Chem,CHEMBL4238964,72820,72.82,No
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1nccn1-c1ccccc1)/C=C/c1nccn1-c1ccccc1,Bioorg Med Chem,CHEMBL4239401,220,0.22,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1nccn1-c1cccc(Cl)c1)/C=C/c1nccn1-c1cccc(Cl)c1,Bioorg Med Chem,CHEMBL4249491,580,0.58,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,COc1cccc(-n2ccnc2/C=C/C(=O)/C=C/c2nccn2-c2cccc(OC)c2)c1,Bioorg Med Chem,CHEMBL4249946,230,0.23,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,COc1ccccc1-n1ccnc1/C=C/C(=O)/C=C/c1nccn1-c1ccccc1OC,Bioorg Med Chem,CHEMBL4245692,290,0.29,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1nccn1-c1nccs1)/C=C/c1nccn1-c1nccs1,Bioorg Med Chem,CHEMBL4246151,320,0.32,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1nccn1-c1cccs1)/C=C/c1nccn1-c1cccs1,Bioorg Med Chem,CHEMBL4241888,320,0.32,Yes
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,O=C(/C=C/c1nc2ccccc2n1-c1cccc(Cl)c1)/C=C/c1nc2ccccc2n1-c1cccc(Cl)c1,Bioorg Med Chem,CHEMBL4250738,30470,30.47,No
CHEMBL4236219,Antiproliferative activity against androgen-sensitive human LNCAP cells assessed as decrease in cell viability after 3 days by WST assay,COc1cccc(-n2c(/C=C/C(=O)/C=C/c3nc4ncccc4n3-c3cccc(OC)c3)nc3ncccc32)c1,Bioorg Med Chem,CHEMBL4240105,38210,38.21,No
CHEMBL4236737,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C,J Med Chem,CHEMBL4241012,31000,31,No
CHEMBL4236737,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(NC(=N)N)cc1)C(N)=O)C(C)C,J Med Chem,CHEMBL4243204,92000,92,No
CHEMBL4236737,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4249395,67000,67,No
CHEMBL4236737,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCCc1c[nH]c2ccccc12)c1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4237970,70000,70,No
CHEMBL4236737,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4103458,45000,45,No
CHEMBL4255969,Antiproliferative activity against human LNCAP cells after 96 hrs by Cell-Titer glo reagent based luminescence assay,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,ACS Med Chem Lett,CHEMBL1957266,160,0.16,Yes
CHEMBL4261465,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4277812,80000,80,No
CHEMBL4261465,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)cc1)C(C)C,J Med Chem,CHEMBL4103458,40000,40,No
CHEMBL4261465,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C,J Med Chem,CHEMBL2179435,45000,45,No
CHEMBL4261465,Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay,CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCc1ccc(C(=N)N)c(N)c1)C(C)C,J Med Chem,CHEMBL4278214,58000,58,No
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,O=C(Nc1ccccc1C(F)(F)F)c1ccc([S+]([O-])c2ccc(O)cc2)cc1,Medchemcomm,CHEMBL4278955,61980,61.98,No
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,O=C(Nc1ccccc1C(F)(F)F)c1ccc(S(=O)(=O)c2ccc(O)cc2)cc1,Medchemcomm,CHEMBL4289627,39310,39.31,No
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,O=C(Nc1ccc(S(F)(F)(F)(F)F)cc1)c1ccc([S+]([O-])c2ccc(O)cc2)cc1,Medchemcomm,CHEMBL4282806,900,0.9,Yes
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,O=C(Nc1cc(C(F)(F)F)ccc1C(F)(F)F)c1ccc(S(=O)(=O)c2ccc(O)cc2)cc1,Medchemcomm,CHEMBL4279355,23180,23.18,No
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Medchemcomm,CHEMBL1082407,20900,20.9,No
CHEMBL4262717,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining-based fluorescence assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Medchemcomm,CHEMBL63560,45270,45.27,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCCCCCOc1c(-c2ccc(OC)c(OC)c2)oc2ccccc2c1=O,Eur J Med Chem,CHEMBL4287783,43900,43.9,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCN(CC)CCCCOc1c(-c2ccc(OC)c(OC)c2)oc2ccccc2c1=O,Eur J Med Chem,CHEMBL4291604,40500,40.5,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc(-c2oc3ccccc3c(=O)c2OCCCN2CCCCC2)cc1OC,Eur J Med Chem,CHEMBL4278194,36000,36,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc(-c2oc3ccccc3c(=O)c2OCCCCN2CCCCC2)cc1OC,Eur J Med Chem,CHEMBL4294419,24100,24.1,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc(-c2oc3ccccc3c(=O)c2OCCCCCN2CCCCC2)cc1OC,Eur J Med Chem,CHEMBL4286537,26500,26.5,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Eur J Med Chem,CHEMBL50,45500,45.5,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,Eur J Med Chem,CHEMBL31574,34100,34.1,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc2c(=O)c(O)c(-c3ccc(OC)c(OC)c3)oc2c1,Eur J Med Chem,CHEMBL77198,24500,24.5,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCOc1c(-c2ccc(OC)c(OC)c2)oc2cc(OC)ccc2c1=O,Eur J Med Chem,CHEMBL4286590,30200,30.2,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,CCCCCCCOc1c(-c2ccc(OC)c(OC)c2)oc2cc(OC)ccc2c1=O,Eur J Med Chem,CHEMBL4285556,22900,22.9,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc2c(=O)c(OC(C)C)c(-c3ccc(OC)c(OC)c3)oc2c1,Eur J Med Chem,CHEMBL4290014,27100,27.1,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc2c(=O)c(OCCCN3CCOCC3)c(-c3ccc(OC)c(OC)c3)oc2c1,Eur J Med Chem,CHEMBL4282676,32200,32.2,No
CHEMBL4275399,Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay,COc1ccc2c(=O)c(OCCCN3CCCCC3)c(-c3ccc(OC)c(OC)c3)oc2c1,Eur J Med Chem,CHEMBL4293961,30700,30.7,No
CHEMBL4275776,Antiproliferative activity against human LNCAP cells,CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,Eur J Med Chem,CHEMBL508185,100,0.1,Yes
CHEMBL4305855,Antiproliferative activity against human LNCAP cells,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,Eur J Med Chem,CHEMBL4448494,22.6,0.0226,Yes
CHEMBL4305855,Antiproliferative activity against human LNCAP cells,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,Eur J Med Chem,CHEMBL3301610,84,0.084,Yes
CHEMBL4308390,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by xCELLigence RTCA analysis,COc1c2c(c(C)c3c1C(=O)OC3)O[C@@]1(C)C[C@]3(O)OC[C@]4(C)O[C@@]5(OC)C[C@@H](OC(C)=O)[C@](C)([C@H]1C2)[C@]43O5,Bioorg Med Chem Lett,CHEMBL4454826,20000,20,No
CHEMBL4308390,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by xCELLigence RTCA analysis,COc1c2c(c(C)c3c1C(=O)OC3)O[C@@]1(C)C[C@]3(O)OC[C@]4(C)O[C@@]5(OC)CC[C@](C)([C@H]1C2)[C@]43O5,Bioorg Med Chem Lett,CHEMBL4520516,27000,27,No
CHEMBL4311435,Antiproliferative activity against human LNCAP cells after 24 hrs by CCK-8 assay,Cc1ccccc1OCCc1ccc(CN2CCN(c3ccccc3)CC2)cc1.Cl.Cl,Bioorg Med Chem,CHEMBL4578449,34870,34.87,No
CHEMBL4311435,Antiproliferative activity against human LNCAP cells after 24 hrs by CCK-8 assay,Brc1ccccc1OCCc1ccc(CN2CCN(c3ccccc3)CC2)cc1.Cl.Cl,Bioorg Med Chem,CHEMBL4464517,41870,41.87,No
CHEMBL4311435,Antiproliferative activity against human LNCAP cells after 24 hrs by CCK-8 assay,Cl.Cl.FC(F)(F)c1ccccc1OCCc1ccc(CN2CCN(c3ccccc3)CC2)cc1,Bioorg Med Chem,CHEMBL4529315,32160,32.16,No
CHEMBL4311435,Antiproliferative activity against human LNCAP cells after 24 hrs by CCK-8 assay,Cl.Cl.N#Cc1ccc(OCCc2ccc(CN3CCN(c4ccccc4)CC3)cc2)cc1,Bioorg Med Chem,CHEMBL4476484,43580,43.58,No
CHEMBL4311435,Antiproliferative activity against human LNCAP cells after 24 hrs by CCK-8 assay,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1,Bioorg Med Chem,CHEMBL142635,22360,22.36,No
CHEMBL4325013,"Antiproliferative activity against AR-positive human LNCAP cells incubated for 7 days in presence of AR agonist, R1881 by WST-8 assay",Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(N3CCC(C#Cc4ccc(C(=O)N[C@H]5C(C)(C)[C@H](Oc6ccc(C#N)c(Cl)c6)C5(C)C)cc4)CC3)CC2)c2ccc(-c3scnc3C)cc2)C(C)C)on1,J Med Chem,CHEMBL4528598,2,0.002,Yes
CHEMBL4325013,"Antiproliferative activity against AR-positive human LNCAP cells incubated for 7 days in presence of AR agonist, R1881 by WST-8 assay",Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(C#Cc3ccc(C(=O)N[C@H]4C(C)(C)[C@H](Oc5ccc(C#N)c(Cl)c5)C4(C)C)cc3)CC2)c2ccccc2)C(C)C)on1,J Med Chem,CHEMBL4525203,2,0.002,Yes
CHEMBL4325013,"Antiproliferative activity against AR-positive human LNCAP cells incubated for 7 days in presence of AR agonist, R1881 by WST-8 assay",CC1(C)[C@H](NC(=O)c2cnn(CCO)c2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL1916251,64.5,0.0645,Yes
CHEMBL4325013,"Antiproliferative activity against AR-positive human LNCAP cells incubated for 7 days in presence of AR agonist, R1881 by WST-8 assay",CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,J Med Chem,CHEMBL1082407,150.8,0.1508,Yes
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CSc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4574474,27160,27.16,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CSc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4584441,43190,43.19,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CSc1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4460683,54330,54.33,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CSc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4436192,43680,43.68,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CSc1cc(C(F)(F)F)cc(C(F)(F)F)c1)(Sc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4475710,430,0.43,Yes
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4517200,57980,57.98,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4591325,28790,28.79,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,CC(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4540512,26340,26.34,No
CHEMBL4339289,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by MTT assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL63560,20440,20.44,No
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL1082407,190,0.19,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)NC(=O)c1cccc(OCC(O)CO)c1,Eur J Med Chem,CHEMBL4455196,740,0.74,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ccccc1,Eur J Med Chem,CHEMBL4473822,710,0.71,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1cccnc1,Eur J Med Chem,CHEMBL4566259,430,0.43,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ccc2cnccc2c1,Eur J Med Chem,CHEMBL4539360,510,0.51,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ccc2c(ccn2C)c1,Eur J Med Chem,CHEMBL4445977,490,0.49,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1cccc2ccccc12,Eur J Med Chem,CHEMBL4548677,870,0.87,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1cccc2cnccc12,Eur J Med Chem,CHEMBL4442652,870,0.87,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1cccc2cccnc12,Eur J Med Chem,CHEMBL4452587,790,0.79,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ncnc2ccccc12,Eur J Med Chem,CHEMBL4435083,510,0.51,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ncnc2ccccc12,Eur J Med Chem,CHEMBL4466577,970,0.97,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ncnc2nc[nH]c12,Eur J Med Chem,CHEMBL4470941,960,0.96,Yes
CHEMBL4362988,Antiproliferative activity against human LNCAP expressing AR assessed as reduction in cell viability incubated for 6 days by CCK-8 assay,C[C@H](Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)Nc1ncnc2nc[nH]c12,Eur J Med Chem,CHEMBL4585044,850,0.85,Yes
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL409,45300,45.3,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL63560,45200,45.2,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CSc1cccc(S(F)(F)(F)(F)F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4548907,25000,25,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CSc1ccc(F)cc1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4589651,26900,26.9,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL3185021,20900,20.9,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(S(F)(F)(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4467371,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1cccc(C(F)(F)F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4553602,24700,24.7,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4551430,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)cc1C(F)(F)F)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4585315,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)c(F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4576275,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1cccc(C(F)(F)F)c1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4525832,28800,28.8,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccccc1C(F)(F)F)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4552358,26300,26.3,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4436003,30000,30,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(COc1ccc(C#N)c(F)c1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4450371,83700,83.7,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(S(F)(F)(F)(F)F)cc1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4550957,29200,29.2,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1cccc(S(F)(F)(F)(F)F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4457017,31300,31.3,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4463808,20700,20.7,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4452812,21000,21,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4538927,92800,92.8,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1cccc(OC(F)(F)F)c1)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4573902,21700,21.7,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4442203,32600,32.6,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4518552,21800,21.8,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4536461,24900,24.9,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC1(C)C(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C(=S)N1c1cccc(S(F)(F)(F)(F)F)c1,Eur J Med Chem,CHEMBL4441685,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC1(C)C(=O)N(c2ccc([N+](=O)[O-])cc2C(F)(F)F)C(=S)N1c1ccc(S(F)(F)(F)(F)F)cc1,Eur J Med Chem,CHEMBL4517068,100000,100,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CC1(C)C(=O)N(c2ccc(S(F)(F)(F)(F)F)cc2)C(=S)N1c1ccc(C(F)(F)F)cc1,Eur J Med Chem,CHEMBL4553610,47400,47.4,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(S(F)(F)(F)(F)F)cc3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL4574240,23000,23,No
CHEMBL4367684,Antiproliferative activity against human LNCAP cells assessed as reduction in cell growth incubated for 96 hrs by propidium iodide based 2D monolayer assay,CNC(=O)c1ccc(N2C(=S)N(c3cccc(S(F)(F)(F)(F)F)c3)C(=O)C2(C)C)cc1F,Eur J Med Chem,CHEMBL4528674,25100,25.1,No
CHEMBL4391661,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by SRB assay,CC(=O)OC[C@H]1O[C@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OCc3cn([C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)nn3)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Eur J Med Chem,CHEMBL4593930,23840,23.84,No
CHEMBL4391661,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by SRB assay,C[C@]12CC[C@H](NC(=O)CNCCO)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O,Eur J Med Chem,CHEMBL4580052,130,0.13,Yes
CHEMBL4391661,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by SRB assay,C[C@]12CC[C@H](NC(=O)CO)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O,Eur J Med Chem,CHEMBL4450350,810,0.81,Yes
CHEMBL4391661,Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by SRB assay,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,Eur J Med Chem,CHEMBL428647,20960,20.96,No
CHEMBL4394443,Antiproliferative activity against human LNCAP cells measured after 96 hrs by celltiter-glo assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,J Med Chem,CHEMBL1082407,42370,42.37,No
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4445510,100,0.1,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,J Med Chem,CHEMBL4457064,60,0.06,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1,J Med Chem,CHEMBL2325741,178,0.178,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,CC(=O)NCC[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,J Med Chem,CHEMBL4460525,130,0.13,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCNS(C)(=O)=O)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,J Med Chem,CHEMBL4441416,50,0.05,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,CNC(=O)C[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,J Med Chem,CHEMBL4440965,50,0.05,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(O)CO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,J Med Chem,CHEMBL4567295,100,0.1,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,J Med Chem,CHEMBL4441825,60,0.06,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NCC(O)CO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4593086,660,0.66,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NCCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4554668,40,0.04,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3CCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4447158,80,0.08,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3CC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4589576,190,0.19,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,CNC(=O)C[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,J Med Chem,CHEMBL4475923,40,0.04,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(N)=O)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4438877,160,0.16,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)O)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4447967,640,0.64,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCn3cncn3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4519793,60,0.06,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCN3CCOCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4450403,410,0.41,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,COCC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,J Med Chem,CHEMBL4568343,250,0.25,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(O)CO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4470606,70,0.07,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4517950,160,0.16,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,J Med Chem,CHEMBL4451765,210,0.21,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,C=CC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,J Med Chem,CHEMBL4449509,160,0.16,Yes
CHEMBL4407363,Antiproliferative activity against human LNCAP cells,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,J Med Chem,CHEMBL3137336,70,0.07,Yes
CHEMBL4407612,Anticancer activity against human LNCAP cells after 72 to 102 hrs by MTT assay,O=C1c2ccccc2C(=O)c2oc(-c3cccc(Cl)c3)nc21,Eur J Med Chem,CHEMBL4537288,30,0.03,Yes
CHEMBL4411621,Cytotoxicity against human LNCAP cells expressing androgen receptor T877A point mutant assessed as reduction in cell viability after 48 hrs by MTS assay,CN(C)CCCn1c(=O)c2ccc3c(=O)n(CCCN(C)C)c(=O)c4c5[nH]c6ccccc6[nH]c5c(c1=O)c2c34.Cl.Cl,J Med Chem,CHEMBL4468209,140,0.14,Yes
CHEMBL4411621,Cytotoxicity against human LNCAP cells expressing androgen receptor T877A point mutant assessed as reduction in cell viability after 48 hrs by MTS assay,CN(C)CCN1C(=O)c2ccc3c4c(c(C#Cc5ccc(CN(C)C)c(O)c5)cc(c24)C1=O)C(=O)N(CCN(C)C)C3=O.Cl.Cl.Cl,J Med Chem,CHEMBL4526946,590,0.59,Yes
CHEMBL4411621,Cytotoxicity against human LNCAP cells expressing androgen receptor T877A point mutant assessed as reduction in cell viability after 48 hrs by MTS assay,CN(C)CCN1C(=O)c2ccc3c4c(c(NCCc5ccc(O)c(CN(C)C)c5)cc(c24)C1=O)C(=O)N(CCN(C)C)C3=O.Cl.Cl.Cl,J Med Chem,CHEMBL4565909,390,0.39,Yes
CHEMBL4412801,Growth inhibition of PSMA-positive human LNCAP cells,CCCC(=O)OCN(C(=O)[C@@H](NC(=O)[C@H]1CCCCN1C)[C@@H](C)CC)[C@H](C[C@@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(O)cc2)C[C@H](C)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)CC[C@@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)cs1)C(C)C,Eur J Med Chem,CHEMBL4542539,3,0.003,Yes
CHEMBL4427891,Antiproliferative activity against human LNCAP cells after 3 days by WST1 assay,CCCCCCCOc1c(-c2ccc(OC)c(OC)c2)oc2ccccc2c1=O,Bioorg Med Chem Lett,CHEMBL4287783,43900,43.9,No
CHEMBL4427891,Antiproliferative activity against human LNCAP cells after 3 days by WST1 assay,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Bioorg Med Chem Lett,CHEMBL50,45500,45.5,No
CHEMBL4431743,Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4060133,190,0.19,Yes
CHEMBL4431743,Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4091018,120,0.12,Yes
CHEMBL4431743,Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,J Nat Prod,CHEMBL517080,870,0.87,Yes
CHEMBL4431743,Cytotoxicity against human LNCAP cells after 72 hrs by resazurin-based colorimetric assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4075872,210,0.21,Yes
CHEMBL4432684,Antiproliferative activity against human LNCAP cells after 3 days by WST or trypan blue assay,O=C(/C=C/C=C/c1ccnc2ccccc12)/C=C/C=C/c1ccnc2ccccc12,Bioorg Med Chem,CHEMBL4450686,980,0.98,Yes
CHEMBL4432684,Antiproliferative activity against human LNCAP cells after 3 days by WST or trypan blue assay,Cn1c(/C=C/C=C/C(=O)/C=C/C=C/c2nc3ccccc3n2C)nc2ccccc21,Bioorg Med Chem,CHEMBL4447468,970,0.97,Yes
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,O=C(Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1)C(O)(CSc1ccccc1C(F)(F)F)C(F)(F)F,Eur J Med Chem,CHEMBL4572299,719,0.719,Yes
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4532191,42810,42.81,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4558409,80720,80.72,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4587862,28710,28.71,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4557725,26450,26.45,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(F)c(F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4549796,83040,83.04,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4584644,100000,100,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CSc1cccc(C(F)(F)F)c1)C(=O)Nc1ccc(C(F)(F)F)cc1,Eur J Med Chem,CHEMBL4544680,22560,22.56,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(F)cc1F)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4531189,37300,37.3,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4593765,100000,100,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccccc1C(F)(F)F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4482919,22600,22.6,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4520829,36510,36.51,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4582085,28610,28.61,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4578937,34722,34.722,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(F)c(F)c1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4583013,34800,34.8,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(F)cc1F)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4579902,30640,30.64,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4560812,27650,27.65,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1cccc(OC(F)(F)F)c1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4553533,63390,63.39,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccccc1OC(F)(F)F)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4566286,33830,33.83,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C#N)c(F)c1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4545276,78270,78.27,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(COc1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4518330,100000,100,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL409,45269,45.269,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4552713,20050,20.05,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4543957,42740,42.74,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4530734,31640,31.64,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4551595,100000,100,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4537113,25700,25.7,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4581759,91590,91.59,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4575675,32930,32.93,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4521349,32080,32.08,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4576047,74020,74.02,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4574383,38650,38.65,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4580927,29300,29.3,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4516905,20460,20.46,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4537876,100000,100,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1cc(C(F)(F)F)ccn1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Eur J Med Chem,CHEMBL4566975,45030,45.03,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CSc1ccc(F)cc1F)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4559439,25190,25.19,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL1738889,20900,20.9,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL63560,45196,45.196,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccccc1C(F)(F)F)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4575699,32230,32.23,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1F)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL4574316,42260,42.26,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4576691,85550,85.55,No
CHEMBL4477865,Antiproliferative activity against human LNCAP cells after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC1(C)C(=O)N(c2cccc(C(F)(F)F)c2)C(=O)N1c1ccccc1C(F)(F)F,Eur J Med Chem,CHEMBL4556561,28280,28.28,No
CHEMBL4477893,Antiproliferative activity against human LNCAP cells assessed as relative inhibition after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,O=C(Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1)C(O)(CSc1ccccc1C(F)(F)F)C(F)(F)F,Eur J Med Chem,CHEMBL4572299,828,0.828,Yes
CHEMBL4477893,Antiproliferative activity against human LNCAP cells assessed as relative inhibition after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL409,47266,47.266,No
CHEMBL4477893,Antiproliferative activity against human LNCAP cells assessed as relative inhibition after 96 hrs by propidium iodide staining based fluorescence 2D monolayer assay,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Eur J Med Chem,CHEMBL63560,47002,47.002,No
CHEMBL4478662,Antiproliferative activity against human LNCAP cells after 72 hrs by MTS/PMS assay,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,J Med Chem,CHEMBL4523032,900,0.9,Yes
CHEMBL4478662,Antiproliferative activity against human LNCAP cells after 72 hrs by MTS/PMS assay,Cl.Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,J Med Chem,CHEMBL4574111,130,0.13,Yes
CHEMBL4481514,Cytotoxicity against human LNCAP cells after 72 hrs by MTS assay,COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC,J Med Chem,CHEMBL4443342,650,0.65,Yes
CHEMBL4481514,Cytotoxicity against human LNCAP cells after 72 hrs by MTS assay,CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO,J Med Chem,CHEMBL4514780,99000,99,No
CHEMBL4482064,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CC[C@@]12CC(C(=O)OC)=C3Nc4cc5c(cc4[C@@]34CCN(C[C@H](O)[C@H]1O)[C@@H]24)[C@@H]1[C@H](O5)[C@@H](O)[C@@]2(CC)CC(C(=O)OC)=C3Nc4c(cc(O)c(OC)c4OC)[C@@]34CCN1[C@@H]24,J Nat Prod,CHEMBL4520335,300,0.3,Yes
CHEMBL4482064,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CC[C@]12C=CCN3CC[C@]4(C(=C(C(=O)OC)C1)Nc1cc5c(cc14)[C@@H]1[C@H](O5)[C@@H](O)[C@@]4(CC)CC(C(=O)OC)=C5Nc6c(cc(O)c(OC)c6OC)[C@@]56CCN1[C@@H]46)[C@@H]32,J Nat Prod,CHEMBL220132,900,0.9,Yes
CHEMBL4482064,Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay,CC[C@@]12CC(C(=O)OC)=C3Nc4c(cc(O)c(OC)c4OC)[C@@]34CCN([C@@H]3c5cc6c(cc5O[C@@H]3[C@H]1O)NC1=C(C(=O)OC)C[C@]35CCO[C@H]3CCN3CC[C@@]16[C@@H]35)[C@@H]24,J Nat Prod,CHEMBL4087281,300,0.3,Yes
CHEMBL4610549,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability,COc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(CCC(=O)NCCCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)cc13)C(=O)N2C,Bioorg Med Chem,CHEMBL4633483,620,0.62,Yes
CHEMBL4612440,Antiproliferative activity against human LNCAP cells incubated for 96 hrs by resazurin assay,O=C(CCCCCCCCNc1nc2cc(C(=O)O)ccc2c2cnccc12)NO.O=C(O)C(F)(F)F,ACS Med Chem Lett,CHEMBL4637976,66700,66.7,No
CHEMBL4612440,Antiproliferative activity against human LNCAP cells incubated for 96 hrs by resazurin assay,O=C(CCCCCCC(=O)Nc1ccccc1)NO,ACS Med Chem Lett,CHEMBL98,690,0.69,Yes
CHEMBL4619226,Suppression of AR-V7 expression in human LNCAP cells expressing GFP,CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](c3ccccc3)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C,ACS Med Chem Lett,CHEMBL4636182,132,0.132,Yes
CHEMBL4628894,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,CNc1c([N+](=O)[O-])c(-c2ccncc2)nc2ncnn12,Bioorg Med Chem Lett,CHEMBL4649271,31670,31.67,No
CHEMBL4628894,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,CNC1=C([N+](=O)[O-])C(c2ccc([N+](=O)[O-])cc2)Nc2ncnn21,Bioorg Med Chem Lett,CHEMBL4643263,28570,28.57,No
CHEMBL4628894,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,Bioorg Med Chem Lett,CHEMBL44657,31210,31.21,No
CHEMBL4629236,Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 24 hrs in presence of 1 uM CuSO4 by resazurin dye based assay,CCN(CC)C(=S)SCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)NC(C)=O)cc1,Bioorg Med Chem Lett,CHEMBL4632808,770,0.77,Yes
CHEMBL4683198,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTS assay,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC(C)=O)c(N5CCN(C(=O)[C@@H]6CCCN6C(=O)c6ccc7ccccc7n6)CC5)cc4[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL4745909,800,0.8,Yes
CHEMBL4683198,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTS assay,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OS(N)(=O)=O)c(N5CCN(C(=O)[C@@H]6CCCN6C(=O)c6ccc7ccccc7n6)CC5)cc4[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL4785329,900,0.9,Yes
CHEMBL4683198,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTS assay,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OP(=O)(O)O)c(N5CCN(C(=O)[C@@H]6CCCN6C(=O)c6ccc7ccccc7n6)CC5)cc4[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL4798007,600,0.6,Yes
CHEMBL4683198,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTS assay,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)c(C(=O)N5CCN(C(=O)[C@@H]6CCCN6C(=O)c6ccc7ccccc7n6)CC5)cc4[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL4798881,800,0.8,Yes
CHEMBL4685261,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@@H]1c2nnc(C)n2-c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1CC1CCCCC1,Eur J Med Chem,CHEMBL4747491,140,0.14,Yes
CHEMBL4685261,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CCOc1ccc(CN2c3nc(Nc4ccc(C(=O)NC5CCN(C)CC5)cc4OC)ncc3-n3c(C)nnc3[C@H]2CC)cc1,Eur J Med Chem,CHEMBL4794106,440,0.44,Yes
CHEMBL4685261,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@@H]1c2nnc(C)n2-c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1Cc1cccs1,Eur J Med Chem,CHEMBL4754471,880,0.88,Yes
CHEMBL4685261,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@@H]1c2nnc(C)n2-c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1Cc1ccsc1,Eur J Med Chem,CHEMBL4755667,710,0.71,Yes
CHEMBL4685261,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability after 72 hrs by MTT assay,CC[C@@H]1c2nnc(C)n2-c2cnc(Nc3ccc(C(=O)NN4CCN(C)CC4)cc3OC)nc2N1CC1CCCCC1,Eur J Med Chem,CHEMBL4749890,620,0.62,Yes
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4ccccc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4741896,21600,21.6,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,COc1c(Br)cc2c(c1Br)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4754276,85900,85.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4cc(Br)c(O)c(Br)c4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4761808,60400,60.4,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,COc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4743980,25900,25.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCOc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4797878,65900,65.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCCOc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4796924,20000,20,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,COC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4741784,55500,55.5,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CNC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4755108,43800,43.8,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCNC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4747377,32300,32.3,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCNC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4777380,20100,20.1,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4cc(F)c(C(=O)NC5CCCCC5)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4761408,84700,84.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(O)CNC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4763339,47500,47.5,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(CO)NC(=O)c1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4758058,34200,34.2,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,COC(=O)c1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4797655,58400,58.4,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CNC(=O)c1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4743380,36700,36.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCNC(=O)c1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4746920,29300,29.3,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4ccc(C(=O)NC5CCCCC5)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4744491,72300,72.3,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4ccc(C(=O)NCCO)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4791149,29100,29.1,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(CO)NC(=O)c1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4740951,44900,44.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4ccc([N+](=O)[O-])cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4790608,75700,75.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4ccc(N)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4748550,44700,44.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(=O)Nc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4786561,23100,23.1,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCC(=O)Nc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4761532,22900,22.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCC(=O)Nc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4791036,34200,34.2,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CS(=O)(=O)Nc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4776844,90200,90.2,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCCS(=O)(=O)Nc1ccc2c(c1)CN1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1C2,Eur J Med Chem,CHEMBL4781936,84100,84.1,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4cc(F)c([N+](=O)[O-])cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4744836,29000,29,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,N#Cc1ncc(N2C(=O)C3Cc4cc(F)c(N)cc4CN3C2=S)cc1C(F)(F)F,Eur J Med Chem,CHEMBL4746710,32100,32.1,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4785113,28300,28.3,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4762739,27700,27.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4753830,27900,27.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CS(=O)(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,Eur J Med Chem,CHEMBL4747097,79000,79,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(=O)Nc1ccc2c(c1)N1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1CC2,Eur J Med Chem,CHEMBL4747326,89700,89.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCC(=O)Nc1ccc2c(c1)N1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1CC2,Eur J Med Chem,CHEMBL4749354,48800,48.8,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCC(=O)Nc1ccc2c(c1)N1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1CC2,Eur J Med Chem,CHEMBL4746330,46000,46,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCCS(=O)(=O)Nc1ccc2c(c1)N1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1CC2,Eur J Med Chem,CHEMBL4751937,48700,48.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCOC(=O)Nc1ccc2c(c1)N1C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C1CC2,Eur J Med Chem,CHEMBL4783690,35700,35.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CC(=O)Nc1ccc2c(c1)CCC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N21,Eur J Med Chem,CHEMBL4761470,41200,41.2,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCC(=O)Nc1ccc2c(c1)CCC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N21,Eur J Med Chem,CHEMBL4795696,39900,39.9,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCC(=O)Nc1ccc2c(c1)CCC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N21,Eur J Med Chem,CHEMBL4794414,32500,32.5,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCCCS(=O)(=O)Nc1ccc2c(c1)CCC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N21,Eur J Med Chem,CHEMBL4797257,54700,54.7,No
CHEMBL4686001,Antiproliferative activity against human LNCaP cells assessed as reduction in cel viability after 72 hrs by MTT assay,CCOC(=O)Nc1ccc2c(c1)CCC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N21,Eur J Med Chem,CHEMBL4783767,23700,23.7,No
CHEMBL4687443,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability incubated for 6 days by cell-titer glo assay,COC(=O)c1ccc(CN2CCC(O)(Cn3cnc4c(-c5ccc(CN)cc5)n(C)nc4c3=O)CC2)c(Cl)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,Eur J Med Chem,CHEMBL4762640,29.6,0.0296,Yes
CHEMBL4687443,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability incubated for 6 days by cell-titer glo assay,C[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CN)cc4)n(C)nc3c2=O)CC1)c1ccccc1.O=C(O)C(F)(F)F,Eur J Med Chem,CHEMBL4750176,20.1,0.0201,Yes
CHEMBL4699934,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability in presence of Cu2+ incubated for 72 hrs by cell titer-glo luminescent cell viability assay,CN(C)C(=S)NN=Cc1nccc2cc(F)ccc12,RSC Med Chem,CHEMBL4764390,1,0.001,Yes
CHEMBL4709119,Antiproliferative activity against androgen-positive human LNCaP cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCCCCn1cc(COCCOCCOC(=O)CC23CC4CC(CC(C4)C2)C3)nn1,Eur J Med Chem,CHEMBL4787330,33890,33.89,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc2cc([C@H](C)C(=O)NNC(=S)Nc3ccc(C(F)(F)F)cc3)ccc2c1,Eur J Med Chem,CHEMBL4745543,92800,92.8,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc2cc([C@H](C)c3nnc(SCc4ccccc4)n3-c3ccc(Cl)cc3)ccc2c1,Eur J Med Chem,CHEMBL4791713,50400,50.4,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc2cc([C@H](C)c3nnc(SCc4ccc(F)cc4)n3-c3ccc(Cl)cc3)ccc2c1,Eur J Med Chem,CHEMBL4761950,33900,33.9,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc2cc([C@H](C)c3nnc(SCc4ccc(C)cc4)n3-c3ccc(Cl)cc3)ccc2c1,Eur J Med Chem,CHEMBL4778199,52200,52.2,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc(CSc2nnc([C@@H](C)c3ccc4cc(OC)ccc4c3)n2-c2ccc(F)cc2)cc1,Eur J Med Chem,CHEMBL4776724,22760,22.76,No
CHEMBL4711329,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay,COc1ccc2cc([C@H](C)c3nnc(SCc4c(Cl)cccc4Cl)n3-c3cccc(Cl)c3)ccc2c1,Eur J Med Chem,CHEMBL4789635,73700,73.7,No
CHEMBL4712300,Cytotoxicity against human LNCAP cells incubated for 48 hrs clonogenic survival assay,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCCCCCCCCCCNC(=O)[C@@H](N)CC(C)C)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,J Med Chem,CHEMBL278911,14,0.014,Yes
CHEMBL4712353,Antiproliferative activity against human LNCaP cells incubated for 72 hrs by CCK8 assay,CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13C2=O,J Med Chem,CHEMBL205190,10,0.01,Yes
CHEMBL4713832,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability,CC(O)(C[S+]([O-])c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Bioorg Med Chem Lett,CHEMBL4779433,25550,25.55,No
CHEMBL4713832,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability,CC(O)(C[S+]([O-])c1ccc(F)cc1F)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F,Bioorg Med Chem Lett,CHEMBL4760488,24402,24.402,No
CHEMBL4713832,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability,CC(O)(C[S+]([O-])c1ccc(OC(F)(F)F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL4783997,36240,36.24,No
CHEMBL4713832,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability,CC(O)(C[S+]([O-])c1ccc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL4756981,95430,95.43,No
CHEMBL4713832,Antiproliferative activity against human LNCaP cells assessed as reduction in cell viability,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,Bioorg Med Chem Lett,CHEMBL409,45200,45.2,No
CHEMBL4767061,Antiproliferative activity against AR-positive human LNCAP cells assessed as reduction in cell viability incubated for 96 hrs by cell-titer glo assay,Cc1noc2c(Br)cc(-c3nc4ccc(N5CCOCC5)cc4n3CC3CCCCC3)cc12,J Med Chem,CHEMBL4782221,570,0.57,Yes
CHEMBL4767061,Antiproliferative activity against AR-positive human LNCAP cells assessed as reduction in cell viability incubated for 96 hrs by cell-titer glo assay,Cc1noc2ccc(-c3nc4ccc(N5CCOC[C@@H]5C)cc4n3CC3CCCCC3)cc12,J Med Chem,CHEMBL4791634,470,0.47,Yes
CHEMBL4767061,Antiproliferative activity against AR-positive human LNCAP cells assessed as reduction in cell viability incubated for 96 hrs by cell-titer glo assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,J Med Chem,CHEMBL1082407,33840,33.84,No
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,CN(CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12)CCCNc1ccc([N+](=O)[O-])c2[nH]c3ccc(O)cc3c(=O)c12,Eur J Med Chem,CHEMBL4791381,53,0.053,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,O=c1c2cc(O)ccc2[nH]c2c([N+](=O)[O-])ccc(NCCCN3CCN(CCCNc4c5ccccc5nc5cccc([N+](=O)[O-])c45)CC3)c12,Eur J Med Chem,CHEMBL4781429,117,0.117,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc(NCCNCCNc2c3ccccc3nc3cccc([N+](=O)[O-])c23)c2c(=O)c3ccccc3[nH]c12,Eur J Med Chem,CHEMBL4788208,250,0.25,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc(NCCCN2CCN(CCCNc3c4ccccc4nc4cccc([N+](=O)[O-])c34)CC2)c2c(=O)c3cc(O)ccc3[nH]c12,Eur J Med Chem,CHEMBL4791829,84,0.084,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCNCCNc3ccc(C)c4[nH]c5ccccc5c(=O)c34)c3ccccc3nc12,Eur J Med Chem,CHEMBL4800638,250,0.25,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCCN3CCN(CCCNc4ccc(C)c5[nH]c6ccc(O)cc6c(=O)c45)CC3)c3ccccc3nc12,Eur J Med Chem,CHEMBL4783708,300,0.3,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCCN(C)CCCNc3ccc([N+](=O)[O-])c4[nH]c5ccc(O)cc5c(=O)c34)c3ccccc3nc12,Eur J Med Chem,CHEMBL4777375,377,0.377,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCCNCCCNc3ccc([N+](=O)[O-])c4[nH]c5ccc(O)cc5c(=O)c34)c3ccccc3nc12,Eur J Med Chem,CHEMBL4784311,123,0.123,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCCNCCCNc3ccc(C)c4[nH]c5ccccc5c(=O)c34)c3ccccc3nc12,Eur J Med Chem,CHEMBL4786611,213,0.213,Yes
CHEMBL4773128,Cytotoxicity against human LNCaP cells assessed as reduction in cell viability measured after 72 hrs by SRB assay,Cc1ccc([N+](=O)[O-])c2c(NCCCN(C)CCCNc3ccc(C)c4[nH]c5ccccc5c(=O)c34)c3ccccc3nc12,Eur J Med Chem,CHEMBL4791145,197,0.197,Yes
CHEMBL4817579,Antiproliferative activity against AR-positive human LNCaP cells assessed as reduction in cell viability incubated for 3 days by MTT assay,CCCS(=O)(=O)Nc1ccc(-c2cc(=O)c3c(O)cc(OC)c(OC(C)C)c3o2)cc1,Eur J Med Chem,CHEMBL4870009,30500,30.5,No
CHEMBL4817579,Antiproliferative activity against AR-positive human LNCaP cells assessed as reduction in cell viability incubated for 3 days by MTT assay,COc1cc(O)c2c(=O)cc(-c3ccc(NC(=O)N4CCCNCC4)cc3)oc2c1OC(C)C,Eur J Med Chem,CHEMBL4852825,22500,22.5,No
CHEMBL4819325,Antiproliferative activity against human LNCaP cells,COC(=O)c1ccc(-c2cn(CC(=O)O[C@H]3c4cc5c(cc4[C@@H](c4cc(OC)c(OC)c(OC)c4)[C@H]4C(=O)OC[C@@H]43)OCO5)nn2)cc1,Eur J Med Chem,CHEMBL4438840,19.6,0.0196,Yes
CHEMBL4821230,Antiproliferative activity against androgen-insensitive human LNCaP cells assessed as reduction in cell viability incubated for 3 days by WST-1 assay,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,Bioorg Med Chem Lett,CHEMBL92,0.2,0.0002,Yes
CHEMBL4830070,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1,J Med Chem,CHEMBL4556790,610,0.61,Yes
CHEMBL4830070,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1,J Med Chem,CHEMBL2325741,460,0.46,Yes
CHEMBL4837997,Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,C=C/C=C/[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,Eur J Med Chem,CHEMBL4865990,28800,28.8,No
CHEMBL4837997,Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,C=C/C=C/[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)C(=O)CC[C@H]3[C@H]12,Eur J Med Chem,CHEMBL4849840,33500,33.5,No
CHEMBL4837997,Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,C[C@]12CC[C@H]3[C@@H]([C@H](/C=C/C=C/C=C/[C@@H]4CC5=CC(=O)CC[C@]5(C)[C@H]5CC[C@]6(C)[C@H](O)CC[C@H]6[C@H]45)CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@H]2O,Eur J Med Chem,CHEMBL4864434,37100,37.1,No
CHEMBL4837997,Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,C[C@]12CCC(=O)C=C1C[C@@H](/C=C/C=C/C=C/[C@@H]1CC3=CC(=O)CC[C@]3(C)[C@H]3CC[C@]4(C)C(=O)CC[C@H]4[C@H]13)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,Eur J Med Chem,CHEMBL4871524,72700,72.7,No
CHEMBL4837997,Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,Eur J Med Chem,CHEMBL139835,59600,59.6,No
CHEMBL4842238,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,J Nat Prod,CHEMBL53463,20,0.02,Yes
CHEMBL4842238,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@H]4O[C@]45[C@@H](OC(C)=O)C=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)C1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4862877,920,0.92,Yes
CHEMBL4842238,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4[C@@H](OC(C)=O)C=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)C1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4850712,680,0.68,Yes
CHEMBL4842238,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4[C@@H](O)C=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)C1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4864487,350,0.35,Yes
CHEMBL4842238,Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@H](O)[C@]45O[C@H]4C=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)C1CC(C)=C(C)C(=O)O1,J Nat Prod,CHEMBL4876149,530,0.53,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CC1(C)[C@H](NC(=O)c2ccc(N3CCN(CC4CN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)C4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL4747369,10,0.01,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CC1(C)[C@H](NC(=O)c2ccc(N3CCN(C4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL4861919,11,0.011,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CC1(C)[C@H](NC(=O)c2ccc(N3CCN(CC4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL4877348,5,0.005,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CC1(C)[C@H](NC(=O)c2ccc(N3CCC(N4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL4879244,14,0.014,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CC1(C)[C@H](NC(=O)c2ccc(N3CCC(CN4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1,J Med Chem,CHEMBL4867584,13,0.013,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CN1C(=O)CCC(N2C(=O)c3ccc(N4CCC(CN5CCN(c6ccc(C(=O)N[C@H]7C(C)(C)[C@H](Oc8ccc(C#N)c(Cl)c8)C7(C)C)cc6)CC5)CC4)cc3C2=O)C1=O,J Med Chem,CHEMBL4849514,237,0.237,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CN1CCN(c2ccc(C(=O)N[C@H]3C(C)(C)[C@H](Oc4ccc(C#N)c(Cl)c4)C3(C)C)cc2)CC1,J Med Chem,CHEMBL4863542,81,0.081,Yes
CHEMBL4844396,Growth inhibition of human LNCaP cells assessed as cell viability measured after 4 days in presence of R1881 by WST-8 assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,J Med Chem,CHEMBL1082407,133,0.133,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6cc7c(cc6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)nn3)CC2)cc1Cl,J Med Chem,CHEMBL4862963,33.1,0.0331,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,J Med Chem,CHEMBL1082407,133,0.133,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCC(N4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)CC1,J Med Chem,CHEMBL4849315,15.3,0.0153,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCN(C4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)CC1,J Med Chem,CHEMBL4854467,22.3,0.0223,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCN(CC4CN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)C4)CC3)cc2)CC1,J Med Chem,CHEMBL4862569,11.4,0.0114,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCN(C4CN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)C4)CC3)cc2)CC1,J Med Chem,CHEMBL4870803,16.2,0.0162,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CC(CN4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C3)cc2)CC1,J Med Chem,CHEMBL4849497,11.6,0.0116,Yes
CHEMBL4844615,Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CC(N4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C3)cc2)CC1,J Med Chem,CHEMBL4872965,21.7,0.0217,Yes
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCCN(CCC)c1ccc(C=O)cc1Br,J Med Chem,CHEMBL5083058,25000,25,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCCN(CCC)c1ccc(C=O)cc1[N+](=O)[O-],J Med Chem,CHEMBL5082977,31000,31,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,O=Cc1ccc(N2CCCCC2)c(Cl)c1,J Med Chem,CHEMBL5093639,37000,37,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,O=Cc1ccc(N2CCCCC2)c(Br)c1,J Med Chem,CHEMBL5086855,46000,46,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCN(CC)c1ccc(C=O)cc1Br,J Med Chem,CHEMBL5093580,47000,47,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCCN(CCC)c1ccc(C=O)cc1OC,J Med Chem,CHEMBL5089352,50000,50,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,Cc1cc(C=O)ccc1N1CCCCC1,J Med Chem,CHEMBL5086460,61000,61,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCCN(CCC)c1ccc(C=O)cc1C,J Med Chem,CHEMBL5088513,61000,61,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,CCCN(CCC)c1ccc(C=O)cc1,J Med Chem,CHEMBL5082115,73000,73,No
CHEMBL5049247,Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay,O=Cc1ccc(N2CCOCC2)c(Br)c1,J Med Chem,CHEMBL5086212,82000,82,No
CHEMBL5052974,Antiproliferative activity against human LNCaP cells after 4 hrs by CCK-8 assay,Cc1nnc(SCC(=O)c2ccccc2)o1,,CHEMBL5079937,34600,34.6,No
CHEMBL5052974,Antiproliferative activity against human LNCaP cells after 4 hrs by CCK-8 assay,Cc1nnc(NCC(=O)c2ccccc2)s1,,CHEMBL5094989,34600,34.6,No
CHEMBL5052974,Antiproliferative activity against human LNCaP cells after 4 hrs by CCK-8 assay,CC(=O)CSc1nnc(-c2cccnc2)o1,,CHEMBL5082772,34600,34.6,No
CHEMBL5052974,Antiproliferative activity against human LNCaP cells after 4 hrs by CCK-8 assay,O=C(CSc1nnc(-c2ccncc2)o1)c1ccccc1,,CHEMBL2035238,34600,34.6,No
